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Earlier work on the biosynthesis of morphine in the opium 
poppy, Papaver somniferum, is reviewed in Chapter I. 
A variety of urmatural codeine precursors, closely related 
structurally to codeine and labelled with 3H at C-2, have been 
prepared and administered to P.somn1ferum plants. Thcir !!::. vivo 
J-Q-demethylation to give the corrP.sponding morphine compounds 
was investigated using radiodllution techniques. Each of the 
feedirig experiments utilised [N-methyl_14C]codeinc as an 
internal standard and the efficiency of the-unnatural J-Q-
demethylations was compared with that observed for thc natural 
conversion of codeine into morphine. Dihydrodesoxycodeine was 
more efficiently converted into dihydrodesoxymorp1inc than was 
codeine into morphine. The least efficiently demcthylated 
urmatural precursor of the series v/as I-bromocodeine. The 
efficient metabolism of dihydrodesoxycodeine suggested that the 
presence of a secondary alcohol group at c-6 was not itlportant 
for the enzymic demethylation. However de methylation of dihydro-
codeine occurred but "as more efficient than for isocodeine. 
As part of this investigation, anew, high yield (69:~) preparation 
of isocodeine from codeine via codeine toluene-£-sulphonate was 
developed. Codeine methyl ether was also fed to P.somniferum 
plant" and shol<n to be converted into morphine methyl ether, 
and into codeine and morpune. Biological methylation of 
14 [N-methyl- C]codeine, to give codeine methyl ether, i'Tas also 
observed, suggesting that codeine methyl ether is a natural 
alkaloid of P.somniferum. 3 110. vlhen [2- H,N-methyl- 'c ]codeine was 
(i) 
3 f i ' fed to the plants the H TC ratios of the isolated codeine 
and morphine were slightly lar~r and significantly different 
(statistically) from that of the codeine precursor. This may 
be due to some de-~-methylation occurring during metabolism. 
The rearrangement of thebaine and its metho-salts in 
concentrated hydrochloric acid and trifluoroacetic acid has 
been investigated and shown to involve red oxonium ion 
intermediates. Quaternary salts of 7,8-dehydrometathcbainone 
have been isolated and characterised. 
(ii ) 
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Chapter 1: 
aeview of the Literature on 
Morphine Biosynthesis. 
1 
Investigations'and speculation on the biosynthetic 
mechanisms ror alkaloid tormation in plants have been ot great 
interest to organic chemists tor the last titty years. The 
experience and knowledge gained in the study ot plant 
biosynthesis has contributed a great dealto our understanding 
ot the chemistry in living systems, and has been further 
extended most recently in the study ot the biosynthetic 
mechanisms ot micro-organisms. 
One ot the th'st methods used to investigate the 
biosynthesis ot a given alkaloid, was to study it's synthesis 
!2 vitro bYbringino together possible highly reactive 
precursors under pseudo-physiological conditions1• This 
procedure very otten produced the correct alkaloid, but was 
open to the criticism that the !2 vitro conditions did not 
parallel exactly with those round in the plants. With the 
increased availability and experience ot simple organic 
molecules containing isotopic atoms (normally 3" and 14C both 
ot which have conveniently long halt lives) the most 
signiticant and rewarding method tor the investigation or 
alkaloid biosynthesis was developed. Here radioactively 
labelled compounds which, usually tram consideration ot 
structural relationships, were thought to be likely 
2 precursors ot the alkaloid were ted directly to the plant • 
Isolation ot the alkaloid and it's radiochemical assay were then 
used to produce evidence tor biosynthetic pathways. 
Although the !2 !!!!2 synthetic experiments were incapable 
or proving a biosynthetic pathway,.or even the involvement 
ot a given compound as a precursor, they have certainly suggested 
directions tor research using the radiotracer techniques. 
2 
One examnle, on whtClh tl groAt dQal ot" work h."'ls been carried 
out, and which is of direct concern here, is the biosynthesis 
of the morphine alkaloids in the opium poppy, Papaver 
somniferum. A very detailed kno,fledge of the biosynthetic 
pathway to morphine has been gained from tracer experiments, 
and probably more is known than for any other group of 
alkaloids. 
Cultivation of the plant Papaver somniferum dates back to 
the stone ages, a",: the use of opium, the dried exudate of the 
unripe seed capsule, as a medicine is mentioned in "Ebers 
Popyrus" which is thought to have been written in l550B.C.3 
Morphine was first isolated from opium as a pure crystalline 
material in 1805 by SertUrner". Morphine also occurs5 in the 
blue poppy Fructus papaveris, Papaver orientate, and Papaver 
spinosum. 
The correct structure for morphine was first postulated by 
Gullnnd and Robinson6 in 1923, and its validity hos since-been 
established by two independent syntheses of the molecule7,8, and 
by X-ray analysis9 of morphine hydroiodide. The complex 
structure of morphine (1). raises the interesting problem of how 
it is constructed in the opium poppy. The problem was first 
discussed by Gulland and Robinson, who, in 1925, put forward a 
10 
very important structural proposal • They suggested that if 
the bonds indicated by x and y in the morphine molecule 
(la 1 R=Me) are broken, and the tetrahydroisoquinoline residue 
rotated about the axis indicated, the carbon skeleton obtained 
(21 R=H) rosembles that of an unsubstituted l-benzylisoquinoline 
1 
system (3; R=R =H). Robinson further postulated that morphine 
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was formed in the plant by sorne sort of oxidative ring closure 
of the l-benzylisoquinoline system, thus establishing a 
theoretical relationship between morphine and the 
benzylisoquinolines. More recently, a further important 
proposal came from Barton and Cohen11 ,mo, en the basis of 
12 
earlier work with Pummerer's ketone ,suggested that the 
C-12-C-13 bond of morphine was formed by phenol oxidative 
coupling of a suitably protected I-benzylisoquinoline. They 
suggested that tha base reticuline (3a; R~e, Rl=H) underwent 
a one-electron oxidation to generate a diradical which, by 
coupling, would yeild the dienone (4). The fifth ring could 
then be formed as indicated and, finally, adjustment of the 
oxidation level of the base (5) would afford the 
hydrophenanthrene alkaloids of opium • 
• (Number refers to structures found only in this chapter) 
l-Benzylisoquinolines (3) are well known, and several 
have been isolated from the opium poppy, ~. reticuline 
itself (3; R=Me, R1=H). It had been suggested in 1910 by 
Uinterstein and Trier1' that l-benzylisoquinolines, !:..Il. 
norlaudanosoline (3; R=R1=H), were themselves derived by the 
combination of t~.C6-C2 units (Ar-C-C). The two units they 
suggested were 3,4-dihydroxyphenylacetaldehyde (6) and 
3,4-dihydroxyphenethylamine (7) (dopamine), since a Mannich 
condensation of the two i2 vitro provided a biogenetically 
modelled synthesis of the benzyltetrqhydroisoquinoline 
skeleton. Both 3,4-dihydroxyphenYlacetaldehyde and 
3,4-dihydroxyphenethylamine were thought to be derivable from 
3,4-dihydroxyphenylalanine(dopa) (8). Further,it was thought 
5 , 
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· ., . 14 that dopa arOBO in nll1nt:o. o.s 1 t rlo{'!CJ ~n lln..l.mal t. J.SOUOB , 
by hTdraxylation o£ the essential amino acid tyrosine (9), 
which has itself been detected15 in the opium poppy. Thus a 
great deal of sound speculation and theoretical knowledge 
"as available, and the problem of morphine biosynthesis was 
ripe for experimental investigation. 
The first experimental results, designed to test the 
16 general hypothesis, were reported by Battersby and, 
independently, by Leetel7 • Both groups of workers fed 
Papaver somniferurn plants with DL-[2_14cJtyrOSine (9), and 
after about a two week period for metabolis~ isolated the 
morphine, which was found to be radioactive. The activity 
,ms retained even after rigorous purification, and 
represented a 0.7 to 1.7% incorporation (Battersby) and 
0.01 to 0.02% (Leete) of the.precursor into morphine. 
According to the original theory.the radiocarbon 
originating from f2-14c]tyrosine should reside only at the 
C-9 and C-16 positions in the morphine molecule (1). The 
most satis£ying chemical degradative work on the radioactive 
16 18 
morphine was carried out by Battersby , • He showed that 
approximately half the total activity was at position c-16 
while the other hal£ resided at position C-9. The isolation 
of c-16 was carried out by methylation of the active 
morphine to give codeine methyl ether methiodide (11). 
Hofmann elimination cleaved the nitrogen to C-9 bond and 
the ~ethine VaS hydrogenated to yeild tetrahydrocodeinemethine 
methyl ether (12). Further Hofmann degredation gave inactive 
trimethylamine and the morphenol derivative (13) which was 
.., 
degraded by cieiiVage of th<i derived GlyCoL Thus formaldehyde 
was obtained containing c-16 of the morphine. The remainder 
of the original morphine molecule was isolated as the 
oxime (14), and the relative activities "ere detennined. 
Isolation of the carbon atom at position-9 involved 
conversion of the radioactive morphine into acetylmethylrnorphol 
(15), which was then oxidised with chromium trioxide to the 
quinone (16). The quinone (16) was oxidised with peracetic 
acid to give the diphenic acid (17) as the major product. 
Treatment of the acid (17) with concentrated sulphuric acid 
gave the coumarin (18). Hydrolysis of the coumarin (18) 
followed by methylation released the required carboxyl group 
to give the acid (19). Dscarbo~lation gave carbon dioxide 
representing C-9 of the radioactive morphine. The carbon 
dioxide was collected as barium carbonate and the activity 
determined. The remaining part of the molecule (20) was 
found to be radio-inactive. Thus tyrosine had been incor-
porated into morphine without scrambling of the radiocarbon 
label. 
16 17 ,.. 14;'1 Both Battersby and Leete also fed DL- l 2- CJpheny-
lalanine (10) and observed incorporation into morphine, but 
to a much smaller extent than that for DL-[2_14C] tyrosine. 
This WaS not thought to be unreasonable since, although 
phenylalanine is a known precursor for tyrosine19, the 
efficiency of conversion of the former into the latter is 
20 known to be low in higher plants • 
Paralle I experiments in which 3 ,4.dihydroxyphen [1_14C] 
ethylamine was fed to the poppy plants were reported by 
8 
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21 Battcrsby ~ld s~pnrately by Loeto. Both observed 
incorporation of radioactivity into l!Io_,:",phine, and 
degradation by the ~ethodz already described showed that 
the radiocarbon resided only at position c-16 of the 
~olecule (1). These results suggest that two different 
units are used by the plant to build the opi1lr.l alkaloids, 
and that one of the~ is likely to be dopamine (7) 
obtainable from dopa by decarboxylation. The other 
C6-G2 unit may be derived from a C6-C3 
intermediate 
(Ar-C-C-CO H). Probably the most favoured22 candidate 2 
being 3,4-dihydroxyphenylpyruvic acid, although proof of 
this is still lacking. 23 It has been shown reoently however 
thato(-keto acids are involved in the biosynthesis of the 
tetrahydroisoquinoline alkaloids, anhalamine ( 21 ) and 
anhalonidine ( 22 ), in peyote cactus (Lophophora vli11irunsii). 
3-Hydroxy-4,5-dimethoxyphenethylamine (23), known to serve as 
an excellent precursor for both (21) and (22), reacts readily 
with pyruvic acid and glyoxylic acid to give the respective 
amino acids (24) and (25). Fresh slices of peyote were used 
to show that the enzymes present were capable of decarboxylat-
ing both peyoruvic acid (24) and peyoxylic acid (25). The 
yeilds of [14c]carbon dioxide obtained in these experiments, 
using the racemates of the carboxyl-labelled acids (24) and 
(25), suggested that decarboxylation was stereo-specific. 
Further, [1_14c]peyoruvic acid and[I,9-14clpeYOXYliC acid 
were administered in separate experiments to intact peyote 
cacti. The anhalonidine (22) isolated from the cacti fed with 
[1_14cJpeyoruvic acid was radioactive, and all the activity 
11 
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was shown to rcsic!<:.: at C-l. Similarly, ::-adioactive 
anha1amine (21) was isolated from the c~cti fed with 
(1,9-14cJpeyoXYlic acid, end degradation showed the radio-
label >tas confined to C-l as expected. 
In the experiments already described, t.he conversion 
of the labelled precursor into morphine was fairly 10>1 
(~. 1%), this is not surprising and certainly did not 
invaiidate the results. It may well be that the precursor is 
inefficeintly absorbed by the plant, or it may be converted 
into substances which are unrelated to the observed end pro-
ducts. 'fhe difference in incorporation of tyrosine into 
11 
morphine observed by Battersby16 (~. 1%) and Leete (~. 0.02%) 
Can be explained by the different feeding methods employed. 
Leetc introduced the precursor ~ the inorganic nutrient 
solution in which the poppies were growing, while Battersby 
utilised the more direct method of injection into the seed 
capsules. The latter seems the most successful method, and 
overcomes sorne of the absor~tion problems. 
Although most of the degradative work described so far 
was carried out on morphine, the workers also observed 
conversion of tyrosine into the other two major alkaloids 
of the opium poppy, codeine (26) and thebaine (27). These 
two terminal alkaloids contain, respectively, one and two 
methyl groups more than morphine, and it was not certain 
which of the alkaloids was the pregenitor of the others in 
tLe series. 24 The c~only held concept was that 2-methylated 
alkaloids were the rn . "tabolic end products: thus the series 
would be morphine, codeine, thebaine. However, if the original 
13 
11 proposa.l of Barton and Cohen lV'Q.S cCl"ract the fully 
methylated alkaloid thebaine should h1>73 been the fir3t in 
the ser:tes, followed by codeine and morphine. Initial 
evidence was provided by rate studies carried out by 
Battersby25 and also Rapoport26 • The approach adopted by 
Batternby tlas to feed a total of forty five plants with 
(2_14CJ tyrosine. Batches of five plants were harvested at 
given times ranging from 4h.to 14 days, and the total 
activities of the isolated thebni:1e, codeine, and morphine 
deterr.tined for each batch. The result.::J sllowed an intial 
rapid incorporation of activity into thebaine followed, over 
a longer period of time, by a rise in the codeine activity. 
This ,""s followed by a steady fall in the activities of 
thebaine and codeine relative to a rapid increase in the 
activity of the morphine. The results suggested that the 
biosynthetic pathway went from thebaine, through codeine, 
to morphine the end product of the synthesis. Rapoport 
on the other hand, exposed mature opium poppies to [14c) 
carbon dioxide atmosphere for selected periods of time. 
The thebaine, codeine, and morphine isolated were randomly 
labelled with carbon-14. Comparison of the total activity 
present in each of the three alkaloi~s, for each of the 
exposure experiments suggested the biosynthetic pathway was 
thebaine --+ codeine --+ morphine. Further work by 
27,28 " . Rapoport provided the most conV1nC1:1g ev,dence that the 
abLve pathway was correct. Samples of thebaine, coceine, and 
t:lorphine, generally labelled with carbon"'14, WG1"e fed 
separately to plants by root absorption. The plant fed with 
14 
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thebaine showeG incoz-poratioa er rc.(~int.'lc-tivity into both 
codeine and morphine, ,mile th9 plant ,~ed with code in", 
showed incorporation of radioactivity only into morphine 
and not thebaine. Morphine itself was not converted into 
either of the other two alkaloids. Thus this section of the 
biosynthetic pathway was shown to involve successive 
Q-dernethylation in going from thebaine to mO:'phine, giving 
11 further ,.eight to the proposals of Barton and Cohen • 
The first st~p29,30,3l, to investi~ate the biosyn~hetic 
intermediates between tyrosine (or suitable C6-C2 units) and 
thebaine, was to feed to the opium poppies (:!:)_.{1_14c] 
norlaudanosoline (28&:;Ial R=R1=R2=H) and (:!:)':[3_14c]norlaudanos_ 
oline (28; R=R1=R2=H), since it was reasoned that this waS 
the l-benzylisoquinoline most likely to be formed first 13 ,32 
in the plant. Both the labelled 1-benzylisoquinoline 
precursors were incorporated into morphine with efficiencies of 
3.9% and 2.2% respectively. These values were higher than 
those observed for (:!:)_[2_14C)tyrOSine fed under similar 
conditions (~. 0.66-1.7%). This was in keeping with 
norlaudanosoline's standing closer t~~n tyrosine to the final 
alkaloids. The morphine isolated from the plants fed <lith 
(!)-[l-14c]norlaudanosoline was degraded by way of the 
Q-acetYlmethylmorphol (15) already described. This ebQwud, 
oS expected, that the radiocarbon was located only at position 
C-9 in the morphine molecule (1). From the plants fed with 
(~)-[3-14clnorlaudanosoline, the isolated radioactive 
thebaine (27) was degraded by conversion first into thebenine 
(29) by treatment with aqueous acid. Complete 2. and ~-
methylation of (29) followed by Hofmann degradation gave the 
16 
as f~nnaldehyde containing, as expected, all the radiofJ.ctivity. 
Thus, the relatively high ;.ncorporation of 
(:}-norlaudanosoline into thebaine, code:'l1i:: i and morphinr.~, 
without randomisation of the labels, made it highly probable 
that this l-benzylisoquinoline lay on the direct 
biosynthetic pathway. 
l'lith thebaine finnly identified as the first 27 ,28 of 
the hydrophenanthre~e alkaloids to be fo~ed, it was not 
unreasonablo to conclude that norlaudanosoline was suitably 
methylated before being converted into thebaine. According 
to previous suggestions11 reticuline (28; R1cH, RcR2=Me) 
would be the required hase. Aqueous solutions of 
{!)-[3-14c]nor-reticuline (28; R=Me, R1cR2cH) and 
{!)-(3-14CJreticuline (28; R1cH, R=R2=~le) were injected 
separately into P. somniferum plants, and it Was found that 
those precursors were incorporated30,31 efficiently into 
the hydrophenanthrene alkaloids. Both {!)-[3-14c]reticuline 
(7.3% incorporation into morphine) and 
{!)-IJ-14C)nor-reticuline (3.6% incorporation into morphine) 
gave higher incorporation into morphine than did 
{!)_(3_14c]norlauctanosoline (2.2%), without randomisation 
of the labels. Independent evidence for the conversion of 
(!)-reticuline into morphine was obtained by B~rton and 
co_workers33 ; (!) _ (1_38 , !:!-methyl .. JAc] reticuline 
(2e; R1cH, RcR2=Me) was incorporated into ~orphine ~gain 
without r~ndomisation of the labels. 
Although it had been shown th~t reticuline was converted 
17 
into the ny<.".::-oph2nanthrcne nl!re.loids, it could be C'Lrgued that 
Q-demethylntion occurred in the plant t~ give n siopler 
benzylisoquinoline which "dS then converted to morphine by 
sooe other route. The possibility was rejected by feeding3~ 
the plants quintuply lecbelled (:::)-reticu~ine (28; if =H, 
R=R.2cMe', with l~C in both methoxyl groups, in the 
~-methyl group and at carbon C-3, and with tritium at 
position C-3. The short term feeding exp~riment gave radio-
active thebaine, j~ which it was shown that no 
Q-demethylation or ~-demthylation had occ~rred during 
biosynthesis. 
Further tracer exPeriments illustrated the 
necessity of both the presence and position of the phenolic 
hydroxyl groups for the natural metabolise of reticuline. 
The necessity 
the fact that 
for two phenolic hydroxyl groups was 
(!)-(3-1~cJtetrahYdrOpapaverine (28; 
shown by 
1 R=R oMe, 
R2=1-1) was not incorporated into morphine to any significant 
extent. 
Reticuline has three structural isomers, the bases 
(31), (32), and (33). The positional requirement for the 
tl(O phenolic hydroxyl groups was demonstrated35 by feeding 
(!) - [1_3H, 3-1~c]protosinomenin., (31), (!)- (1_3H lorientaline 
(32), and the (!)- [1-3HJoonZyliSOquinoline (33) to 
P. scmniferum plants Uf.der normnl conditions. Only the 
incorporntion of activity into morphine W3S investigated, 
and was found to be negligible. There is the possibility 
that these precursors (31), (32), (33) could be converted 
into alkaloids unr~lnted to Clorphine. F·.)r exar.1ple 
18 
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orientllli:-,e {32~ could be cOHve~-t:Gd into isoth,:~b8.ine (34) in 
P.\ sornniferum. It 0 k 36 th' 0 1 0 0 th . 15 nmm t:\"... or::,'~nta 1ne 1S (j 
precuraor of isothebaine, nnd th.:lt thebnine occurs together 
with icothebaine in ~apnveL orientale. 
sho>m that, (!) .. o p_14C ]reticuline (28; 
:t·c hns hot-revl';!r beGn 
was 
incorporated37 into thebaine in ~~aIQ, but the 
isothebain~ isolated was radioinnctive. In r,arallel 
experioents it was shown that (:)(3-14c}oriontaline (32) 
was converted37 by ~orientale i71to iso·thebaine but not 
into thebaine.. Roticuline seems to U8 th2 only 
~-mcthYlated, diphenolic benzylisoquinoline precursor of 
tlorphinc in P. scmniferur.t, also the enzyme systems 
operating in P. somnferun and F. orio~tale are highly 
specific in their action. 
Although no~laudnnosaline serves29 os n good precursor 
for morphine, it ~ay not necessarily be one of the natural 
biosynthetic intermediates. Methylation to give the required 
rcticuline. may occur prior to isoquinoline formation. This 
°bOIOt lOk 1 0 F 0 28 b d th t passl. 1. 1 Y seeelS un 1. e Y t s~nee ra.nc1S 0 serve a 
4-hYdroxY-3-methoxYPhen[1-14C]ethYlarnine (35) was not 
incorporated into ~orphine. Thus here again the enzyme 
systems carrying out the chenical changes are behaving in a 
very specific manner. No investigation of conve?sion of 
4-hYdrOXY-3-methoXYPhen[I-14c )ethYlamine (35) into the base 
(36) was made. 
The 'fOrk with benzylisoquinolinc delOcribed so far was 
carried out using racernntcs. However, it would be 
expected that the enz~es c~rrying out the p~rticulnr 
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chemical changes would be stereo~"ecific, and that only one 
of the two optical isomers would act a~ a direct substrate. 
The use of resolved quadruply labelled precursors35 ; carrying 
tritium at the asymmetric centre, was very informative about 
the detailed ~le of reticuline in the biosynthesis of the 
morphine alkaloids. 
S-(+)-Reticuline (37; R1=H, R=R2=Me) was first isolated 
from Anona reticulata39 and has the illustrated absolute 
configuration. n. .. absolute configuration of the morphine 
alkaloids (1, 26, 27) is well established40 , and it is 
R-(-)- reticuline (38; -R1=H, R=R2=Me) which should- be the 
precursor for thebaine (27), codeine (26), and morphine (1). 
< S~parate, singly-labelled samples of (+)-reticuline (37; R1=H, 
R=R2="le) and (-)-reticuline (38; Ri=", R=R2=Me) were prepared. 
Appropriate quantities of each were mixed to give effectively 
quadruply labelled precursors with 14C in the skeleton at 
C-3, in the 4-methoxcfl group, and in the ~-methyl group, and 
with tritiUCl at C-l. The quadruply labelled precursors, 
(+)-reticuline and (-~reticuline were fed by injection to 
separate P. samniferum plants35 • Good incorpor~tion of 
(-)-reticuline into the hydrophenanthrene alkaloids was 
observed; but degradation of the isolated thebaine showed 
that there was only a 30-40% retention of t".itiw" activity. 
Surprisingly there was nlso good incorporation of 
(+)-reticuline into the hydrophenanthrene alkaloids, but 
onl-: n 13-18% retention of tritiwn activity ,<as observed. 
The incorporation of (+)-reticuline, together \frit.h the loss 
of tritiwn activity from both the (+)- a~j (-)-isorners could 
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only be rationalised by convorsion Vid the interoediate 
--.. 
l,2-dehydroreticuline (39; R1=H, R=R2~~e). This was shown 
to be the case35 , sinoe when [3_14C]-l,2-dehYdroreticuline 
was fed to the plants, the highest ever :;"corporation of a 
benzylisoquinoline into morphine (10.5%) was observed. 
R-(+)-Norlaudanosoline (38; R=R1=R2=H) oorr~sponds 
in absolute configuration with morphine (1). However 
[ 14} ° 1 2 S-(-)- 3- C norlaudanoso11ne (37; R=R =R =H) was 
incorporated (6.7%) more efficently into morphine than was 
the enantiomer R-(+)-13-14C}norlaudanosoline (38; R=R1=R2=H) 
(0.45%), therefore suggesting that there was not ready 
interconversion of the enantiomers by oxidation-reduction 
at this point in the biosynthetic pathway. This was 
f d o 38 [ 14 J ' supported by ee 1ng 3- C -l,2-dehydronorlaudanosoline 
1 2 (391 R=R =R =H), which showed very poor incorporation int"o morphine 
(o.on~). Nevertheless the morphine isolated from plants 
fed with (:)fl-3H, 3-14c)norlaudanosoline (28; R=R1=R2cH) 
contained less than 10% of the original tritium present, and 
this loss must therefore occur at a later stage in the 
biosynthesis. It was also shown38 that [3_14cJ-l,2_ 
1 2 dehydronor-reticuline (39; R =R =H, R=Me) was incorporated 
significantly, presumably through conversion either into 
l,2-dehydroreticuline (39; R1=H, R=R2=Me) by ~-methylation, 
or into nor-reticuline (28; R1=R2=H, R=Me) by reduction. 
Nor-reticuline had been shown previously3 1 to act as a 
pre,"ursor for morphine, and this was confirmed by feeding 
(:)_{1_3H, 3-14c}nor-reticuline (28; R1=R2=H, R=Me) to the 
plants. Incorporation similar to that of before was observed, 
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and 82% of the tritium prQGont et the aS~9tric centre was 
lost during biosynthesis. In similar experiments 
+ [3 14 14 1 . ( 1 (-)- 1- H, 3- C, N-methyl- C.laudanoso11ne 28; R=R =H, 
R2=l>le), another possible intermediate bet":':oen 
S-(-)-norlnudanosoline and R-(-J-reticuline, showed good 
incorporation into morphine with 88% loss of tritium from 
position C-l. It appenrs thnt, in the conversion of 
S-(-)-norlnudenosoline into R-(-)-reticuline, necessary for 
the fort!lation of "'<',,"phine, the enzyme syntem is not as highly 
specific as had been observed et other st<':;ges in the 
biosynthesis. For example, R-(+)-norlaudanosoline showed 
n minimum incorporation into morphine, as was the case with 
4-hydroxy-3-methoxyphenethylnmine and the structural isomers 
of reticuline, (31), (32), and (33). So long as methylation 
takes place at the correct positions, and occurs after form-
ation of the initial b6nzylisoquinoline, it does not appear 
to make any difference whether ~-methylation precodes or 
follows 2-methylation. 
The loss of tritium from the asymmetric centre of the 
precursors nor-reticuline and laudanosoline, could be explained 
by an oxidation-reduction process on nor-reticuline (as 
Scher.Ie 1) and on laudanosoline (Scher.Ie 2). en the other hand 
both precursors could first be methylated to give reticuline, 
followed by the production of R-(-)-reticuline, with loss of 
tritium from C-l, ~ 1,2-dehydroreticul~ne. The last 
proposal seems the most likely, since the opium poppy has 
been shown to contain approximately 60% of S-(+)-reticuline 
and 40% of R_(_)_reticuline41 • Separate experiments using 
1.2 
radiodilutj on ana lysis woro in agrt!~ment ,and showed that 
the S-(+)-forrn predominated. The use of resolved 
laudnnosoline and nor-reticuline as precursors is likely to 
show· more precisely the exact nature of ~he partially 
methylated intermediates in the natt~al system. The 
oxidation-reduction equilibrium which appoars to exist 
between S(+)- and R(-)-reticuline and 1,2-dehydroreticuline, 
coulci in theory involve the enomine (40) as .!J, fOUl'th pavtner. This 
waB 38 shown not to be the case by feeding both 
(+)- and (_)_[9_3H, 3-14cJreticulin0. It might be interest-
ine to s~e if the enamine (40) is itself metabolised by the 
plant to give morphine, since it differs only slightly from 
reticuline, but is methylated at all the correct positions. 
Further evidence for the involvement of reticuline was 
provided by Rspoport 43 cn· the basis of C4C)csrbon dioxide 
exposure experiments. Comparison of the relative specific 
activities of the isolated reticuline and thebaine gave 
additional support for reticuline being the required 
benzylisoquinoline precursor of the hydrophenanthrene 
alkaloids. 
As outlined earlier, the original proposals considered 
that R-(-)reticuline (38; R1=H, R=R2 =Me) underwent phenol 
oxidative coupling ~ the resonance stabolised diradical 
(41), to give the then unknown dienone (4), which, after 
isomerisation to (5), was reduced and dehydrated t~ yeild 
thebaine (27). The dienone (42E4; R=H) was synthesised by 
reduction of thebaine (27), using sodium in liquid ammonia 
to give dihydrothebaine-~ (43). The phenol (43) was aceylated, 
and oxidised to give (42;R;<OAe), which gave the required 
25 
MeO 
I 
HO 
~o ~o 
OH 
(40) (41) 
2 
Meo 30 t ~O ?' 
'"R 0 +~ HO 
. 
sI • H 
MeOC. ~O 
0 
(42) (43) 
~O h ~ H~ s 
Mt-O 
b I , , , H oH 
MQ..O 
J 
(44) (45) 
~ienone (42; R=H) on mild alkaline hydrolysis. A dienone 
alkaloid subsequently isolated from Croton salutaris, and 
called salutaridine, was found to be identical with 
(42; R=H). Using synthetic 9-R(+)-salutaridine <42; R=H) 
as a carrier alkaloid for 1E vitro experiments it wns 
possible to show that tritiuc labelled (:)-reticuline and 
R-(-)-reticuline, but not S-(+)-reticuline, were converted 
into the dienone33 ,45 (421 R=H). The reaction conditions 
were those known to promote phenol oxidative coupling. 
The next stage in the research was to test salutaridine 
(42; R=H) as a biosynthetic intermediate for the 
hydrophenanthrene alkaloids. This was carried out as a 
~ . 
callaborative effort by groups at Imperial College and 
the University of Liverpool. 
[1-3HJsalutaridine and (16-14c]salutaridine(both 
prepared from thebaine) were fed separately to F. somniferum 
plants. Very efficient incorporation into thebaine, codeine, 
and morphine was observed, the total incorporation values 
being as high as 150/0. The thebaine isolated from the plants 
fed with [1_3Hlsalutaridine was converted, after dilution 
with inactive material, into salutaridine (421 R=H). 
Bromination of (42; R=H) at the C-l position gave inactive 
I-bromosalutaridine, showing that no scrambling of the 
radiol~bel had occurred during biosynthesis. Thus 
9-R-(+)-salutaridine waS established as the first 
biosynthetic intermediate to be formed after the oxidative 
cou~ling of R-(-)-reticuline. Moreover, by feeding 
P. somniferum plants (:)-t3-14clnorlaudanosoline 
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the extracted alkaloids with radioinactive salutaridine 
(42; R=H), it was possible to demonstrate that radioactive 
salutaridine had been formed. This overcame any objections 
that salutaridine Was not a natur~l alkaloid of the 
opium poppy. 
It WaS found that salutaridine (4) did not34 ring 
close under acidic or basic conditions to give the enone (5). 
It was reasoned tllo.t 'the open form (4) was thermodynamically 
the more stable, suggesting that ~ !i!2 closure of the 
benzofuran ring, to give thebaine~ required a separate 
b " h " 1 t M ct'f' t" f th "11 11 d 10C emlca s ep. 0.1 lea 10n 0 e orlglna y. propose 
biosynthetic pathWaY was necessary, and subsequent 
suggestions46 ,47 involved reduction of salutaridine to the 
dienol (44), which could then undergo cyclisation as indicated 
to give thebaine. Chemical support for this modified route 
was provided by 12 !i!r2 studies. Redu~tion of salutaridine 
with sodium borohydride gave two epimeric alcohols33 ,34 
called sQlutaridinols I and 11 (44), differing only in the 
stereochemistry of the alcoholic group at C-7. Both these 
dienols gave thebaine on very mild treatment at pH3-4. In 
the work carried out at Imperial College samples of 
[l,7-3Hlsalutaridinols I and II were fed separately to 
poppies, while the Liverpool University group prepared and 
fed (3_3H, l6- 14CJsalutaridinols I and 11. Both groups 
fo~~d that salutaridinol-I was incorporated far more 
efficiently into thebaine (10 to 30 times) than was 
salutaridinol-II, and that there was no loss of triti~ 
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from position C-7. The retention of tritium at position C-7 
showed that salutaridinol-I was metabolised directly to give 
thebaine without prior oxidation to salutaridine (42; R=H). 
Salutaridinol-I was also incorporated ve:-y efficiently into 
codeine and morphine, however, significant tritium loss from 
C-7 occurred during the conversion of thebaine to codeine. 
Thus the results support the biosynthetic pathway' 
Salutaridine (42; R=H) ~ salutaridinol-I ( 45 ) ~ 
thebaine ~., and high enzyme specificity, in the 
metnbolism of only snlutnridinol-I, "I<1S llcnin demonstrated. 
It was later shown45 that salutaridinol-I has the 
configuration indicated by the partial structure (45), the 
alcohol group being on the same side of the molecule as the 
nitrogen bridge. This was thought to be surprising, since, 
if the cyclisation indicated by (46) involving a one step 
SN~ displacement occurs, then it would be salutaridinol-II 
(46) which would have the correct configuration. It was 
reasoned that an additional step was involved in the bio-
chemical process. Two possibilities were put forward, 
although no experimental evidence for these has been 
reported. The first involves SN2 displacement of the 
hydroxyl (or a phosphate ester) at C.7 in salutaridinol-I 
(45) by an enzyme functional group, giving an enzyme bound 
intermediate with the inverted configuration necessary for 
1 • 
an SN2 rIng closure. The second ~ossibility requires a 
p.-.eliminary allylic rearrnngement to give the isomer (47), 
which then has the correct configuration for direct SN2 
displacement at position C~5. 
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\'le may now consider the 18~t stage of "the biosynthesis, 
nacely, the conversion of thebaine (27) into codeine (26). 
The fonnation of codeine from thebaine must involvp at least 
onc inte~ediate, since both reduction a~~ Jemethylation are 
occurring. The nature of this inte~edillte will depend on 
,""ich of these two processes occurs first. The most 
favoured mechanism 11 34 '*6 postulated ' , that de!!lethylation 
occurred first, to give neopinone (!~8) thence codeinone 
('*9) and codeine. 'l'his mechanism might BJQlain the loss of 
tritium from C~'~7 which occurred du~·~.:~(J ~O:1.,r2rsion of 
thebaine into codeine during the salutaridinol experiments3'*. 
Further, it had been shown that sodium borohydride reduction 
of ccdeinone gave codeine as the only product,*8. The second 
postulated'*9 mechanism involved reduction of thebaine as the 
first step to give codeine methyl ether (50), followed 
by demethylation to yeeld codeine. Some evidence for 
this mechanism was provided by BrOCkmann_Hanssen50 , who 
showed that codeine methyl ether was present in the mother 
liquors produced during the extraction and purification of 
morphine from opium. The possibility that codeine methyl 
other was fonned as run artifact in the mother liquors, 
perhaps by reduction of thebaine, was eliminated by 
extraction of a sample of opium powder. The presence ~fcodeine 
methyl ether . Vias t!'.3i'1 indicated by gas and thin layer 
chromatography. This last mechanism could alsc account for 
thE loss of tritium from C-7 of thebaine during conversion 
to codeine by postulating ·::he further intennediate neopine 
methyl ether (51). 
30 
(46) 
/ 
o 
0""'-::: 
(48) 
M.e.O 
(50) 
In order to gain evidence for the existence of either 
of these two intermediates (~9) and (50), Rnpoport 51 r.~rried 
out two series of experiments. In the fi~st, 60 day old 
F. somniferum plants were exposed (for ~h) to an atmosphere 
of r1~cJcarbon dioxide. The non-phenolic alkaloids were 
isolated and the specific activities determined using a gas 
chrcmatograph-flow counter system. Codeine methyl ether 
coulJ not be detected by either m,,~,s or >:adioactivity. 
However codeinon~ ~s detected and its specific activity 
lay between those of the isolated ':."",baine and codeine. 
In the second series of experiments codeine methyl ether 
(50) and codeinone (~9) which were generally labelled .. ith 
1~C were fed separately to the plants. The pbenolic and 
non-phenolic alkaloids were isolated, and this timeradioinactive 
codeine and morphine were added to act as carriers. The 
specific activities were determined hy scintillation counting 
and showed that codeine methyl ether had been converted into 
codeine to the extent o~ ~.7% and into morphine (3%), but 
that 51.5% was isolated as unmetabolised codeine methyl 
ether. In the codeinone feeding experiment, an incorporation 
into codeine of 1~.5% and morphine of 2.8% was observed, and 
l~% of the codeinone was recovered. On the basis of the 
1~CO exposure experiments, and the high conversion of 2 
codeinone into codeine, Rapoport suggested that codeinone 
is the required intermediate in the conversion of thebaine in-
t·., codeine. The details showr. by Rnpoport indicate however, 
that codeine methyl ether is incorporated as efficiently into 
morphine as is codeinone. Furthe~ evidence for codeinone 
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being the required intermediate was provided by Battersby52,53. 
(2-3H)Codeinone was fed to P. somniferum and showed good 
incorporation into morphine (18.4%) and c0deine (4.8%). 
Bnttersby53 also prepared [2-3H)codeine I."d [6_3H )codeine, 
the two were mixed to give effectivtty [ 6-3). . . 2, H code1ne 1n 
,thich ·~he activity ratio of the labels "e" known. [ 2,6_3H) 
Codeine was fed to the plants and the morphir.e and codeine 
isolated. The tritium at C-2 in the morphine was removed 
by exchange and th~ C-2 to c-6 tritium "",,"[.io calculated. 
The codeine was oxidised to codcinolle <.lnU '~he i"'atio 
determined. It was found that the tritium ratios in the 
isolated alk~loids did not differ significantly from 
those in the precursor. Thus no codeine to codeinone 
conversion occurs prior to the formation of morphine. 
Rupoport's51 conversion (4.7%) of codeine methyl 
ether into codeine in P.samniferum was confirmed 
independently by BrOCkmann-Hanssen49• [3_methoxy_14c) 
Codeine methyl ether was prepared. and fed to five opilDll 
poppies. The non-phenolic alkaloids were isolated and the 
codeine purified by chromatography, and crystallised to 
constant specific activity. The incorporation of codeine 
methyl ether into codeine was 2.5%, and Zeisel 
Q-demethylation of the codeine showed that all the activity 
resided in the Q-methyl group. It was thought that too 
large an amount of precursor had been used for too few 
pl •• nts (56mg, 0.24lmCi for 5 plants), and this had resulted 
in a swamping of the biosynthetic pool. A second feeding 
er~eriment was carried out (using 5mg.of precursor and 10 
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plants), and this resulted in a codeine methyl ether to 
codeine conversion of 15.8%. The conclusion that the 
authors drew from these results was that t.he opium popP:r 
possesses the ability to demethylate cod",ine methyl ether 
to give codeine, but that this does not p~ove that the ether 
is a natural intermediate formed during normal biosynthesis. 
The workers failed to prove the presence of codeine methyl 
ether in P.somniferum, by feeding (!)-r3-1~cJreticUline and 
using radioinactivp. codeine methyl ethe~ ns a carrier. This 
part of the biosynthesis is still open to question, and will 
be discudsed later in connection with our own work. 
However it does seem that here is another example where the 
enzyme system, involved in demethylation, is not all that 
specific. 
Thus a great deal is understood about the way in 
which morphine is built up in the plant. But the mechanism at 
formation of the initial benzylisoquinoline, and of the 
thebaine to codeine conversion is still open to serne doubt. 
One point is fairly certain however, that the enzyme 
systems carrying out the various chemical changes, with only 
two exceptions, are highly specific for the formation of 
morphine. 
Chapter 11. 
Metabolism of Unnatural Precursors 
in Papaver somnifsrum. 
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Introduction 
Ideally, in the study of any biosynthetic pathl'lay only 
the natural precursor should be incorporated efficiently into 
the natural product. The general case is illustrated below in 
Scheme A in which the natural precursor (X) is converted into 
the natural product (Y). 
X • Y 
,r~t~ 
X' - ~ Y' 
Scheme A 
However, examples have been reported50 ,51.,S4 of the incor-
poration of an unnatural precursor into a natural product, 
represented generally in Scheme A by an (X') to (Y) conversion. 
'n'10 examples will serve to illustrate this latter type of 
incorporation. The first has already been discussed in some 
detail and is associated 1'1ith morphine biosyntheSis. Codeine 
methyl ether (6; 1\ = R2 = Me) (complete proof for its natural 
occurrence in the plant is still lacking), represented in 
Scheme A by (X'), is converted by P.somniferum )l into the 
natural alkaloid (Y) morphine (6; ~ = ~ = H). The second 
example was described by I.eeteS4 in connection with the bio-
synthesis of Nicotine. Here the unnatural precursor [6 -N-
14 " methyl ,2- C]ornithine (1) (X'), Nhen fed to Nicotiana tabacum 
plants, was incorporated into the natural alkaloid nicotine 
(S; R=H)-(Y). Degradation showed that only the ~-methyl and 
2' carbon atoms of the nicotine (S; R=H) were radioactive. 
* (Number refers to structures found only in this chapter) 
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[ - 14~ HOI'lever, when the natural precursor 2- "",rni thine (2) is 
fed to the plants,both the 2' and 5' carbon atoms of the isolated 
nicotine (5; R=H) are radiolabelled.55 The latter process is 
represented by an (X) to (Y) conversion in Scheme A. The 
authors suggested54 the plant contained nonselective enzymes 
I~hich were capable of catalysing the decarboxylation 0< 
6 -!!-methylorni thine (1) to give !!-methylputreseine en l'lhich 
was utilised by way of the !!-methyl- d -pyrrolinium salt 
(I!,; R=H) for forming the pyrrolidine ring of the naturally 
occurring nicotine. 
We were interested in extending the general concepts of the 
above fields of research. Our aim was to investigate the 
possibilities of an unnatural precursor being converted, by 
a selected natural plant system, into an unnatural product. 
That is, to observe an X'--. y' conversion, where both the 
unnatural precursor and product are fairly closely related to 
their natural counterparts. Thus, in this theoretically possible 
conversion, the structural relationship between the unnatural 
product (y') and the natural product (y) will be exactly the same 
as that between the unnatural precursor (X') and the natural 
precursor (X). 
At the start of our \'Iork this type of (X') to (y') con-
version had not 
one example was 
been observed in any plant system. HO'.'lever, 
56 
recently reported by Rapoport, and ar;ain 
\'Ias connected with the biesynthesis of nicotine. It had been 
established previouSly57 that 1-methyl-1-pyrrolinium chloride 
(4; R=H, Hal-=Cl-)-(X), was an efficient precursor <01' the 
5G pyrrolidine ring of nicotine (5; R=H)-(Y). Rapoport showed 
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that the unnatural precursor [3_l4C]-l,3-dimethyl-l-pyrrolinium 
chloride (4; R=C!J' Hal-=Cl-)-(X'), was incorporated by 
N.glutinosa tobacco plants into [3-l4c]methylnicotinc (5; 
Two feedinc> experiments were carried out and 
the incorporation into 3' -methylnicotine, 1.e. the (X' )to 
(y') conversion value, ranged from 5-11%. Further, thc 2' 
carbon atom of 3' -methylnicotine vias assigned an (s) config-
Ul'ation, the same absolute configuration as the 2' carbon atom 
of the natural nicotine (5; R=H). In this example, only 
conversion of l,3-dimethyl-l-pyrrol1nium chloride ill"GO 3'-
methylnicotine (Le. the X' to y' conversion) was tcsted. 
No direct comparison was made Vii th the natural conversion of 
l-methyl-l-pyrrolinium chloride into nicotine (~.tlle X to Y 
conversion) under the same conditions of feeding. 
We considered it important not only to determine if any 
(X') to (y') conversion occurred, but if it did, to cain some 
measure of its efficiency compared with that of thc natural 
(X) to (Y) process. Our approach for this type of study was a 
little more sophisticated tllan tllat adopted by Rapoi~rt,56 
and again is best described in general terms by l'C:ference to 
Scheme A. If the plant system to be studied were fed 1'Ii th a 
mixture of the unnatural precursor (X') labelled '"Iith tritium, 
and "\he natural precursor (X) labelled with l4c , it 'Iould then 
be possible to observe any (X ') to (Y ') conversion and to 
compare it directly with the natural (X) to (Y) conversion for 
a given feeding experiment. The natural precursor therefore 
uould act as an internal standard for a particular experiment. 
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Similarly it would be possible to measure the extent of the 
other conversions which might occur, i.e. all those implied 
by Scheme A. 
Tbis then was the reasoning behind our approach I'1hich, 
given that the normal biosynthetic intermediates have been 
determined. can be applied in principle to the study of the 
metabolism of a suitable unnatural precursor by any higher 
plant. We chose to studY the application of these ideas to 
the demethylation of codeine (6; ~=Me, R2=H)-(X) to Give 
morphine (6; ~=~=H)-(Y) in the opium poppy, P.somniferum. 
The reasons for this selection were three-fold. Firstly, the 
process is fairly simple and believed to involve only one step. 
The product, morphine is thought to be the final all~loid (but 
see below) in the biosynthetic sequence and is not readily 
metabolised, during the proposed time scale of our experiments, 
to give other end products. Secondly, the P .somniferurn plants 
are fairly easy to grow, and also a 
the technique of feeding precursors 
great deal is knolm about 
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to them. Thirdly, there 
is some indication that tile enzymes involved in the conversion 
of codeine into morphine are not highly specific and therefore 
it seemed reasonable that the type of incorporation \'Thich Ne 
sought might occur, Further, it was hoped by undertal;ing this 
study to gain insight into the Nay in which the enzyme system 
carries out the demethylat10n process. 
One further point must be made. Some evidence is available 
to suggest that morphine is metabolised under natural conditions 
r." 
to give other products. Fairbairn and his co-workers:'>u found 
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that [2-3H)morphine (6; Ri=R2=H) gave other radioactive products 
when treated with poppy latex over a period of eleven days. The 
products were phenolic and "morphine like", but no structural 
determination was carried out. Fairbairn had shown prCViOusly59 
that poppy latex, isolated from the seed capsules of P.somniferum, 
is capable of incorporating precursors into the morphine alkaloids 
in the same way as the plant itself. 
Having outlined the problem we can now 'discuss in more 
detail the experimental approach. To define more exactly the 
mode of action of the demethylating enzyme responsible for 
the conversion of codeine into morphine in P.sonmiferum, we 
considered it necessary to investigate all the possible 
conversions implied by Scheme A. To cover adequately these 
possibilities it was decided to carry out two different types 
of feeding experiment. The first type will be described as a 
double-label feeding experiment although, in the strict sense 
this is not so. Here, each of the unnatural modified codeine 
precursors, labelled with tritium, were separately mixed with 
14 [N-methyl- C)codeine (6; Ri=Me, R2=H), which was selected to 
serve as the internal standard for each feeding. Each of the 
mixed precursors was then fed separately to the plants. Thus, 
the conversion of the unnatural precursor (X') into (yt) or into 
codeine and morphine, was observed by the incorporaticn of 
tritium activity. Further, the concurrent metabolism of codeine 
was followed by incorporation of 14c acti vi ty into morphine, 
(x'). or (y t ) • 
It seemed likely that, if any of the unnatural precursor 
(x') was converted into codeine and morphine, the incorporation 
41. 
value would be fairly low compared with the incorporation of 
14 [N-methy1- Cjcodeine into morphine. Thus for a doub1c-1abe1 
feeding the small amount of tritium activity, representing the 
conversion of unnatural precursor (X') into codeine and morphine, 
would be swamped by the 14c activity present derived from the 
internal standard [N_methyl_14C ]codeine. To overcome this 
possible problem, a second type of feeding experiment was carried 
out involving the unnatural precursor (X'), labelled \'Iith 
tri ti urn, alone. 
The selection of suitable unnatural precursors can now 
be discussed. 
Selection of Unnatural Precursors for Feeding Experiments:-
The selection of unnatural precursors (X') for feeding 
experiments was of necessity fairly arbi tary since \'Ie had 
initially no idea which modified COdeine compounds (X'), if any, 
would show incorPoration of the type we were seeking, i.e. 
(X') to (Y'), (X') to (X) to (Y), and (X') to (Y') to (Y). We 
expected various functional groups in the codeine molecule (6; 
~ =Me, R2=) would be involved in binding with the enzyme during 
demethylation to morphine. We could only guess which \'Iould be 
important and our selection of unnatural precursors Has aimed 
primarily at defining the possible binding sites associated with 
the C-ring (Ftg.1.). Thus, - most 0 f the unnatural pro cursors 
involved modifications to the C-ring of codeine althoUGh all were 
fairly closely related to codeine itself. ~ reference to the 
type of modification involved the precursors may be placed into 
three different groups as follows : -
(a) Modification to the position of the oxygen atom in the 
1~2 • 
secondary alcohol group at position c-6 in the C-ring of codeine. 
The shape of the codeine molecule is illustrated in Fig.l, l"Ihile 
a more detailed representation of the configuration of the C-
ring is shol'm in Fig.2. The secondary alcohol function of 
codeine is on the opposite side of the molecule to the C-15 -
C-16 nitrogen bridge, and occupies the 6a-position in Fig.2. 
The exact position of the oxygen in the codeine molecule may 
be important during demethylation in the plant. Thus isocodeine 
(8; R1=Me, R2=H) the 6~-epimer of codeine would be a suitable 
unnatural precursor. Similarly, hydrogenation of the 1,8-o1cfinic 
double bond of both codeine and isocodeine will alter the 
shape of the C-ring from half-boat to chair, and hence the 
position of the oxygen function. In Fig.3, dihydrocodeine 
(1; Rl =Me, R2=H) has the oxygen function at the 6a-pos1tion, 
and dihydroisocodeine (9; ~=Me, R2=H) at the 6~-position. 
The compounds selected as unnatural precursors in this group 
were :- dihydrocodeine (1; Rl=Me, R2=H), isoeodeine (8; 
~ =Me, R2=H), isocodeine methyl ether (8; Rl =R2=Me), dihydroiso-
codeine (9; Rl=Me, ~=H), and dihydroisocodeine methyl ether 
(9; ~ =R2=f.le) • 
.,) f.lodification of the functional group attached to thc 
C-6 position of codeine (6; ~ =Me ,R2=H). The presence of a 
hydroxyl group at c-6 may be important in binding the molecule 
(6; Rl =Me, R2=H) to the enzyme surface during demethylation. 
Codeine methyl ether (6; ~ =R2=Me) and dihydrodesoxycodeine 
(10; R = He) were selected to test this effect. Dihydrodesoxycodeine 
(10; R = Me) possesses a dual advantage as an unnatural precursor. 
43. 
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Not only is there no oxygen containing functional group at 
position c-6 but also the absence of the 7,8-olefinic double 
bond ensures that there are no likely centres in the C-ring 
for co-ordination to the enzyme. 
(c) Modification by attachment of a large functional 
group to the aromatic ring of codeine. The compound selected 
was 1-bromocodeine (11; R = Me); the reasoning behind this 
choice will be outlined later during discussion of this feeding 
experiment. 
During I",ork-up of the feeding experiments inactive samples 
of the four associated alkaloids were used as carriers for 
dilution analysis. Thus a further consideration in selecting 
unnatural precursors (X ') was that the morphine analogue of the 
modified codeine precursor should be a known compound and fairly 
easily prepared on a small scale. 
Labelling of Unnatural Precursors.-
All the unr,atural precursors were labelled with tritium at 
position C-2 (6). The starting material was [2-3H]morliline 
60 
obtained, as described by Kirby and Ogunkoya, by the 
base-catalysed nuclear exchange of morphine (6; Ri=R2=H) with 
tri tiated water in dimethylformamide. Other workers have shown 
beyond doubt that the tritiated morphine produced in this way 
is labelled only at the C-2 position. The stability of the 
tritium label in [2-3H]morphine, under most of the conditions 
that it was likely to encounter in our hands, has been 
53 61 62 
established by Battersby. Moreover, it has been demonstrated ' 
that monohydric phenols and catechol derivatives do not exchanc;e 
46. 
ortho and ~-tritium under biological conditions similar to 
those present in P.sonmiferum. Thus tritium is unlikely to 
be lost by exchange from the phenolic. alkaloids during b10syntilcsis 
or isol~tion. 
was 
To establish exactly the required conditions, the exchange 
studied agaln53,58 by n.m.r. spectroscopy using deuterium 
oxide. From these experiments the best results were obtained 
o by carrying out the ,exchange in a sealed tube at 100 C for 
100 hr. Morphine was isolated as a nearly pure white material 
only when very l'1gorous precautions \'Tere taken to flush the 
exchange tube free from oxygen and carbon dioxide prior to sealing. 
The exchange was also studied using potassium !-butoxide 
and it was found necessary to use 2 moles of this base to dissolve 
the morphine in deuterium oXide. Observation using n.m.r. 
spectroscopy showed the exchange did not produce sIgnificant 
'Z 
amounts of [2-- Hjmorphlne. This was in contrast to the resul-ts 
repor1S\i by Steinreich,63 but in agreement Ni th the observations 
6lf 
of Ingold, Raisin, and Wilson. The latter workers had found 
that the maximum rate of exchange occurred when equal con-
centrations of phenoxide and undissociated phenol (PhOD) were 
present. 
The labelled morphine was metllylated using trimethylalllliriiurn 
65 0 'L 
ethoxide at 115-120 C to yield [2--Hjcodeine, the starting 
material for the syntheSis of all the unnatural precursors. 
The trimethYlanilinium cation was obtained by the exothermic 
reac tion between metllyl toluene-,!!-sulphonate and dImethylaniline, 
to give trimethylanllinium toluene-,!!-sulphcnate which, on 
treatment with sodium ethoxide under anhYdrous conditions, gave 
trimethylanilinium ethoxide, the required methylating roagent. 
The methylation reaction proceeded well in about 6o-70~';, and 
the [2-3H)codeine had essentially the same molar specific 
activity as the original labelled morphine. 
Synthesis of Unnatural Precursors and their Morphine Analogues.-
In preparing the unnatural precursors we required methods 
which, firstly gave a high yield of the required product, and 
secondly would not involve loss of tritium from the codcine 
molecule. Some of the literature methods were inefficient, and 
it l'las therefore necessary, in certain instances, to develop 
new preparations. Exact conditions required for the preparation 
of all the unnatural precursors were established using radio-
inactive starting materials. In general, the labelled, 
unnatural precursors were prepared by the same route as 
their radioinacti ve counterparts, which were required for 
radiodilution during feeding 1·lork-up. Thus for simpliCity 
only the preparations of the radiolabelled unnatural precursors 
will be discussed here, exce pt in those cases where a 
different method was used for the preparation of radioinactive 
material. FUll details of the preparation for both radiolabelled 
and radioinactive modified codeine compounds appear in the 
experimental section. The preparation of the morphine analogues, 
also required for radio dilution, is described in sequence 
with the corresponding unnatural codeine compound. 
[2-3H)Dihydrocodeine (7; l1. =Me, R2=H) was 
prepared66,67,68 by hydrogenation of [2-3H)codeine in 
methanol solution, using palladised charcoal as catalyst. 
48. 
Preparation of the labelled precursor was carried out on a 
small scale (~. 30 mg.) and even after purification ~ the 
picrate i t ~Ias impossible to obtain the material crystalline. 
However in the preparation of radioinactive dihydrocodeine, 
carried out on a larger scale (~. 200 mg.), the material was 
obtained crystalline but only after cons1derable difficulty. 
The difficulty encountered in crystallising this compound was 
most likely due to the presence of a small amount of unreduced 
codeine which could only be removed by repeated crystallisation 
of the picrate, followed by regeneration of the free base. The 
free base ~/aS regenerated by pouring a chloroform solution of 
the picrate salt dC\m a column of neutral grade III alumina. 
64 65 Similarly, d1hydromorphine (7; Ri=R2=H) was prepared ' 
by hydrogenation in ethanol solution. The product was readily 
crystallised, but the reaction consistently produced low yields. 
It could be that the phenolic alkaloid was adsorbed on the 
charcoal catalyst. Use of glacial acetic acid as the solvent 
for hydrogenation failed to produce an increase in the recovery 
of product. 
[2_3H jlsocodeine (8; Ri =/·Ie, R2=H).- Originally 69 iso-
codeine was prepared by hydrolysis of a-chlorocodide (12; X=Cl) 
or the ~-halogenocodides (14; X=Cl, Br, or I). The reaction 
mixtures resulting from such hydrolysts .. contained pseudo-
codeine (14; X=OH), allopseudocodeine (15; X=OH), in addition 
to isocodeine which was normally obtained, in very low yield 
(~. 6-8%), by fractional crystallisation of suitable derivatives 
and salts. For the preparation of the labelled precursor it 
, 
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was necessary to devise a r.lore efficient method. In! tially, 
the method developed involved treatment of [2-3H]COdeinc 
tolucne -E-sulphona te (13; X=TsO) with hexade cyl trimethy lannnoni um 
acetate, prepared from the corresponding bromide and silver 
acetate, in benzene solution at room temperature. It l'las 
expected that, under these non-solvolytic conditions, a clean 
SN2 attack of acetate at position C-6 would occur, since it 
is lmown 70 that codeine toluene-,E-sulphonate reacts \'Iith 
chloride ion to give a-chlorocodide (12; X=Cl). Indeed, 
[2-3H]isocodeine acetate (12; X=OAc) was isolated, and none 
of the SN2' product acetyl-allopseudocodeine (15; X=OAc) uas 
detected. The isolated acetate was hydrolysed using aqueous 
methanolic sodium hydroxide to give [2_3H]isocodeine in 
40-50% yield, based on [2-3H)codeine. It was very important, 
when preparing 71 [2-3H)codeine toluene-,E-sulphonate, by 
treatment of [2_3H]codeine ~Iith toluene-,E-sulphonyl chloride 
o in pyridine, to carry out the reaction at 0 C. The preparation 
outlined by Karrer and Widmark72 was inadequate and gave 
predominantly a-chlorocodide (12; X=Cl). Presumably, SH2 
displacement of the tosylate by chloride ion occurs at 
o 
temperatures higher than ~. 5 c. 
Ne hoped originally, by choosing hexadecyl trimethylammonium 
acetate as the source of acetate, to promote SN2 displacement, 
and that the hexadecyltrimethylannnonium cation would be 
precipitated from the benzene solution as the tosylate salt, 
thereby facilitating the work-up procedure. However, isolation 
of the required product from the reaction mixture was 1;ladc 
extremely tedious by the detergent properties of the 
51. 
hexadecyltrimethylamrnomum cation. A more satisfactory method 
for the isolation of isocodeine, especially from larger scale 
reaction mixtures, was developed. Here, basic hydrolysis of 
the total reaction mixture obtained from the treatment of codeine 
toluene-£-sulphonate with hexadecyltrimethylammonium acetate, 
generated isocodeine ~~. The offending cation was then 
removed very efficiently by precipitation with Reinecke's salt, 
NH4[Cr(NCS)4(N1S)21. H20, and pure isocodeine was obtained 
by chromatography and crystallisation. The yield using this 
modification .las increased to 65-70;" based on codeine. 
Due to the difficulty of recrystallisation, neither the 
labelled nor the radioinactive codeine toluene-£-sulphonate 
was specially purified before use. ~Ie were therefore anxious 
to obtain a quantitative measure of the contamination of 
isocodeine by codeine, and this was carried out in the followine 
14 
manner. [N-methyl- C]Codeine was converted into the corres-
ponding toluene-£-sulphonate and, after treatment with 
hexadecyltrimethylammonium acetate the total reaction mixture 
was divided into two portions. One \'laS processed by the modified 
method already described, to give labelled isocodeine which, 
after one crystallisation, was mixed \'li th a lmown amount of 
radioinactive codeine. The mixture >las separated and, after 
the codeine had been rigorously purified, its activity was 
determined by scintillation counting. In this way, the 
crystalline isocodeine was shown to contain 0.035% codeine, 
and was considered sufficiently pure for our experiments. This 
figure could probably have been reduced by further crystallisation 
of ihe isocodeine. The other portion of the reaction mixture lIas 
52. 
mixed directly with inactive codeine Vlhich, after isolation, ,·,as 
14 purified and counted for C activity. The reaction mixture 
was found to contain 1.33% of the original codeine. The contam-
inating codeine could arise during hydrolysis of the reaction 
mixture, but is most likely due to contamination of the starting 
material. 
The preparation of isomorphine (8; ~;R2;H) was carried 
out according to the method outlined by [·1aklei t and Eognar. 73 
This was not entirely successful and modification of the 
work-up procedure was required. 3-Q_AcetYlmorphine74 was 
treated with a pyridine solution of toluene-£-sulphonyl chloride 
to yield 3-Q-acetylmorphine tOluene-£-sulphonate75 (6; 
Hydrolysis with dilute acetic acid should, 
according to the original authors,73 give pure isomorphine 
which can be crystallised directly. In our experiments 
hydrolysis produced a complex mixture of phenolic alkaloids, 
in which isomorphine occurred as the major component. Thus 
the mixture was acetylated under conditions known to give 
3-Q-acetylation, and 3-Q-acetylisomorphine (8; Rl;Ac, ~;H) 
was eventually obtained pure by column chromatography on neutral 
grade V alumina. Isomorphine was obtained by crystallisation 
after basic hydrolysis of the 3-Q-acetylisomorphine. The 
necessity to form the 3-Q-acetyl derivative arose because of 
the extreme difficulty, encountered throughout the whole of 
the work, in chromatographing the phenolic alkaloids. 
[2-3H)Codeine Methyl Ether (6; ~ ;R2=Me).- During 
the methylation of [2-3H]morphine to give the correspondingly 
labelled codeine, a small amount of a by-product formed. 
53. 
The-Rf value of the by-product (0.65 alum1na/chloroform system) 
was slightly larger than that of codeine (0.40) and isolation 
was possible using column chromatography. The n.m.r. spectrum 
suggested that this by-product was codeine methyl ether. 
Confirmation came from the m.p., and the material was there-
fore utilised for feeding experiments. Crystalline codeine 
methyl ether, prepared by the above method formed in only about 
7% yield, and even after extensive investigation of the reaction 
conditions it was not possible to increase this beyond 12%. 
Thus, for preparation of the larger quantities of radioinactive 
codeine methyl ether, the original method described by Mannich76 
was utilised. This required complete methylation of codeine 
using dimethyl sulphate and treatment of the reaction mixture 
with aqueous potassium iodide to give codeine methyl ether 
methiodide. Iodide ion was exchanged for chloride by 
treatment with silver chloride, and tha derived oodeine methyl 
ether methochloride was dry distilled in vacuo to liberate methyl 
chloride. Codeine methyl ether was obtained by chromatographinc; 
a chloroform solution of the solid material tlhich remained after 
the distillation. 
Preparation of morphine methyl ether (6; ~ =H, ~=Me) also 
involved the method originally reported by Mannich. 76 
MethoxYmethylmorphine (16), obtained from the sodium salt of 
morphine and chlorodimethyl ether, was treated with hydrogen 
peroxide to yield the suitably protected methoxYmethylmorphine 
~-oxide (17). The protected morphine compound (16) was 
6-Q-methylated using dimethyl sulphate, then reduced in aqueous 
54. 
solution vri th sulphur dioxide. Morphine methyl ether was 
obtained pure after extraction and crystallisation. 
During the trial preparation of morphine methyl ether, 
study of the n.m.r. spectra of the various intermediates 
revealed an interesting effect. The n.m.r. spectrum of the 
methoxymethylmorphine compound (16) in deuterochloroform, 
showed the methylene protons Ha and Hb (see 16) as an AB 
system, with chemical shifts '1'" 1~.52 and 5.00 C~ = 6.0 Hz). 
At first it ,'ras thought the methoxymethyl protecting group had 
been introduced at the chiral centre c-6 (see 16), thus 
explaining the magnetic non-equivalence of the methylene 
protons. HOl'lever, the compound (16) sho~/ed no colour reaction 
with ferric chloride and was insoluble in aqueous sodium 
hydroxide, showing that the methoxymethyl function was in 
fact attached only to the aromatic ring and not to c-6. 
Magnetic non-equivalence and consequent geminal coupling of 
methylene protons, similar to Ha and Hb is not unusual in 
itself, and a number of other examples have been previously 
reported. 77 But what is surprisillB is that the n.m.r. spectrtu:l 
of methoxymethylmorphine !i-oxide (17), which possesses an 
addi tional chiral centre, reveals the methylene protons as a 
sharp singlet, 'r4.8O. Further, ~Ie were able to prepare a 
sample of 3-,Q-benzylmorphine (6; R1=CH2Ph, R2=H), and its 
n.m.r. spectrum again showed the methylene protons as a 
singlet at 'T' 4.90. Exactly what causes these methylene 
protons in one case to display magnetic non-equivalence, and 
in the other t~ro examples accidental magnetic equivalence, is 
not fully understood. Time was not available for a fuller 
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investigation, but it might be useful to observe the effects 
of both solvent and temperature on the n.m.r. spectrum of 
these compounds. 
(2-3H]Dihydrodesoxycodeine (10; R=CH3 ).- (2-
3H]Codeine 
toluene-E-sulphonate (13; X=TsO) nas again required, and its 
reduction USing lithium aluminium hydride to give ~-desoxycodeine 
(18; R=CH3 ) proceeded exactly as reported by Rapoport and 
69 Banner. After hydrogenation using Adams catalyst the 
reaction mixture contained a small amount of impurity, and 
the labelled dihydrodesoxycodeine I"las chromatographed prior 
to crystallisation. The impurity is most likely fonned by 
hydrogenolysis, resul:ting in opening of the oxide bridge and 
generation of a phenolic compound. Larger scale reaction to 
produce a quantity of radioinactive material proceeded in the 
same satisfactory manner. 
More difficulty nas encountered during the preparation 
of dihydrodesoxymorphine (10; R = H). The use of pyridine 
hydrochloride for de-Q-methylation of phenol methyl ethers 
is well knonn,78 and Rapoport79 has reported that 
~7-desoxycodeine is de-Q-methylated in this manner at 
215°C to give L}-desoxymorphine (18; R = H). We attempted 
to repeat Rapoport I s preparation, but the reaction mixture beca.r.le 
badly charred, and only a trace of ~7-desoxymorphine was isolated. 
However, pyridine hydrochloride de-Q-methylation of dihydrodesoxycodeine 
gave a fairly clean reaction product '1hich, after chromatography 
on grade HI alumina, gave the required dihydrodesoxymorphine. 
The phenolic alkalOid, obtained pure by sublimation and 
crystallisation, was characterised by m.p., optical rotation, 
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and n.m.r. spectrum. The overall yield from the demethylation 
was not good (~. 20%). 
The preparation of l-bromo-[2-3H]codeine was achieved53 by 
mild bromination of [2-3H]codeine acetate (6; Ri=CH3 , R2=Ac) 
using only 1 mol. of bromine. Basic hydrolysis of the O-acetyl-
l-bromo-[2-3H]codeine, followed by extraction and crystallisation 
gave the required product. [2-3H]Codeine acetate was obtained 
by acetylation of [2_3H]codeine in pyridine with acetic anhydride. 
Once again, preparation of the corresponding morphine analogue 
proved difficult. An acetic aCid/acetic anhydride solution of 
diacetylmorphine (6; Ri =R2=Ac) was bromina ted by care fully adding 
a solution of bromine in acetic acid. Evaporation of the 
solution gave a solid, showing a sharp n.m.r. singlet at 
~2.88 corresponding to one aromatic proton at C-l or C-2. 
The shift down field, when compared with the mid-point of 
the aromatic quartet'T' 3.38 in diacetylmorphine, suggested that 
brominabon had taken place. The material, which was assumed to 
be l-bromodiacetylmorphine, was hydrolysed with aqueous base. 
The hydrolysate Nas acidified to pH 3-4 with dilute hydrochloric 
aCid, and then adjusted to pH 6 by careful addition of sodium 
hydrogen carbonate. Rapid, chloroform-propan-2-ol extraction 
of the aqueous solution and evaporation gave a highly insoluble 
product, which ,"ras chromatographically pure. A white micro-
crystalline precipitate was formed after addition of sodium 
hydrogen carbonate to a hydrochloric acid solution of this 
insoluble product. Because of the lack of physical data 
80 
available on l-bromomorphine, a portion of the precipitate 
was treated with diazomethane. Methylation to give 
58. 
1-bromocodeine, characterised by m.p. and n.m.r. data, proceeded 
very easily. A sufficient supply of 1-bromomorphine was obtained 
in this manner. 
Isocodeine methyl ether (8; R1 =R:?=14e) had previously been 
81 prepared by methylation of isocodeine using dimethyl sulphate. 
A suitable preparation of [2-3H]1socodeine methyl ether was 
achieved by heating [2_3H]codeine toluene-£-sulphonate in 
methanol with a solution of sodium methoxide under reflux. 
Even after rigorous purification, ~ the picrate, the product 
would not crystallise. Purification by distillation as 
81 
re ported by Small and Browning was of 11 ttle use. However, 
proof that the correct compound had been obtained was provided 
by the n.m.r. spectrum which, with the addition of a Signal at 
~ 6.63 (6-0Me), was identical with that obtained for isocodeine. 
Both [2-3H)dihydrOisocodeine methyl ether (9; ~=~=II'Ie) and 
[2-3H]dihydroisocodeine (9; ~=CH3' R2=H), were obtained by 
catalytiC hydrog;·'Hlation of the corresponding 7,a-unsaturated 
compound. Both compounds were obtained crystalline, and the 
n.m.r. spect,a Here consistent with their structures. The 
preparation of dihydroisocodeine methyl ether has not been reported 
previously. 
Samples of these labelled precursors were obtained in the 
manner set out above and administered to P.somniferum plants. 
At the time of these feeding experiments it was thought that 
preparation of their morphine analogues, necessary for 
radiodllution, Hould be relatively simple. However later, 
in the light of experience gained in preparing the morphine 
analogues of the mOdified codeine precursors already described, 
59. 
it was realised that preparation of isomorphine methyl ether 
(8; ~=H, R2=MG), dihydroisomorphine methyl ether (9; ~=H, 
R2=Me), and dihydroisomorphine (9; ~=R2=H) would prove extremely 
difficult. The time necessary to overcome these difficulties 
was not available, and therefore analysis of these particular 
feeding experiments was not possible. 
Precursor Feeding Experiments. - Full details of the 
precursors used in both double- and single-labelled feeding 
experiments are presented in Table 1. These precursors were 
administered to P • somni ferum as foll0l1s. Each was dissolved 
in dilute hydrochloric acid (~. 1.0 ml.). For the double-
labelled feeding experiments, addition of a known small volume 
14 
of an aqueous solution containing [N-methyl- C]codeine hydro-
chloride provided the internal reference standard. The acidic 
solutions of precursors were then adjusted to pH 7 by addition 
of sodium hydrogen carbonate. Normally, too seed capsules 
of thre~ of the plants, P.somniferum Halle variety, were injected 
wi th about half of the aqueous precursor solution using a 
hypodermic syringe. Most of the remaining precursor solution 
was injected on the second day, followed on the third day by 
de ionised water (0.5 ml.) to ensure good mixing in the seed 
capsule. Initial injection of precursor solution took place 
about five to seven days after petal fall, and the plants were 
harvested seven to eight days thereafter. Each of the double-
and single-label feedings were carried out in the above manner. 
However, a small quantity of the aqueous precursor solution 
used in each of the double-labelled feedings was held back 
60. 
Precursor (X I ) Weight S~c.Activ1tl Total Activitl 
mg. mCi/m.mol. mCi x 1.0-2 
(2_3H]codeine 1.2.81. 1..35 5.78 (a),(d) 
(2-3H1dihydrocodeine 10.81. l.2l 4.34 (a),(O),(d) 
(2-3H]dihydroCodeine 1.0.97 1.,2l 4.4 (b), (c), (d) 
(2_3H]isocodeine 9·75 1..2l 3.96 (a),(d) 
(2-3H]isocodeine 9.23 1..2l 3.74 (b),(d) 
(2-3H]Codeine methyl 7.46 1..29 3.09 (a),(d) 
(2-3H]codeine methyl 1.1.28 1..29 4.66 (b),(d) 
ether 
(2-3H]dihydrodeSoXy- 1.4.1.4 0.82 4.07 (a),(e) 
-codeine 
(2-3H]dihydrodesoxY- 20.47 0.82 5.89 (b),(e), (f) 
-codeine 
(2-3H]-1.-bromocodeine 1.3.66 0.93 3·35 (a),(e) 
(2-3H]-1.-bromocodcine 1.3.98 0.93 3.43 (b),(e),(f) 
(2-3H]1socodeine r'lethyl 1.0.30 1..09 3.78 (a),(c),(d),(f) 
ether 
(2_3H]dihydro_ 1.4 .47 1..03 4.88 (a),(d),(f) 
isocodeine 
(2_3H]dihydrOiSO_ 9.08 1..1.4 3.43 (a),(d),(f) 
codeine methyl ether 
Table 1. 
(a) double-label fseding in whioh this sample of unnatural precursor 
1.4 has been mixed with [N-metgyl- C]oodeine,~. 0.01. mCi. 
(b) single-label feeding 
(c) precursor sample could not be crystallised and was used as an oil 
(d) feeding experiment carried out in July 1.969 season 
(e) feeding experiment carried out in July 1.970 season 
(f) feeding experiment not worked-up 
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in order to determine the 3H/ 14C ratio. It was then possible 
14 
to calculate the total activity of [N-methyl- C]codeine added 
in each case. 
General Procedure for Isolation of Alkaloids.- After 
harvesting, the plants were removed to the laboratory, and 
the roots washed with water to remove any soil. In most cases 
the wet weight of the plants was determined, although in the 
double-labelled feedings of July 1969 no weighir~s were made. 
The three plants associated with each feeding were cut up into 
small pieces and left to stand for about two Neeks in ethanol 
(~. 250 ml.). Total alkaloids were extracted from the three 
plants .associated with a particular feeding by, firstly, 
macerating the plant pieces in the ethanol solution using a 
Sunbeam Blender. The resulting ethanol and pulp suspension 
was filtered through celite, and the pulp washed with further 
quanti ties of ethanoL (total ~. 800 ml.). Evaporation of 
the eth<..nol solution f.ave a green mass which, after dissolving 
in dilute hydrochloric acid (0.5 N, ~. 150 ml.), was extracted 
with ether (5 x 50 ml.) to remove non-basic material. The 
ether extract Has washed with water (2 x 50 ml.) and the washings 
combined with the dilute hydrochloric acid solution. The total 
acid solution, after adjusting to pH 8 by addition of sodium 
hydrogen carbonate, was extracted with chloroform-propan-
2-01 (v/v, 9:1, 10 x 50 ml.). Evaporation of the organic 
extract in a tared flask gave the total weight of crude alkaloids. 
An estimation of the tritium activity present was attempted, 
but in general the values obtained were inaccurate because 
colour quenching occurred in the scintillation counter. 
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The first stage in analysis of the feeding experiments 
was to dilute the crude alkaloid extract with the radioinactive 
alkaloids required to serve as carriers. Thus, the extract 
from the feeding of the modified codeine precursor (X') was 
diluted with kno;m weights of the phenolic alkaloids morphine 
and (Y'), and non-phenolic alkaloids codeine and inactive (X'). 
Subsequent stages of the work-up required reisolation and 
purification of these four alkaloids, follol1ed by their radio-
active assay. Fairly typically, the alkaloids were first 
separated into phenolic and non-phenolic fractions. Traditionally 
16,33,53 1 ph ( the pheno ic and non- enolic alkaloids i.e. codeine 
and morphine) have been separated by extraction from aqueous 
solution. Initial extraction using chloroform at pH 14 
removes the non-phenolic alkaloids, and morphine is then 
extracted after the pH has been adjusted to 7. 
proved inadequate when investigating the [2_3H, 
This method 
14 N-methyl- C J-
codeine feeding since both the isolated codeine and morphine 
fractions were still contaminated ~Ii th the green/brown plant 
material. Removing this contamination from morphine using 
normal chromatographic methods proved impossible due to the 
phenolic properties of the alkaloid. He anticipated that 
greater difficulties would be encountered with the other 
feedings which demanded purification of two phenolic alkaloids. 
Therefore a more suitable method, which 1'1ould give very 
aean separation of phenolic and non-phenolic alkaloids and 
also remove the chemical contamination, was required. 
82 McIntosh and co-workers have reported the use of 
Permutit ion exchange resin for separating codeine and morphine 
We reinvestigated this method of separation using a fine mesh 
anion exchange resin, and made suitable adaptations to give 
our previously defined requirements. 
The 'anion exchange resin was prepared in the manner outlined 
in the experimental section (Chapter IV). '!be resin was 
obtained finally in the hydroxide form, and after washing 
wi th 50% aqueous methanol, was slurried into a glass column. 
A trial run using codeine and morphine to test the separation 
of non-phenolic and phenolic alkaloids proved successful. The 
codeine and morphine were dissolved in dilute hydrochloric acid 
and, after basification with potassium hydroxide, the solution 
was poured onto the column of resin. Elution Nith 50% aqueous 
methanol gave 9G% recovery of the non-phenolic alkaloid codeine. 
The phenolic alkaloid morphine, held by the column because of 
the ionic properties of the phenolic group, was eluted using 
0.1 N hydrochloric acid, the recovery being 94~~. Both alkaloids 
were chemically pure by t.l.c. However, \~e required to know 
if there was any radiochemical contamination of the alkalOid, 
and also if any tritium was exchanged from the [2-3H]morPhine 
under the acidic conditions of the separation. 
The following procedure proved sui table to demonstrate that 
this method of separation was completely suitable for our 
experiments. A known weight of [2-3H]morphine with specific 
activity 6.03 x 105 dis/min/ms. was miXed with a known weight 
of radioinactivc codeine, and separation carried out using 
the ion excha:r\£;e me thed • The isolated codeine (99% recovery) 
showed a slight trace of tritium activity (total 259.9 x 
2 10 dis/min.) \'rhich represented a 0 .11~2~ contamination by 
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labelled morphine. A 92% recovery of pure [2-3H)morphine was 
achieved, and its specific activity was found to be 6.49 x 
105 dis/min/mg. Thus, labelled morphine did not exohange tritium 
under the separation conditions, and it is reasonable to assume 
that this situation will apply to all the other phenolic 
alkaloids discussed in connection with these feeding experiments. 
In a similar ~Iay, [2-3H)codeine with total activity 3.37 x 107 
dis/min. was mixed with a known weight of radioinactive morphine. 
After separation, the morphine (91% recovery) showed a small 
amount of tritium activity (total 3.79 x 103 dis/min.), which 
represented 1.13 x 10-2% contamination by the radiolabelled 
codeine. 
Separation of the phenolic and non-phenolic fractions of 
the orude alkaloid extract, isolated from the [2-3H,N-methyl-
14C)codeine feeding, using the above method I~as very successfUl, 
The coloured plant material was held by the ion exchange 
medium, and both the isolated fractions l'lere substantially pure. 
No modification of the method was required for the other feeding 
experiments, and in all cases the coloured plant material was 
removed. The observed contamination of the phenolic alkaloid 
fraction by the non-phenolic (1.13 x 10-2%) and ~ versa 
(0.142%) was considered inSignificant, especially in view of 
the rigorous purification that each alkaloid I~as subjected to 
even before crystallisation to constant specific activity. 
The only corrmon feature in the l'lork-up of the feeding 
experiments was the dilution with radioinactive alkalOids, 
and the separation into non-phenolic and phenolic alkaloid 
fractions. Otherwise, each of these experiments (Table 1) 
required a completely different work-up procedure. The double-
labelled codeine feeding has already been mentioned, and this 
will be described first in the following discussion of the 
analysis of the feeding experiments. 
Separation and Purification of Alkaloids. 
Double-Labelled Codeine Feeding.- [2-3H)Codeine 
1.4 
was mixed with [N-methyl- C)codeine, to give effectively 
double-labelled [2_3H, N_methyl_1.4c)codcine tlhich was fed to the 
plants in the ~Iay already described. This feeding was carried 
out so that we could establish independently a typical value for 
the incorporation of codeine into morphine and confirm that 
Significant de-!!-methylation did not occur. The conditions used 
for feeding this natural precursor were employed later for the 
unnatural preCUl'sor experiments. Moreover, it t'las possible 
during the wor!;-up of this feeding to anticipate and overcome 
problems of separation that were likely to occur with the other 
feeding experiments. 
The traditional1.6,33,53 extraction method was used to obtain 
the non-phenolic alkaloid fraction for this particular feeding 
experiment. The fraction consisted mainly of codeine which was 
obtained pure by chromatography on neutral grade III alum1na. 
Initial attempts to crystallise the codeine to constant specific 
activity resulted in a progressive drop in the 3~4C ratio, 
the value beinG larger than that calculatad for the precursor. 
The small amount of solution held back from the feeding was 
used to determine the V 4c ratiO (5.32) for the precursor. 
The labelled codeine isolated from the plant was rechromatographcd, 
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and crystallised to constant specific activity after dilution 
with more radioinactive codeine. At constant specific activity 
the 3tV-4c ratio was 5.69, which was fairly close to the value 
obtained for thc precursor. Radiochemical purity of the codeine 
was established by treatment with picric acid to form the picrate. 
[2_3H, N_methyl_14C]Codeine picrate was re crystallised and the 
free base regenerated by decomposition of the alkaloid salt on 
a column of neutral grade III alumina. The recovered codeine 
had essentially the same specific activity as that before 
picrate formation. The recovery of unmetabolised codeine, based 
on the 3H acti vi ty, was 2.88%. The corresponding value based 
14 
on the C activity was 2.69%. 
The morphine isolated from the original extraction procedure 
was purified to remove contamination by plant material using 
ion exchange chromatography. Essentially pure morphine was 
obtained which, after further dilution with radioinactive material, 
was recrystallised from methanol to constant specific activity. 
Again the 3Hf14c ratio decreased progressively finally reaching 
a value of 5.56. At which point the 3H molar specific activity 
5 14 
of the morphine l1as 46.0 x 10 dis/min/mmoL and the C 
molar specific activity was 82.8 x 104 dis/min/mmol. 
Radiochenueal purity of the isolated morphine was shown 
by formation of the diacetyl derivative. A trial experiment 
using a sample of [2-3H]morphine indicated that there was no 
loss of tritium on formation of this derivative. The diacetyl 
derivative of the biosynthetic morphine showed, after chroma-
tography and crystallisation, a 3H activity of 41.0 x 105 
14 4 dis/min/mrnol. and a C activity of 82.1!- x 10 dis/min/mmol. 
These figures represented a codeine into morphine incorporation 
of 1.04% based on 3H specific activity, very similar to the 
14 
value of 0.9~ based on C specific activity. Surprisingly 
the 3a;l4c ratio for the isolated codeine (5.69) and morphine 
(5.57) were not exactly the same, and differed slightly from 
the ratio determined for the precursor (5.32). Statistical 
analysis of these ratios (see Appendix) demonstrated that 
the differences ~lere Significant. However, we considered that this 
did not seriously affect the use of [N_methyl_14C)codeine 
as an internal standard. The results of the natural precursor 
feeding were therefore largely as expected, and the details 
are summarised in Table 3. 
[2-3H)Dihydrocodeine (7; !h~=H) Feeding.-
The crude alkaloids from both the double- and single-labelled 
feedings were separated by ion exchange, and recovery of their 
respective phenolic and non-phenolic fractions was high 
(above 95%) with the exception of the phenolic fraction 
from the double-labelled feeding (recovery 56%). Separation 
of dihydrocodeine from codeine, and dihydromorp.'1ine (7; 1\=~=H) 
from morphine t'1as very difficult since the respective pairs 
of alkaloids ran almost together in most t.l.c. systems. 
Basic silica p.l.c. plates, made using sodium hydroxide 
solution instead of water, proved most suitable for separating 
these pairs of alkaloids. Initially, several separatiOns of 
the codeine/dihydrocodeine fraction, isolated from the single-
labelled feedil1[l, were achieved using alumina p.l"c. plates 
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impregnated with silver nitrate. 
D1hydrocodeine, obtained from the initial separation of 
14 3 the non-phenolic alkaloids, showed some C as well as H 
activity. 14 It was important to know if this C activity arose 
from a genuine incorporation or because of inadequate separation 
from codeine; the following procedure was used for purification. 
The dihydrocodeine (X I ) was mixed with an equal weight of radio-
inactive codeine (X). Plate chromatography, as described above, 
allowed rei solation of the radioactive dihydrocodeine (X'). 
After radiochemical assay, the dihydrocodeine was again diluted 
with radioinactive codeine and the separation repeated. The 
whole purification procedure was normally carried out about 
five times, for each of the four alkaloids associated with 
the feeding, until we were satisfied that they were free from 
major radiochemical contamination. This technique was used 
in the work-up of all the feeding experiments, resulting in 
rigorou~ purification of the isolated alkaloids. 
The single-labelled feeding experiment was looked at first, 
and the best conditions for work-up were established. This 
feeding showed an incorporation of dihydrocodeine into dihydro-
morphine of 0.51% (see Table 2). The double-labelled feeding 
showed similar incorporation 9f dihydrocodeine into dihydro-
morphine (0.59%). The simultaneous codeine into morphine 
incorporation Has 1.26%, making the unnatural conversion 46.7% 
as efficient as the natural one (Table 3). Although the 
results from both the double- and single-labelled feedings 
were substantially in agreement, the latter shOl-led conversion 
of dihydrocodeine into codeine (0.1%) and into morphine (0.02%) 
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while the former showed no conversion of this type. '!he 
possibility that conversion into codeine and morphine had 
occurred in the double labelled experiment, but had not been 
14 
observed due to the relatively high C activity of both the 
codeine and morphine, was considered. FUrther, the codeine 
and morphine isolated from the single-labelled experiment 
had a very low tri tiuin count rate i.e. 100-200 cpm/rng. (see 
Chapter IV). However, it will be recalled that the (2_3H]_ 
dihydrocodeine precursor was obtained as an Oil, and was 
poss1bly contaminated by (2-3H]codeine. 1berefore, a sample 
of the precursor was mixed with radioinactive codeine; which 
was reisolated, and purified by chromatography and crystallisation. 
In this way it Has shown that the original precursor material 
was contaminated by (2_3H]codeine, the maximum value being 
0.735%. 
The presence of 0.735% [2-3H]codeine in the [2-3Hnihydro-
codeine precursor used for the single labelled experiment would 
mean that the apparent incorporation (0.1%) of dihydrocodeine 
into codeine is really a 15.4% recovery of unmetabolised codeine. 
14 This figure is in agreement with the recovery (N-methyl- C]codeine 
(19.4%) for the double-labelled experiment. Similarly the 
apparent incorporation (0.02%) of dihydrocodeine into morphine, 
corresponds to a conversion of the contaminating codeine into 
morphine of 2,116%. 
The recovery of unmetabolised dihydrocodeine in both the 
double- and single-label EKperiments was rather high (31.8% and 
39% respectively). as was the recovery of unmetabolised codeine 
(19.4%) • These high values may be due to the precursor's 
being allowed too short a time for metabolism. It does 
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demonstrate, hOl'/ever, the importance of the double labelled-
feeding experiment which utilises an internal standard. 
The labelled dihydromorphine isolated was shown to be 
racUochemically pure by forming the diacetyl derivative. The 
derivative was heated with aqueous methanolic potaSSium carbonate 
in a sealed tube and the dihydromorphine isolated showed that 
96% of the radioactive label had been lost by exchange. Thus 
3 the tritium label in the [2- Hldihydrocodeine had not been 
scrambled during its conversion into dihydromorphine. 
[2-3HlIsocodeine (8; R1=CH3,R2=H) Feeding.- The 
initial separation and purification using the ion exchange 
procedure worked well. The non-phenolic alkalOids, codeine and 
isocodeine, were separated and purified prior to crystallisation 
by chromatography on neutral grade HI alumina. The phenolic 
alkaloids isolated from the plants were purified by chromatography 
of their 3-Q-acetyl derivatives on neutral grade V alumina (see 
above) • 
In the single- labelled feeding experiment isocodeine 
showed a 0.27% incorporation into isomorphine, and negligible 
incorporation into codeine « 8.1 x 10-3%) and morphine 
(<: O.o2%HTable 2). The double-labelled feeding showed 
high incorporation of isocodeine into isomorphine (1.38%), but 
14 
the [N-methyl- cl codeine incorporation into labelled morphine 
was even higher (9.1%). Comparison of the unnatural conversion 
with the natural one gives an efficiency of only 15.2% (Table 
3). Exchange of the tritium label from the isomorphine, isolated 
from the double-labelled experiment, showed again that the 
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labelling pattern of the precursor had been preserved during 
its biological demethylation. 
[2-3n]Codeine Methyl Ether (6; !la =~=Me) Feeding.-
Again the separation of the phenolic and non-phenolic alkaloids 
isolated from both the double- and single-labelled eXperiments 
was fairly good (79-100%). Use of alumina P.l.c. plates gave 
good separation of the non-phenolic alJ<aloids, codeine and 
codeine methyl ether. The purification technique, whereby 
the isolated radioactive alkaloid (X') is miXed with radio-
inactive (X) and then reisolated, was employed as in the work-
up of all the other feeding experiments. Much more dHficul ty 
was again encountered during the separation of the phenolic 
alkaloids, morphine and morphine methyl ether (6; ~=H, R2=Me). 
Although inadequate, it was possible to obtain some separation 
of these two alkaloids using p.l.c. alumina plates developed 
in an n-butanol/di-n-butyl ether/ammonium hydroxide solvent 
system. Later, however, better separation was obtained using 
n-butanol/di-n-butyl ether/acetic acid83 as the solvent. 
The single-labelled feeding experiment showed incorporation 
(Table 2) of codeine methyl ether into codeine (0.88%) and 
morphine (0.05%), but its major conversion was into morphine 
methyl ether (1.02%). These results were in reasonable agree-
ment with those obtained from the double-labelled eXperiment 
(Table 3). Here, codeine methyl ether was incorporated into 
codeine (0.491$), morphine (0.08%), and into morphine methyl 
14 
ether (0.62%). The conversion of the [N-methyl- Clcodeine 
into morphine tlas 0.90%, giving the unnatural 3.0-dimethylation 
. -
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process a 69.4% efficiency compared with the natural one. 
14 Surprisingly the [N-methyl- C]codeine showed a 0.18% incorporation 
14 
of C activity into codeine methyl ether. This 6.Q-methylation 
~las 20.1% as efficient as the natural 3.Q-demethylation of 
codeine to give morphine (1.e. the X - Xl efficiency value). 
X-Y 
A sample of the labelled precursor material was mixed with 
radioinactive codeine which-, after reisolation and. crystallisation 
showed that the [2-3H]codeine methyl ether contained 0.006% of 
codeine. This amount of contamination by codeine was insignificant 
and therefore the observed incorporation of codeine methyl ether 
into codeine and morphine was genuine, and not due to the presence 
of [2-3H)codeine. 
[2_3H)DihYdrodesoxycodeine (10; R = CH3 ) Feeding.-
Although both double- and single-labelled feeding experiments were 
performed, only the double labelled one was Norked-up. In! tial 
separation of the phenolic alkaloids, morphine and dihYdrodesoxy-
morphin., (10; R = H), using basic silica p.l.c. plates developed 
in methanol was not too successful. The dihYdrodesoxymorphine 
fraction contained some morphine while the morphine fraction 
~Ias contaminated by dihydrodesoxymorphine. Earlier however, 
during preparation of dihYdrodesoxymorphine, it was found that the 
latter alkaloid was readily soluble in chloroform and easily 
chromatographed on neutral grade III alumina. Therefore it was 
not surprising that good separation of the phenolic fractions 
\~as achieved using neutral grade V alumina. Grade V alumina 
allowed the morphine to be eluted, by a chloroform-methanol solvent 
miXture, after removal of the dihYdrodesoxymorphine with 
chloroform. Fractions isolated in this way from the column 
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~Iere analysed using t.l.c. chromatography and scintillation 
counting. 
The dihydrodesoxycodeine showed very high incorporation into 
dihydrodesoxymorphine (9.27%), higher indeed than the parallel 
14 
conversion of [N-methyl- C]codeine into labelled morphine 
(8.55%). No incorporation into any of the other alkaloids was 
observed, and 30 .6i~ of the unnatural precursor was recovered 
unmetabolised. Therefore this unnatural precursor was demethylated 
by the plant to give the corresponding unnatural product with 
greater efficiency than that for de methylation of the natural 
precursor, codeine. 
[2_3H]-1-BromOCOdeine (ll;R = CH3) Feeding.- All the 
feeding experiments described so far have involved unnatural 
precursors modified Qy changes to the C rin~ of the codeine molecule. 
Incorporation of all these precursors into unnatural products has 
been observed. To extend our study we were anxious to investigate 
the inccrporation of other unnatural codeine precursors which 
had been modified at a different 'site' in the codeine molecule. 
~le decided to investigate the effect of modification to the 
aromatic ring of the codeine molecule and, in particular. the 
metabolism of l-bromocodeine by P.somniferum. Originally 
l-chlorocodeine was selected as the unnatural precursor, but 
investigation of the literature indicated that the morphine 
analogue, 1-chloromorp.l-tine, 'Ias not a crystalline compound. 
Again, both double- and single-labelled feedings of 
[2_3H]-1-bromocodeine were carried out, but only the double-
labelled experiment was analysed. The phenolic alkaloids isolated 
from the ion exchaIl8e separation were treated with pyridine and 
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acetic anhydride and their Q-diacetyl derivatives obtained. 
Separation of these two diacetyl derivatives Nas effected by 
p.l.c. on alumina plntes. But subsequent purification of the 
phenolic alkaloids, after basic hydrolysis of their diacetyl 
derivatives, was by p.l.c. on basic silica plates. The non-
phenolic alkaloids could not be separated, as previously, by 
chromatography on alumina. However, their separation was also 
effected using p.l.c. on basic s11ioa plates. The main problem 
associated with this feeding experiment was that of the insolubility 
of I-bromomorphine (11; R = H). Again, as during its 
preparation, the alkaloid was obtained as a micro-crystalline 
material by precipitation from neutrc.l solution. 
The (2-3H]-1-bromocodeine precursor showed a 0.15% 
incorporation into labelled 1-bromomorphine. Not only was this 
the lowest (X') into (y') conversion we had observed, but also 
the least efficient (5.9%) relative to the concurrent codeine 
into morphine conversion (2.57%). A fairly high recovery of 
unmetabolised I-bromocodeine (35.2%) and codeine (61%) was 
observed. Although the isolated I-bromomorphine was 'crystallised' 
to constant specific activity and we were able to provide proof 
of its radiochemical purity by derivative formation, no attempt 
Has made to remove the tritium label from the molecule by 
exchange. The reason vIas simply the insolubility of 1-bromo-
morphine in all suitable solvents. The other three alkaloids 
\'lere shown to be radiochemically pure in the normal manner. 
Discussion of Results. The advantage of carrying 
out both double- and single-labelled experirilents has been 
demonstrated, and there is fairly good agreement between both 
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sets of results. However, the most important results are those 
obtained from the double-labelled feeding experiments which 
utilise the internal reference standard. These results are 
presented in Table 3, and a graphical representation of the 
efficiencies of the unnatural conversions compared with the 
natural one is given in Fig. 4. 
It can be readily seen that both the unnatural precursors 
dihydrocodeine and isocodeine were incorporated into their 
corresponding unnatural products. Of the tl'/O, isocodeine is 
the least efficiently 3-Q-demethylated relative to the natural 
conversion of codeine into morphine. That dihydrocodeine, which 
contains no 7,8-olefinic double bonc, is incorporated into 
dihydromorphine suggests that the unsaturation present in the 
C ring of codeine is not involved in CO-Ordinating the 
molecule to the surface of the demethylatin,c; enzyme. It seems 
, likely that the oxygen of the C-6 group in both dihydrocodeine 
and isccodeine in some way hinders the co-ordination of the 
particular precursor to the enzyme surface. A better idea 
of the differing environments occupied by tile C-6 hydroxyl 
group in code1ne, dihydrocodeine, and isocodeine can be 
gained from the follOl"ling. The C ring of the unsaturated codeine 
molecule (Fig.5) has a half boat conformation,84 giving the 
hydroxyl group at c-G a quasi-equatorial position below the 
plane of ring C E.Ild on the opposite side of the molecule to the 
nitrogen bridge. Thus in isocodeine (Fig.7) the hydroxyl function 
occupies a ouasi-axial position above the plane of ring C and on 
the same side of the molecule as the nitrogen bridge. "hen 
the C ring is saturated, as in dihydrocodeine (Fig.6), it has 
76. 
Results of Single Labelled Feeding Experiments 
Involving Modified Codeine Precursors 
Hodif1ed codeine X' X-Codeine y' Y-Morphine 
Erecursor [2-3H]X' %re cove !l I % incor- I 
[2-~)dihydrocode1ne ~rat1on 39 0.51 
[2-3H)isocodeine 9.4 < 8 .l.x1.0 -3 0.27 < 0.02 
[2_3H) codeine 16.4 0.88 1.02 0.05 
methyl ether 
Table 2. 
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Resul t of Double Labelled Feeding Experiments 
Involving MOdified Codeine Precursors 
Xi X yi Y 
Modified precursors 
[2-"'H)X' and I:---
internal standard-X. 
Codeine !·!orphine 
% recovery/incorpor- I 
ation 
[2_3H) codeine 2.88 1.01} 
14 2 .69 [N- CH_)codeine 0.99 ;; . 
[2-3H)dihydrocodeine 31.8 zero 0.59 zero 
14 19.4 1.26 [N- CH_)codeine zero zero 
"' [2_3H) isocodeine 32.0 <0.01 1.38 <0.01 
111 [N- CH
3
) codeine <3. 73xlO-3 J6.2 <0.05 9.1 
[2_3H) codeine 
met£ti:l ether 
[N_1 CH
3
)codeine 
[2-3H]dihydro-
desoxycodeine 
14 [N- CBL)codeine 
- ;; 
[2-"'H)-1-bromo-
codeine 
14 [N- CH_)codeine 
.:> 
(1) 18.11 
(2 ) 0.18 
30.6 
<0.08 
35.2 
<0.03 
0.49 0.62 0.08 
14.6 < 116xlO-4 0.90 
zero 9.27 zero 
38.4 <0.07 
< 2.20xlO-2 0.15 
61.0 <0.04 2.57 
Table 3 
Efficiency of 
Conversion 
(a ) 
1.5.2 
69.4, (b ) ... 54.5, 
(c) .-8.9, 
(d).-20.1, 
109 
5.9 
(a).- The efficiency of the unnatural conversion (X') into (y') 
expressed as a % of the natural conversion (X) into (y) ~. 
X'- y' value 
X_y 
(b). X' _ X efficiency. (c).- X' ~ Y efficiency. (d).- X ~ X'efficiency 
X _y X ~y X_Y 
(1) Total % incorporations of [2-3H)codeine methyl ether = 0.49 
+ 0.62 + 0.08 = 1.15(~ 
(2) 14 Total % incorporations of [N-methyl- C]codeine = 0.18 + 
0.90 = 1.08% 
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Fig. 4. 
~.l% X-X' % 
~I"---" X _ y 
109% ;-1\ -
Dihydrodesoxycodeine 
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n 
a slightly deformed chair conformation.84 Thus the hydroxyl 
group at c-6 is located under the plane of the ring in an 
axial position and, on the opposite side of the molecule to 
the nitrogen bridge. Dreiding models of codeine (Fig.5), 
dihydrocodeine (Fig .6), and isocodeine (Fig. 7) I~ere constructed, 
and a more quanti tati ve illustration of the liay in i'lhich the 
position of the oXYGen function is changing l'las obtained. 
l-leasurement of the distance from the C-6 oxygen to, the ni trogen 
(a), to the oxygen of the aromatic methoxyl (ArOCH3 ) (b), 
and to the oxygen of the oxide bridge (c), Has made for each 
of the three models. The distances measured (a), (b), and 
(c)are illustrated in Figs. 5, 6, and 7; their values are given 
in Table 4. 
(!!.) 
Codeine (Fig.5) 6.5 
Dihydrocodeine (Fig.6) 6.0 
Isocodeine (Fig.7) 5·5 
Table 
<!~) 
Approx.Distance 
4.5 
3.S 
6.2 
4 
~ 
2.6 
2.5 
3.5 
Originally, from the results of the dihydrocod~ine and 
isocodeine feedings, it was thought that the precursors might 
be co-ordinated to the enzyme via the lone-pair electrons of 
the c-6 oxygen or ~ hydrogen bonding involving the hydroxyl 
group. Therefore the differing positions of the c-6 oxygen 
l'lere making co-ordination difficult (compared with codeine) and 
hence reducing the efficiency of 3-Q-demethylation. If this 
was the case dihydrodesoxycodeine, which possesses no c-6 oxygen, 
should show very inefficient incorporation, by P.somniferum, into 
SO. 
H 
7 
M~N 
Fig. 5 Fig.6 
Fig. 7 
its corresponding unnatural product. However, the incorporation 
of dihydrodesoxycodcine into dihydrodesoxymorphine \~as more 
efficient than the codeine demethylation process. Therefore 
the presence of the C-6 hydroxyl group is unnecessary for 
3~-demethylation. However, when the c-6 hydroxyl group is 
present its exact position is important the most efficient 
demethylation occnrring for codeine rather than for 
dihydrocodeine or isocodeine. 
The above measurements, made for codeine (Table 4), are 
the same as those for Codeine methyl ether, which showed very 
good incorporation into morphine methyl ether (0.62~). Further, 
we also observed incorporation into codeine (0.4gr,j) and into 
morphine (0.08%), a result whieh is in agreement with the 
findings of Brockmann-Hanssen 49 51 and also Rapoport. 
Comparison of the total percentage incorporations of codeine 
methyl ether (1.15%), and codeine (1.08%), into both natural 
and unna.tural products suggests that the former is at least as good 
and possibly a better metabolised precursor than codeine (Table 
3). The unnatural incorporation of codeine methyl ether into 
morphine methyl ether >Ias 69.4% as efficient as the natural 
one, and results from both double- and sinGle-labelled 
experiments were in good agreement. Surprisingly, I"/e also 
observed the incorporation of codeine into codeine methyl ether 
(0.18%). This suggests that codeine methyl ether occurs 
naturally in P.somniferum and that some sort of equilibrium 
exists between codeine and its methyl ether. If this is 
correct, then there might be two possible routes for the 
conversion of thebaine into codeine, one proceeding ~ 
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codeine methyl ether. Evidence provided by both Rapoport51 and 
Battersby53 favours the route which involves codeinone as an 
intennediate. Further work is therefore necessary to establish 
the exact nature of the intermediate involved during the natural 
conversion of thebaine into codeine. Probably the most sui table 
experiments would involve feeding radiolabelled thebaine, and 
investigating its incorporation into all the alkaloids that can 
theoretically serve as the intermediates. It would also be 
interesting to investigate if codeinone is incorporated into 
morphinone under conditions similar to those in which codeine 
methyl ether is incorporated into morphine methyl ether. 
We turn now to the feeding ex; "lr!ments ~ri th the unr.;;tural 
precursor l-bromocodeine. Introduction of a bromine atom at 
C-l in codeine is lil<ely to exercise both an electronic and a 
steric effect on the 3-methoxyl group. Therefore it was not 
surprising to observe the very low efficiency for the conversion 
, 
of l-tt"omocodeine into l-bromomorphine. The 101'1 incorporation 
value is most likely due to the steric influence of the bromine 
atom which hinders the close approach of the enzyme to the methoxyl 
group and thereby inhibits demethylation. Even though the 
incorporation value is low it is surprisinz that the enzyme 
system still possessffithe ability to accept this unnatural 
precursor. 
We were able to show in all our other feeding experiments, 
by exchange of the tritium label, that all the unnatural phenolic 
alkaloids were biosynthesised from the unnatural precursors 
without scrambling of the label. As indicated previously the 
tritium label, assumed to be at C-2, of thc isolated radioactive 
l-bromomorphine was not removed by exchange due to solubility 
problems. However, it was considered unlikely, in view of 
our previous experiences, that the unnatural precursor 
l-bromocodeine was broken down into smaller components before 
being incorporated, by the plant, into l-bromomorphine. 
In conclusion, 1'1e have observed that a particular demethyl-
ating enzyme or system of enzymes, in P.somniferum, is capable 
of accommodating unnatural precursors and converting them with 
surprising efficiency into their corresponding unnatural 
products. We have been able, through these studies, to gain 
some insight into the way in which this enzyme system works. 
In extending the "ork which h'\s been described here, it 
I~otlld be very 1)seful to study the parts played by both the nitrogen 
associated with the C-15-C-16 bridge and the oxygen of the oxide 
bridge during demethylation of suitable unnatural precursors. 
It may be that the lone-pair electrons of the nitrogen play an 
important part during the demethylation of codeine, and feeding 
of a codeine metho-salt would provide evidence for this. 
Similarly the oxygen of the oxide bridge mtly be important, and 
feeding the unnatural codeine type precursor (19), to 
P.somniferum, would be of interest. This compound (19) is 
modified in both the C ring and the aromatic ring close to the 
site for demethylation; there is also one less hetero atom 
available for the donation of lone-pair electrons. 
Studies, similar to our own, could be usefully applied to 
other plant systems. It may be, that work of this type will 
help to increase our understanding of the mechanisms by 
which alkaloids are biosynthesised in their natural systems 
84. 
and certainly of the substrate specificity of the enzymes 
involved. A great deal of interest is no\'] shmm in the 
mechanisms and cnzymology of alkaloid formation, and it is 
this area which ,-/ill provide the most challenging topics for 
future research. 
Chapter III 
OxoniUJ:! Ion Intennediates in the RenrranQer.lent of Thebaine 
86. 
The importance of the l-be~zylisoquinoline, 
reticuline, and its phenel oxidative coupling for the 
biosynthesis of morphine has been described in Chapter I. 
Study85 of the biosynthesis of the Erythrina alkaloids, 
erythratine (4) and erythraline (5) in Crythrina crista_Ralli, 
has demonstrated the importance of the l-benzylisoquinoline 
(1) as a precursor. After the initial para-para phenol 
oxidative coupling of ~-norprotosinomenine (1) to give (2) 
it is thought that rearra~gemcnt, involving the nitrogen 
lone-pair electrons, occurs to give ultimntely erysodienone 
(3) (sec Scheme 1) >rhich subsequer,tly gives erythratine (4) 
and eryth,."aline (5) as indicated. 4. "inilar type of 
rearrangement is involved in the suggested biosynthetic 
pathway 
Eiers. 
to protostephanir.e (11; RI =~~2=1.le) in Stephania japonica 
86 The ;:;ostulated path>Tay involves initially para-para 
phenol oxidative coupling of the l-benzylisoquinoline (6) to 
give the dienone (7; R=H). The dienol (8), formed by 
Q-methylation and reduction of (7; R=H), mny then undergo the 
rearrangement (8) ~ (9) --. (10), followed finally by reduction 
of (10) to !:)i ve protostel'hanine (11; RI =R2=l';e) • Scme 
""' evidence for this path>ray was provided by Hackett who 
observed that the rnorphinandienor.e (7; R=H) WaS incorporated 
(2.95D by S. japonica into ,Jrotostephanine. JUSO, Battersby 
~ ~.87 have been able to synthesise protostephanine by a 
route l<hich is related to the above biosynthetic pathway 
(Scheme 2.). These l<orkers oxidised the di~henol (6), using 
ferricyanide, to give the dienone (7; R=H) which was 
0 
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Q-methylated to give protostephanone (7; R=Me). Reduction 
of ('1; R:.Me) gave a quantitative yield cf the epimeric 
dienols (8) which, rearranged to give (12) on catalytic 
treatment with sulphuric acid. ~'.'hen the dienone (12) 
was heated with magnesium iodide and the products reduced 
"Ti th lithium aluminium hydride the two phenols (11; RI =H, 
R2"",e) and (11, Rl =R2=H) were isolated. Q-Methylation of 
these two phenols, using diazomethane, gave protostephanine 
(11; Rl =R2=Me). A similar diencne (13) was obtained
88
, 
!.!!. vitro, from a mixture of the ~-acetylnorsinoact1tinols (1"') 
kept at room temperature in IN 'hydrochloric acid; thc 
dienols (1"') were derived from norsinoncutine (15). This 
result wns at the time a little surprising to the authors 
in view of thlJ: accepted rearrangement of the salutnridinols 
(described in Chapter I) to give thebaine. 
Another morphinandienone all<aloid found to 
undergo a similar acid catalysed rearr~ngement, involving 
the nitrogen IPne pair electrons, is amurine (16). It was 
observed89 thnt (16), when heated ,.i th 3Nhydrochloric acid 
gave (21). The mechanism suggested for this rearrangement 
in outlined, (16)~ (21), and is analogous to that proposed 
by Stork90 for the transformation of thebaine (22) into 
thebenine. It was thought that when thebaine (22) is 
dissolved in concentrated hydrochloric acid, ns in the 
initial stages of tha latter transfonilation, that the 
resultant9l red solution contains90 the protonated form of 
the dienone (23; R=H). Atter.lpts to isolate the dienone 
from the red solution have always given ill defined products9l , 
90. 
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ho~rever, reduction of the solution gives metathebainone9l ,92 
(24). He ,rere interested not only to identify the major 
constituents of this red solution, but also, because of the 
general biosynthetic significance, to study in detail the 
meclmnism of the rearrangement. l'le investigated spectrophoto-
motrically the reactions of both thebaine and its metho-salts 
in concentrated hydrochloric acid and in trifluoroacetic acid. 
The metho-salts of thebaine were used in our study since, in 
these compounds, the nitrogen lone pair electrons ere not 
available for aromatisation of the C-ring. Fleischhncker 
~ E!.93 later reported the preparation of 7,8-dehydrorneta-
thebainone methoperchlornte (25; R=~;e) by treating thebaim, 
methoperchlornte with aqueous perchloric ncid. 
The rearrang~ent, in concentrated hydrochloric 
acid, of thebaine and its rnethoiodide and methochloride was 
studied using u.v. spectrornetry. The final solutions had 
identical U.Vo spe~trn and corresponded well with thnt 
recorded for thebaine in hydrochloric acid. However 
preparative scale work waS unsatisfactory due to the low 
solubility of the thebaine metho-salts in concentrated 
hydrochloric acid. Use of trifluoroacetic acid did not 
hel?, but it was found that the u.v. spectra of the metho-
salts in this acid were identical with those obtained in 
hydrochloric acid. The work described above was carried out 
by lI-ir R. T. Channon in these laboratories. 
We anticipated that the problem of solubility 
could be over~orne by using thebaine methotrifluoroacetate 
93. 
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and trifluoroncetic acid. The u.v. spectral changes for 
the rearrangement of thebaine methotrifluoroacetate in 
concentrated hydrochloric acid were studied. The re~ction 
proceeded at qualitatively the same rate as for the other 
methe-salts (t,ca. 2 min at 34°c) and the u.v. spectra of 
a 
the final solutions were identical to those observed by 
Channon. The shape and intensity of the absorption curve 
at ca. 400nm., for all the metho-salts, was sensitive to 
acid conccntr~tion; addition of concentrated sulphuric 
acid cC\used enhancement while addition of water reduction 
of absorption in this region. It appeared that quaternisa-
tion of thebaine did not significantly "Iter the course of 
the acid-cata'lysed rearrangement. 
Thus, thebaine methotrifluoroacetate, prepared 
f'rom the corresponding methiodide by treatment w"ith silver 
trifluoroacetate, was selected for the detailed investigation 
of the re~rrangement. This salt dissolved readily in tri-
fluoroacetic acid to give a solution which rapidly develop-
ed an intense absorption band at 420 l1r.l. (Fig. I. curve J~). 
This band diminished in intensity with time at ambient 
tenperature, and was eventually re~laced by a broad b~nd 
(Fig. 1. curve B.), A 322 ru", (€ 7,130). 
max. 
The high 
solubility of thebaine methotrifluoroacetate in trifluoro-
acetic ecid enabled us to observe th~ rearrangement using 
n.m.r spectroscopy. A quantity of the metho-salt (~. 60-
7Omg.) was dissolved in trifluoroacetic acid and immediately 
transferred to an n.m.r. tube. The spectrum of the freshly 
95. 
generated red solution showed the ~ethoxonium ion 
(25; R' =R' '=t-ie) to be present as the major species 
(see Table 5). The presence of the ion (25; R'=R"=Me) 
was indicated primarily by the position of the 6-methoxy-
group which resonated at lower field (s, ~ 5.34) than 
the aromatic methoxy-group (s,'1: 5.94). The Olefinic 
~roton signals showed the expected94 H(5,7) and H(7,8) 
coupling constants (J 7 2.2 and J
7 
8 10.1 Hz). The 
-5, - , 
methoxy-singlet, occurring at '1' 5.34, dir.1inished with 
time and was replaced by L\ signal at '1' 5.98 which is 
presumably due to methyl trifluoroacetate. After Ih. 
the solution, then yellow, gave nn n.C1 .... spectrum fully 
consistent \dth that expected for the quaternary dienone 
(23; R=Ne). 
The rearrangcnent was c(!rriecl out on u 
preparative scale, and. thebaine methotrifluoroncetnte \-taB 
allowed to react to ccm~.lletion (the solution was yellow) 
., 
in trH'luoroacetic acid at room temperature. The solvent 
",as removed ..!!! vacuo and the trifluoroac~tatc anion l:lnS 
replaced by chloride, using "nn ion exchange resin, to give 
7,8-dehydrcmetathebainone ;;,ethochlorlde (23;R~T·.'-e) 
~ -1 \ aCIorpholiS yellow powder; 1660cm., " max mnx (EtCH) 
304nm. (€ 8(50). The same salt was obtnined more direct ly 
by troating thebaine methotrifluoroacetnte t"ith ccncentrc.ted 
hydrochloric ucid. 
The u.v. spect~~ of the prepared dienone (23; 
R=Me) ''''s obFerved. This showed a wavelength shift 
(A 304~322 and 44orun.) upon addition 0'" alkali, 
mox. 
96. 
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Fig. 1. 
Electronic absorption spectra of dehydrometathebainone 
derivatives in CFs .C02 H ; 
R" = Me), (E) the dienone 
(A) the methoxonium ion (25; R'= 
(23; R= Me); the wavelength 'scale 
expands two-fold below 350 nm. 
N.rn.r. sEectra of deh;ydrome'tathebainone derivatives 
., values (J in Hz) 
H-5 H-7 H-8 MeO MeN Solvent 
(23; R= Me) 3.58 3.61 2.50 6.17 6.59, D2 0 
(2.2) (10.0) '1.14 
2.78 3.26 2.30 5~96 6.46, CF3 • C0,t H 
6~89 
(25; R'= R' , 1.96 • 1.40 5.34, 6.32 , CF3 • C0.1. H 
= Me) (2.2) (10.0) 5.94 6.82 
(25; R'= Me 1.97 • 1.40 5.34, CF3 .C0;t H 
R' '= H) 5.99 & H;LS04 
(25; R'= H 2.09 • 1.46 5.90 , 6.32 , CF3 • CO,.H 
R' '= Me) 6.82 & H,t S04 
• Signals,for H-7 overlap aromatic quartet ./'ca. 2.9 
Table 1. 
resembling that otzerved for metathebainone ( A 296~ 
. max. 
317 and 425nm.) and is consiztent with the presence of an 
enone chrornophore conjugated with e phenyl residue which 
carries an ortho-hydroxyl-group. The dienone (23; R=Me) 
waS hydrogenated to give rnetathebainone methochloride. 
Chloride ion WaS exchanged for iodide and the observed u.v. 
and i.r. spectra were identical with those obtained for the 
product isolated after treating an authentic sample of 
metathebainone with methyl iodide. The dienone (23; RdMe) 
was characterised further as its erystalline Reineckate salt. 
Addition of concentrated sulphuric acid (ca. 2% v/v) to a 
solution of the dienone (23; RdMe) in trifluoroacetic aci~ 
generated the hydroxonium ion (25; R'=H, R"cl-Ie); .A max. 
407nm. (~11,8oo). The n.rn.r. spectrum of this ionic 
species (see Table 1.) closely resembled that of the initially 
observed 6-+Q-methyl derivative (25; R' =R" =Me). 
The spontaneous demethylation of the 
methoxonium icn (25; RI=RI'=Me) to give the dienone (23; 
R=Me), in trifluoroacetic acid, wns studied further. The 
tranSformation waS not significantly accelerated by an 
increased concentration of trifluoroacetate nnion, pro-
duced by addition of sodium acetate to the solution. Also, 
"Then thebaine rnethotrifluoroacetate was aissolved in tri-
fluoroacetic acid containing concentrated sulphuric acid 
(2% v/v) (hereafter abbreviated to CF3 .C02H-H2S04 ) a 
I I I 
solution of the red methoxonium ion (25; R =R =~1e), 
~max. 420nm. (£ 14,800), was produced which "as stable 
98. 
for several h. Therefore it appeared that neither the 
trifluoroacetate cnion nor the resonance stabilised 
hydrogen sulphate anion were sufficiently good 
nucleophiles to promote loss of the methyl group. However, 
addition of wnter (~. 2% v/v) to the red trifluoroacetic 
acid solution produced an increase in the rate of 
demethylation, while the use of freshly dried trifluoro-
acetic acid as solvent had the rewerse effect. Thus the 
demothylation of the oxonium ion must involve attack of 
water at C-6 as the initiai step. 
Thebaine itself dissolved in trifluoroacetic 
acid to give a transient red compound, ). 420_., 
max. 
presumably the methoxonium ion (25; R'=Me, R"=H). This 
species decomposed too rapidly at 350 C to be conveniently 
studied by n.~.r. spectroscopy. In CF
3
.C02H-H2S04 , however, 
thebaine formed a stable red soluticn,)., • 420n.m. 
max 
("E 15,400). The n.m.r. spectrum of this solution wns 
observed and indicated, particularly by occurrence of a 
singlet at..,... 5.30, that the ion (25; R'=I"e, R""cH) Was 
present. The solution of thebaine in trifluoroacetic acid 
lias kept at room temperature until disappearance of the 
42~. absorption band was complete. At this point the 
solution showed no significant u.v. absorption above 
300~, and was yellow in colour. It seemed likely, in view 
of other evidence90 ,95" thnt decaoposition of the ion 
(25; R' =l4e, R" =H) in the absonce of ',liner"l "cid involved 
loss of the proton fr~ nitrogen and collapse of the dienone 
syste~ to give the iQini~ salt (26). An indication of this 
caue frou the n.o.r. of the bleached solution which showed 
a onc-proton singlet at 1r 1.90 corresponding to the vinyl 
proton of the ininiuo group in (26). 1'!e hoped to deoonstrate 
the presence of (26) by reducing the bleached solution to 
give neodihYdrothebaine (27). Hydrogenation gave a product 
not unlike an authentic snople of (27) which was provided 
by Dr. K. H. Bentley. Final prcof was provided by Hr. Channon. 
He reduced an ethanol solution of the gUl".Dy residue, obtained 
by evaporation of the acid solvent, using sodiuo borohydride 
to give neodihydrothebaine, identical with the authentic 
scnple. Previous preparations of neodihydrothebnine 
involved95 ,96 successive treatoent of thebaine with 
Dagnesiuo iodide and n hydridic reducing agent. 
Thus the red solution obtained by dissolving 
thebaine in concentrated hydrochloric acid appears, fra] the 
u.v. __ visible spectruo, to contain the protonnted dienone 
(23; R=H) and the hydroxoniun ion (25; R'=R' '=H), these 
being in the ratio of ~. 3:1. However the anount of 
hydroxoniuo ion present depends upon the age and hence 
concentration of the 'concentrated' hydrc;chloric acid. 
Basificntion of the solution, as ~ preli~inary step to 
isolation of the products, may induce aromatisation of the 
diono,-= ring by renoval of the proton attached to nitrogen. 
In view of our findings it is possible97 , 
in the c~se of the rearrangeoent of ~-acetylnorsinoacutinols 
88 (l~), observed by Stuart 2!~. ,that the expected 
dihydrofuran rino closure was achieved first nnd it ,'18S 
100. 
this product .mich then underwent furth~r rearrangeoent to 
give the dienone (13). 
101. 
Chapter IV 
Experimental Section 
1.02. 
General Methods 
Solvents.- All solvents were distilled at least once. 
:Benzene and ether were dried over sodium wire after distillation. 
Tetrahydrofuran was initially dried over sodium wire, then with 
lithium aluminium hydride from which it was distilled Just 
before use. In general, chloroform was only purified by 
distillation before use. However when dry chloroform was 
reqUired, the solvent was shaken with magnesium sulphate and 
calcium chloride (after distillation) and decanted as required. 
Physical Methods.- Melting points were determined on a 
Kofler block apparatus, and are uncorrected. 
1 H Nuclear magnetic resonance spectra 11ere determined at 
60 M.Hz. on a Perkin-Elmer RlO spectrometer. In general spectra 
were determined in deuterochloroform and tetramethylsilane was 
used as the internal standard. Some spectra V1ere determined in 
D20 and also DC~ and t-butanol was used as the internal standard. 
The spectrometer o operatedat a temperature of 34 C. 
Infra-red spectra were determined in chloroform solution 
(solution cell 0.1 mm.) or in NUJol mull using Perkin-Elmer 
237 or 257 speetrophotometers. All spectra vlere calibrated 
using polystyrene film at ~ 1601, and 909.8 -1 cm. 
Ultra-Violet spectra were determined in ethanolic solutions 
(see part B of this Cha;>ter) using a Pye-Unicam SP-BoO spectro-
photometer. 
Optical rotation measurements were made at ~. 200 C in 
chloroform on ethanol solution. 
Hydrogenation.- All hydrogenations were carried out at 
atmospheric pressure and ambient temperature, ~. 200 C. 
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Chromatography.- (a) Unless otherwise stated all column 
chromatography was carried out using neutral grade III alumina 
with chloroform as solvent. In general, the weight of alumina 
used was fifty times that of the material to be separated. 
(b) Analytical thin layer chromatography on alumina was carried 
out using Merck GF254 Alumina. The miXture, consisting of water 
(68 ml.) and alumina (45 g.), was spread in a 0.25 mm. layer on 
twenty (20 cm. x 5 cm.) plates. The plates vlere activated at 
l400 C for 2 hr. 
(c) Preparative thin layer (p.l.c.) chromatography was carried 
out using Merck PF2Sif Alumina. The miXture, conSisting of 
~Iater (120 ml.) and alumina (90 g.), was sprcad in a 0.5 mm. 
layer on five (20 cm. x 20 cm.) or one (1 m.) plates. Water 
was allowed to evaporate from the plates for about 12 hr.; 
o ' then they were activated at 120 for 2 hr. 
(d) Thin layer chromatography on silver nitrate/alumina plates 
was exactly as for (b), and (c) except that the water used in 
each case contained, respectively, 4.5 and 9.0 g. of silver nitrate. 
(e) SeparatiOns on basic silica plates utilised Merck GF254 
silica for analytical and PF254 silica for preparative work. 
The Silica (50 g.) was slurried with O.lN sodium hydroxide (90 
ml.) and spread in a 0.5 mm. layer onto five (20 cm. x 20 cm.') 
plates (or one x 1 m plate). Analytical plates used half 
quantities with a 0.25 mm. layer. The plates were activated 
at l40°c for 2 hr. before use. 
In general, for preparative work, ~. 100 mg. of material 
was spread on aIm. plate, while ~. 20-30 mg. of material 
was used for a 20 cm. x 20 cm. plate. 
104. 
Analytical plates were examined using the Dragendorff 
Reagent,B3 and also iodine. 
Counting Methods.- Both 3H and 14C were determined by liquid 
scintillation counting using a Beckrnan CPM-100 Liquid Scintillation 
System. The liquid scintillator consisted of 2;4-diphenyloxazole 
(PPO) (1.9 g), and l,4-~s-(4-methyl-5-phenyloxazol-2-yl)benzene 
(dimethyl POPOP) (0.1 g.) dissolved in Analar, sulphur-free 
toluene (500 m!.). The liquid scintilla tor l'las stored in a 
, 0 
dark bottle, under nitrogen, at ~. 0 C. After use, the 
scintlllator liquid ~Ias flushed with dry. oxygen and carbon dioxide 
free nitrogen 
The instrument l'las used to count in two channels, Cllannel I 
3 14 
counting mainly H activity, and Channel II counting mainly C 
activity. The 'voltage window'was set to give optimum efficiency 
for counting in both Channels I and 11, however, a certain amount 
of cross-over was observed i.e. 14c activity contributed to the 
Channel I count. The efficiency of counting and the amount of 
cross-over was determined using the hexadecane standards, 
[1_14C}n_hexadecane and [1,2-3H21-n-hexadecane, of known specific 
- 2 
activity (1.73 x la? and 0.44 x 10 dis/min/mg respectively). 
For determining the activity of a sample containing both 14C and 
3H the following simultaneous equatiOns apply. 
Cl = aA + bB 
C2 = xA + yB. 
Cl and C2 are the counts indicated by the instrument for 
Channel I and Channel II respectively. A and B are the actual 
activities (dis/min) of, respectively, 3H and 11~C in the sample. 
The % efficiency of counting 3H in Channel I is represented by(a4, 
105. 
14 > 
while that of counting C is represented by(b). 
of counting 3H in Channel II is represented by x, 
The efficiency 
14 
and of C by y. 
Using the standards, the following typical values were obtained; 
a = 44%, b = 25%, x = 0.055% (considered negligible), and 
y = 63%. 
The 3H and 14C activity of a crystalline solid was determined 
by Neighing a known amount (~. 0.5 mg.) into a coun>ting bottle, 
and adding dimethylformamide (0.1 m!.) and scintillation liquid 
> (5.0 m!.). The sample prepared in this way ~/as then counted by 
the instrument. 
Dimethylformamide was doubly distilled and dried over 
calcium hydride. It \>/as checked periodically for contamination. 
Throughout this Chapter and also in Chapter II Specific 
and Total Activities are measured in 'disintegrations'/min/mg., 
and 'disinte gra tions ' /min, and these will be I'Iritten as dis/min/mg. 
and dis/min respectively. When the actual counts, recorded by 
the instrument, are given as counts per min this will be written 
as cpm. Specific Activity has been abbreviated to s .a. 
Feeding Work-up.- (a) All chloroform-propan-2-o1 extractions 
use these solvents in a v/v ratio of 9:1. 
(b) Volumetric Count - In the early stages of isolation of 
an alkaloid from a particular feeding it was neither possible nor 
convenient to crystallise before determining the specific activity 
in the normal way. However some estimation of the acti vi ty 
present was required. This was carried out by addition of 
ethanol (5.0 ml.) to an accurately known weight of the alkaloid. 
An al1quot of the ethanol solution (0.1 m!.) ~/as removed and placed 
in a counting bottle, then evaporated in a stream of dry nitrogen •• 
106. 
Liquid scintillator (5.0 ml.) and dimethylformamide (0.1 ml.) were 
added and the count determined. 
(c) Washing - This procedure was used for purifying both the 
non-phenolic and the phenolic alkaloids isolated from the plants. 
Thus, if, after separation of the alkaloids A1 and A2 , it was 
found that Al contained acti vi ty most likely to have arisen by 
contamination with A2 , the following purification was carried out. 
Active alkaloid 1\ (x mg.) was mixed with a radioinactive sample 
of A2 (x mg.) and separation repeated. Thus A1 has been ''washed'' 
once with radioinactive A2 to remove traces of active A2 
(A) Experimental details associated with Chapter II. 
Preparation of Radioinactive Alkaloids. 
68 
Dihydrocode1ne. - Codeine (0.199 g.) in dry methanol 
(10 ml.) was hydrogenated (uptake 16.3 ml., H2; calc. 16.1 ml.) 
using 10% palladised charcoal as catalyst (25 mg.). The catalyst 
\"Ias removed by filtration through celite, and evaporation of 
the solvent gave a colourless oil. The oil, in ethanol (2 ml.), 
was treated with an ethanolic solution (1 ml.) of picric acid 
(0.145 g.). The dihydrocodeine picrate was crystallised twice 
o from ethanol (m.p. 168 C decomp.), and the free base recovered 
from the picrate by pouring a Chloroform solution through a 
column of alumina. Dihydrocodeine was obtained as pure white 
107. 
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crystals from ethanol (0.164 g., 83%), m.p. 110-112 C (lit., 
112_113°C);~(CDCl_)98 3.}4 (q, 1,2-H), 5.42 (d, J 5.0 Hz, 
~ -
5~-H), .£!!.. 6.0 (broad s, 6-H), 6.15 (s, Ar-m.le), 7.70 (s, N-Me). 
Dihydromorphine .67 _ Morphine (0.214 g.) was hydrogenated 
(uptake, 19.3 ml.~; calc. 18.1 ml.) in ethanol (20 ml.) using 
10% Pd/C (20 mg.) as catalyst. The solution Has evaporated after 
filtration through celite to remove the catalyst. Crystallisation 
of the dihydromorphine 
(lit.,67 155-157°C); 
(97 mg, 45~) was o from ethanol; m.p. 153-155 C 
diacetyldihydrom~rphine derivative ~ 
(CDCl3 ) 3.32 (q, 1,2-H), 4.95 (broad s, 5-H), 5.52 (d, ~ 5.5 Hz, 
6-H), 7.65 (s, N-Me). Hydrogenation, as above, but in glacial 
acetic acid, gave dihydromorphine in only 37% yield. 
Isocodeine:-
(i) Hexadecyltrimethylammonium acetate.- Hexadecyltrimethyl-
ammonium bromide (4.0 g.) in ethanol (20 ml.) was added to a 
finely powdered suspension of silver acetate (1.8 g.) in ethanol 
(20 ml.). The mixture was shaken in the dark for 2 hr., then 
filtered through celite to remove the precipitated silver bromide. 
Evaporation of the solvent ~ vacuo gave the required quaternary 
ammonium acetate as a ~Iaxy solid (4.1 g). The purity of this 
material (typically 93%) \~as determined by titration, of an 
aqueous solution, with hydrochloric acid using methyl red indicator. 
(ii) Codeine tOluene-E-sulphonate.71 - Codeine (1.44 g.) in 
pyridine (1.6 ml.), cooled to OoC, was treated with an ice-cold 
solution of toluene-E-sulphonyl chloride (1.02 g, 1.1 mol.) 
in pyridine (1.3 ml.). After being kept in ice for 4 hr., 
the mixture was poured into ice-water with rapid stirring. 
A pink precipitate formed on addition of concentrated ammonia 
(.£!!.. 2 ml.), and the superna tant liquid was decanted. The 
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pink crystalline material was washed with water, and filtered off. 
Hater was removed ~ vacuo over calcium chloride and phosphorus 
pentoxide to give crystalline codeine toluene-E-sulphonate (1.99 g, 
o 71 0 99%), m.p. 119-12l C (lit., 121 C). 
(iii) Isocodeine.- The codeine toluene-E-sulphonate (1.99 g) in 
benzene (20 ml. )Nas treated with hexadecyl trimethylammonium 
acetate (2.14 g, 1.2 mol.) and agitated for 12 hr., at room 
temperature. The benzene was evaporated and the residue 
dissolved in 50% aqueous methanol (50 ml.) then treated with 
2N sodium hydroxide (10 ml.). After 12 hr. at room temperature 
the reaction mixture was .. neutralised with solid carbon dioxide and 
in water (80 ml.). The resulting red precipitate was filtered 
off through celi te and washed with portions of chloroform-
methanol (1:1) (total (801 ml.). Evaporation of the combined 
fil trate and washings gave a red oil which was chromatographed 
on alumina (50 g.) in chloroform. Evaporation of the chloroform 
gave isocodeine which crystallised from ethyl acetate as prisms 
(0.98 g, 68% from codeine), m.p. 173-174°C (lit.,99 171-1720 C), 
[a)n- 1490 (~0.48 in CHC13 ) (lit.,99_150.~ in CHC13 ); ~ 
(CDC1
3
)100 4.00 (m, 7-H), 4.40 (q, ~ 10 ai~ 1.7 Hz, 8-H), 5.20 
(broad s, 5-H), and 5.78 (d, ~ 5.7 Hz, 6-H). 
14 Radiodilution AnalysiS of Isocodeine.- [N-methyl- C)Codeine 
(307 mg, s.a., 2.58 x 105 dis/min/mg; total activity 7.92 x 107 
dis/min) was converted into its toluene-E-sulphonate (373 mg.) 
which was treated, without prior crystallisation, with 
hexadecyltrimethylammonium acetate (405 mg.) (as above). After 
evaporation of the benzene, the total reaction mixture was 
109. 
dissolved in metl.anol (25 ml.) and divided into two equal 
portions. ~socodeine (104 mg, s.a. 2.73 x 105 dis/min/mg; 
total 3.82 x 107 dis/min), m.p. 170-171oC (lit.,99 171-1720C) 
was isolated from one portion in the described manner. After 
the one crystall.isation from ethyl acetate "\;his material was 
miXed with radioinactive codeine (74.4 me.). The mixture WaS 
separated chromatographically on alumina and the codeine 
~igorously pUrified, then crystallised from benze~ to constant 
60 (101 0 specif:f,c act:l,vity. m.p. 155-15 C lit.,· 156-l57 c). 
nadiochemical purity was demon~trated by picrate formation. 
The specific activity of the purified codeine (l3? dis/min/mg.) 
correSpo!1<j.ed to the Prel'lenqe of 0.0?5% cOdeil1e :l,n the isococieine 
sample. The other portion of the reMt:l,ol1 mixture was 
mi){eci ciirect:l,y with radioipact:l,ve godei)'le (63.1, fig.). The 
al~loids were ~eparated after hydrolYl'lis Of the mixture and 
treatment with Re~nec~e's l'lalt, The l'lpeqifiq act!vity Of the 
codeine, m.p. l55°C (lit.,lOl 1,56_15700), (~,a. e419 dial 
m!n/mg.) shgwed that l.3?% gf the or:l,~l1al. COcle~l1e WaS preSent 
:l,n the tgtal, reaction m1,Jcture. ";L'lle :l,l'locodeine :l.sola ted (106 
mg, 69%), m,p. l72,.173°C (Ht,,99 l71_J.720C), haci a l4c 
spec~f:f,c agtivHy Of 2.e9 <t 195 d:L.l'l/rn:in/mg. 
Isomorphine.- MOrph:ine (9.66 g.) WaS Stirred :l,n water 
(966 ml.) with sodium hydrogen carbonate (97 g,) and aCetic 
anhydride (49 ml.) adged droPWise. After all, the morPhine had 
dil'lso:l,vecl, the aqueouS soJ.ution was eXtraqted with chloroform 
(6 x 50 ml.) and evaporation in vacuo gave 3_£,.acetYlmOrPhine74 
as a colourless oil (10.95 g, 9?%); } . (CHCJ.-) 2920, max. y 
1758 (AcOAr,C=O), 1493, 1450, -1 ....... 995 cm ;, (CDC13 ) 3.35 
llO. 
(q, 1,2-H), 4.28 (q, ~ 10 Hz and ~ 2 Hz, 7-H), 4.78 (q, 
~ 10 and ~ 2 Hz, 8-H), 5.10 (d, ~ 8 Hz, 5-H), 5.82 (broad 
m, 6-H), 7.60 (s, N-Me), 7.75 (s, AcOAr). The 3-Q-acety1-
o 
morphine (10.95 g.) in pyridine (44 ml.) >Ias treated at 0 C 
with an ice-cold pyridine (43 ml.) solution of toluene-E-
sulphonyl chloride (7.03 g, 1.1 mol.). o After 6 hr. at 0 C, 
the pyridine solution was poured, with rapid stirring, into 
water (1 l.) saturated with sodium hydrogen carbonate. The 
aqueous mixture was extracted using chloroform (6 x 50 ml.) 
Which, after drying, was evaporated in vacuo to yield 
3-Q-acetylmorphine tOluene-E-sulphonate75 (12 g, 90% from 
morphine) as a red gum;~(CDC13) 2.15, 2.62 (q, TsOAr-H), 
3.35 (q, 1,~-H), 7.55 (5, N-CH3 ), 7.73 (s, Ar-CH3 ). 
3-Q-Acetylmorphine toluene-E-sulphonate (12 g.) was heated 
under reflux73 for 4 hr. with a mixture of glacial acetic 
acid (58 ml.) and \~ater (500 ml.). The reaction mixture 
was made alkaline USing conc. ammonium hydroxide then 
extracted with ethyl acetate (4 x 50 ml.). The solvent 
was evaporated in vacuo to give a mixture (7.2 g.) which was 
treated, in water (700 ml.) and sodium hydrogen carbonate 
(70 g.), with acetic anhydride (35 ml.) to give the 3-Q-
acetyl derivatives. 74 The slow removing fraction (Rf 0.15 
on alumina plates developed in chloroform) was isolated by 
chromatographing on neutral grade V alumina (230 g.) in 
chloroform. The isolated 3-Q-acetyl derivative (2.46 g.), 
'\) 1758 cm. -1, was hydrolysed by treating E.n aqueous-
max. 
methanol (1:1) (20 ml.) solution with 2N sodium hydroxide 
(8 ml.). Solid carbon dioxide was added to adjust to pH-7; 
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extraction with chloroform-propan-2-ol (9:l) (6 x 20 ml.) and 
evaporation gave a colourless oil (1.98 g.). Crystallisation 
from ethyl acetate-methanol gave isomorphine as prisms (0.75 g, 
o 1.02 0 0 8% from morphine), m.p. 249 C {lit., 251-252 C, [a)D-l64 
(~ 0.39 in MeOH) (lit.73_ 1.670 in MeOH); ~(DC1) 3.23 Cs, 
1.,2-H}, 3.98 (m, 7-H), 4.33 (q, l 1.0 Hz and 2 Hz, 8-H), 5.1.0 
(broad s, 5-H), 5.78· Cd, l 5.7 Hz, 6-H), 7.02 Cs, N-Me). It 
was found neoessary to dry the compound at 1.200 C for 24 hr. to 
remove all traces of methanol after crystallisation. 
Codeine methyl ether.- The preparation ~las essentia1.ly that 
described by Mannich 76 with slight modification. Codeine 
(3.0 g.) in 1.N sodium hydroxide solution (1.5 ml.) at·OoC was 
treated with dimethy1. sulphate (1..98 ml.) and stirred vigorously 
in ice until all traces of the methylating reagent disappeared. 
Further 1.0 N sodium hydroxide (0.99 ml.) and dimethyl sulphate 
(0.99 ml.) were added and the mixture again stirred. The 
process was repeated twice more, followed, after 4 hr., by 
drop-wise addition of a solution of potassium iodide (20 g.) 
in water (20 ml.). An oil separated which crystallised on 
·cooling and gave after filtration and washing with oold water 
codeine methyl ether methiodide (4.58 g, 98%), m.p. 238-2400 c 
(lit.,76 241.°c). Iodide ion was exchanged for chloride by 
shaking with freshly prepared silver chloride (2.01. g.) in 
water (1.0 ml.) for 4 hr. The precipitated silver iodide was 
filtered off through celite, and evaporation of the filtrate 
gave codeine methyl ether methochloride (3.64 g, 98%), 203-
207°C (lit.,76 208°c). Dry distillation/sublimation (0.5 
o 
mm Jig, at 1.40 C for 2 hr.) of codeine methyl ether methochloride 
1.1.2. 
liberated methyl chloride. The residue and sublimed material 
were warmed with 2 N hydrochloric acid, then filtered to remove 
undissolved solid. Basification to pH-10 and extraction with 
chloroform followed by evaporation ~ ~ gave a light brown 
gum (2.23 g.). The major fraction (Rf 0.65) was isolated as a 
colourless oil by column chromatography on alumina in chloroform. 
Crystallisation was from ethanol to give codeine methyl ether 
o 76 0 _ 100 (1.74 g, 56%), m.p. 140-141 e (lit., 140-141 C); • (CDC13 ) 
3.45 (q, 1,2-H), 4.25 (m, 7-H), 4.65 (q, i 10 Hz and 2 Hz, 
8-H), 5.0 (q, i 6.5 Hz and 1.5 Hz, 5-H), 6.20 (s, ArOCH3 ), 6.50 
(s, -OCH3 ), 7.56 (s, N-eH3 ); 
76 Morphine methyl.ether. - Sodium ethoxide solution (12.0 
m!.), prepared from sodium (4.6 g.) and ethanol (110 m!.) 
followed by addition of water (57 ml.), was added to morphine 
(2.5 g.) in ethanol (8.0 m!.). Ether (~. 20 m!.) was added 
to the resulting pale yellow solution, and the derived 
sodium salt of morphine (obtained as a white precipitate) (2.76 g.) 
was filtered off and dried ~ vacuo with phosphoric oxide. 
A stirred ice-cooled suspension of the morphine sodium salt 
in dry ethanol free, chloroform (15 ml.) was treated 
drop-wise with a solution of chlorodimethyl ether (1.2 ml.) 
in chloroform (1.6 ml.). After 1 hr., the solution was 
washed wi";;h 5% sodium hydroxide (10 m!.), dried over sodium 
sulphate and evaporation of the chloroform ~ vacuo gave 
a yellow gum (Rf 0.55 on alumina plates in chloroform) 
which showed only slight contamination by t.l.c. Chroma-
tography on a column of alumina (60 g.) in chloroform 
gave pure 3-Q-methoxymethylmorphine (0.86 g.) as a colourless 
113. 
gum;~(CDC13) 3.22 and 3.46 ( ABq, !!. 9 Hz, l,2-H), 4.30 
(m, 7-H), 4.78 (q,!!. 10 Hz and 2 Hz, 8-H), 4.52 and 5.00 (ABq, 
!!. 6.0 Hz, -0-CH2-0-), 5.14 (d, !!. 6.0 Hz, 5-H), 5.64 (broad m, 
6-H), 6.56 (s, CH3-O-), 7.59 (s, N-C~). The methoxymethyl-
morphine was treated with hydrogen peroxide (2 ml.) in a platinum 
basin, and slightly warmed. A yellow solution resulted after 
12 hr. at room temperature, and the excess of hydrogen peroxide 
and water was removed !!! vacuo over phosphoric oxide. 'lbe oil 
formed was dissolved in methanol, then evaporated down to 
dryness to yield a brown micro-crystallised powder - methoxy-
methylmorphine !i-oxide (1.03g); ~ (DC1) 3.25 and 3.47 (ABQ, 
!!. 9 Hz, l,2-H), 4.27 (m, 7-H), 4.62 (m, 8-H), 4.80 (s, -O-C~-O), 
4.92 (d, !!. 6 Hz, 5-H), 6.52 and 6.57 (s,S,O-N-C~). The 
methoxymethylmorphine !i-oxide (1.03 g) in 2N sodium hydroxide 
o 
solution (5 ml.) was vigorously stirred at 0 C with dropwise 
addition of dimethyl sulphate (0.7 ml.). Another portion of 
dimethyl sulphate (0.4 ml.) and 10 N sodium hydroxide was added 
after 2 hr., and the process repeated after a further 2 hr. The 
aqueous solution was acidified by addition of 2N sulphuric acid 
and the hydroiodide salt of the 6-Q-methylmorphine !i-oxide was 
formed by addition of potassium iodide (1.7 g.) in water (5 ml.). 
The resulting white precipitate was not filtered off as described 
by Mannich. Instead, the aqueous solution of the hydroiodide 
was saturated with sulphur dioxide gas, then kept with stirring 
o 
at 40 C for 2 days. The solution was neutralised with sodium 
hydrogen carbonate and extracted with chloroform-propan-2-ol 
(10 x 20 ml.). The extract was dried (MgS04) and evaporated 
in vacuo to yield a colourless oil (363 mg.). Crystallisation 
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of the 011 from ethanol gave morphine methyl ether (288 mg, ll%), 
m.p. 239-2400 C (lit.,76 2420C);'!'(DCl) 3;25 (q, l,2-H), 4.72 
(d,J 6 Hz, 5-H), 5.82 (m, 6-H), 6.50 (s, 6-0CH)' (s, N-CH3 ); 
~ (D20/K-~toxide) 3.40 (s, l,2-H), 4.92 (d, ~ 6 Hz, 5-H), 
6.45 (s, 6.OCH)' 7.62 (s, N-CH3 ). 
103 3-0-Eenzylmorphine. - Morphine (171 mg.) in ethanol 
(5 ml.) was heated under reflux for 3 hr. with 2N sodium ethoxide 
(1 ml.) and benzyl ohloride (0.5 ml.). Water (20 ml.) and 5% 
sodium hydroxide (2 ml..) were added after oooling, and the solution 
extracted with chloroform (4 x 10 ml.). After drying over 
magnesium sulphate the solution was evaporated in vacuo to give 
an oil which was essentially pure (major fraction Rf 0.18) by 
t.l.c.on alumina plates developed in chloroform. Purification 
by chromatography on a column of alumina in chloroform followed by 
crYstallisation from ethyl acetate gave 3-Q-benzylmorphine (64 mg, 
~ 0 103 0 '--
"'::11"), m.p. 132-134 C (lit., 132 C); r(CDC13 ) 3.30 and 3.47 
. . 
(AEq, ~ 9 Hz, 1,2-H), 4.32 (m, 7-H), 4.78 (m, 8-H), 4.90 (s, 
Ar-~-O-), 5.17 (d, ~ 6 Hz, 5-H), 5.82 (broad In, 6-H), 7.62 (s, 
N-CH)' 
Dihydrodesoxycodeine.71 _ Codeine (3.78 g.) was converted into 
o 
codeine toluene-~-sulphonate which was dried in vacuo at 60 C for 
12 hr. The crystalline derivative (4.74 g.) in dry tetrahydrofuran 
o (15 ml.) at 0 C was treated dropwise with a slurry of lithium 
aluminium hydride. (0.5 g.) in tetrahydrofuran (15 ml.) under a 
dry nitrogen atmosphere. The pink tosylate solution turned yellow 
during reduction and, after the last traces of lithium aluminium 
hydride had been washed into the reaction mixture, the whole 
was heated under gentle reflux for 3 hr. After cooling to room 
ll5. 
temperature ether (50 ml.) was added followed cautiously by 
''later to destroy excess lithium aluminium hydride. Celite 
was added and the mixture filtered, the residue being washed 
with ether (20 ml.). The f11 tra te was extracted with 3N 
hydrochloric acid (8 x 25 ml.) and after basification to 
pH-l0 with aqueous potassium hydroxide, this extract was 
extracted with chloroform (6 x 25 ml.). The organic extract 
was dried over magnesium sulphate then evaporated in ~ to 
yield a colourless oil (3.42 g.) which contained two components 
(major fraction Rf 0.80) by t.l.c. (alumina-chloroform). 
Chromatography of the major fraction on a column of alumina in 
chloroform followed by crystallisation from ethanol gave 
8 1-desoxycodeine (3.31 g, 93%), m.p. 83-84°c (lit .. 71 82_830C). 
[alD- 64
0 (~0.62 in CH30H) (lit.,71 _680 in CH30H);'r'(CDC13 )98 
3.45 (q, l,2-H), 4.30 (m, 1-H), 4.61 (q, ~ 8 Hz and 2 Hz, 8-H), 
5.15 (t, ~ 5 Hz, 5-H), 5.15 (broad s, 6-H), 6.20 (s, ArOCH3 ), 
1.58 (s, N-C~). The ,d-desoxycodelne (989 mg.) in methanol 
(20 ml.) was hydrogenated (uptake 88.2 ml.H2; calc. 86.1 ml.) 
using platinum oxide (20 mg.) as catalyst. The mixture was filtered 
through celite, and evaporation of the solvent gave an oil (1.014 
g.) consisting of two components(maJor fraction Rf 0.10) by 
t.l.c. (alumina-chloroform). Column chromatography and 
crystallisation from methanol, of the resulting oil, gave 
dihydrodesoxycodeine (849 ms, 86%), m.p. 103-105°C (lit.,71 
102-1050C);'r(CDC13 ) 3.
1fO (q, l,2-H), 5.45 (t, ~ 8 Hz, 5-H), 
6.20 (s, ArOCH3 ), 1.60 (s, N-CH3 ). 
Dihydrodesoxymorphine.- Dihydrodesoxycodeine (1.08 g.), 
prepared as described above, was mixed with pyridine hydrochloride 
(6.0 g.), obtained by passing hydrogen chloride through an ether 
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solution of P,rridine. o The miXture was heated at 21.2-21.5 C 
under a nitrogen atmosphere of 15 min., after which the reaction 
mixture was immediately cooled by addition of water (25 ml.). 
Non-phenolic material was removed by ether extraction (3 x 
1.0 ml.) after the solution had been made alkaline with 2N 
sodium hydroxide. The aqueous basic solution was adjusted 
to pH-6 by addition of 2N hydrochloric acid then extracted 
with chloroform-propan-2-01 (9:1.) (6 x 1.0 ml.) which was 
dried over magnesium sulphate. Evaporation of the organic 
solvent gave a brown gum, a chloroform solution of which was 
poured through a co1.umn of alumina. The colourless oil 
obtained after evaporation of the solvent was sublimed (0.2 
o 
mm of Hg, 1.70-1.80 C for 4 hr.) and the derived solid material 
was dissolved in chloroform. Evaporation of the chloroform 
in vacuo gave a foam which crystallised with ethyl acetate 
to give dihydrodesoxymorphine (31.0 mg, 30%), m.p. 1.890C 
79 0 [1 0 79 (lit., 1.88-1.89 c), a D-68 (£ 1..26 in CH30H) (lit., 
-67.2 £. 1..31. in ethanol); ....,., (CDC13 ) 3.25 and 3.40 (ABq, 
~ 9 Hz, 1.,2-H), 5.42 (broad m, 5-H), 7.52 (s, N-C~). 
1.-Bromocodeine.53- Codeine (1..01.5 g.) was set aside for 
20 hr. in dry pyridine (45 ml.) and acetic anhydride (22. 5 
ml.); the solution was then evaporated in vacuo. The 
residue in water (50 ml.) was treated with sodium hydrogen 
carbonate and the 6-Q-acetylcodeine extracted with chloroform 
(6 x 20 ml.); ~ (CDC13 ) 3.32 and 3.47 (ABq, ~ 9 Hz, 
1.,2-H), 4.90 (broad s, 5-H), 6.1.5 (s, ArOCH3 ), 7.57 (s, 
N-C~), 7.85 (s, 6-0 Ac). The acetylcodeine (1..1.1. g.) in 
acetic acid (46 ml.) and acetic anhydride (2.3 ml.) was 
1.1. 7. 
treated drop-wise with a solution of bromine (260 mg.) in 
acetic acid (370 ml.) then kept in the dark at room temperature 
for 48 hr. Evaporation of the solvents ~ vacuo followed 
by basification \~i th aqueous sodium hydrogen carbonate (SO 
ml.) allowed 6-Q-acetyl-l-bromocodeine to be obtained as a 
gum after extraction with chloroform (5 x 20 ml.); ~(CDC13) 
3.27 (s, 2-H), 5.00 (broad s, 5-H), 6.30 (s, ArOCH3 ), 7.70 
(s, N-~), 8.00 (s, 6-0 Ac). The acetyl derivative in 
aqueous-methanol (1:1) (30 ml.) was treated with 2N sodium 
hydroxide (5 ml.) and the solution set aside for 5 hr. 
Neutralisation with solid carbon dioxide was followed by 
chloroform (5 x 20 ml.) extraction. The solvent was dried 
over magnesium sulphate and evaporated to give a colourless 
gum, which crystallised from ethanol to give 1-bromocodeine 
as needles (946 ~~, 73%) m.p. 162-163°C (lit.,104 161_162oC); 
~ (CDC13 ) 3.20 (s, 2-H), 4.30 (q, ~ 10 Hz and 2 Hz, 7-H), 
4.75 (q, ~ 10 Hz and 2 Hz, 8-H), 5.15 (q, ~ 6 Hz and 1.5 Hi, 
5-H), 5.80 (broad m, 6-H), 6.22 (s, ArOCH3 ), 7.60 (s, N-C~). 
l-Bromomorphine.- Morphine (1.02 g.) in pyridine (10 ml.) 
and acetic "nllydride (5 ml.) was heated for 2 hr. on a water 
bath to yield diacetylmorphine (1.28 g.). The crystalline 
derivative in acetic acid (48 ml.) and acetic anhydride (3 ml.) 
was treated drop-\~ise with a solution of bromine (285 mg.) in 
acetic acid (380 ml.) then kept in the dark at room temperature 
for 45 hr. The solvents were ao-aporated off ~ ~ 
and water (60 ml.) was added to the residue which was made 
alkaline with sodium hydrogen carbonate and extracted with 
chloroform-propan-2-on (5 x 20 ml.). The colourless gum 
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obtained after evaporation was hydrolysed using aqueous-
methan91 (1:1) (30 ml.) and 2N sodium hydroxide (5 ml.). 
After 4 hr. the solution was acidified with 2N hydrochloric 
acid, 'then solid sodium hydrogen carbonate carefully added 
to give pH-6, followed by rapid extraction with chloroform-
" 
propan-2-01 (5:1) (5 x 25 ml.). The solvent was dried 
over magnesium sulphate and evaporated in vacuo to give an 
off-white solid. This solid was dissolved with warming ° 
in 2N hydrochloric acid (~. 4 ml.), sodium hydrogen carbonate 
added to pH-7, and after standing at room temperature for 4 
hr. the niicro-crystalline preCipitate filtered off. After 
drying .!!! vacuo at 1000C the isolated product (380 mg. ,28% from 
morphine ), o m.p. ;> 250 C was shown to be 1-bromomorphine in 
the following way. The compound (81 mg.) l'las suspended in 
methanol (5 ml.) and treated at OoC with ethereal diazomethane 
solution (~. 3 ml.), then stirred at room temperature for 
12 hr. The product, isolated by chromatography on a column 
of alumina and crystallised from ethanol, was 1-bromocodeine 
(78 mg.), m.p. 160_131oC (lit.,104 161_1620C); ~ (CDC1
3
) 
3.15 (s, 2-H), 4.30 (q, ~ 10 Hz and 2 Hz, 7-H), 4.75 (q, 
~ 10 Hz and 2 Hz, 8-H), 5.15 (d, ~ 6 Hz, 5-H), 5.80 (broad 
m, 6-H), 6.20 (s, ArOCH3 ), 7.57 (s, N-CH3 ). 
Preparation of Radiolabelled Precursors. 
[2-3H]Morphine.- This material was prepared on numerous 
occasions and the following is typical of the method used. 
A solution of anhydrous morphine (0.48 g.) in dry dimethyl-
formamide (2 ml.) was treated, in the, exchange tube, with 
tritiated water (3.6 mCi/mmol.) (0.5 ml., 100 mCi). The tube 
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was flushed with dry, carbon dioxide and oJC:;f(!ftn free, ni tro(!ftn 
for 1 hr., then sealed. The morphine was dissolved by heating 
the tube on a hot plate, then the solution was heated in boiling 
water for 100 hr., cooled and poured into water (10 ml.). 
The crystallised morphine was collected (410 DIg.), washed 
o 
with cold water, and dried.!!! vacuo at 100 C. The specific 
activity of [2-3H]morphine, obtained in this way, was typically 
1.4 mCi/mmo1. 
[2-3H]Codeine:-
The methylation of [2-3H]morphine was also repeated 
several times; the following method was typical. 
(i) Trimethylanilinlum Ethoxlde.- Methyl toluene-g-
sulphonate (9.3 g.) and dimethyl aniline (6.05 g.) were 
heated at 1200 C to yield the trimethylanilinium toluene-
g-sulphonate salt as an ice blue solid. The salt (5.0 g.) was 
shaken with IN sodium ethoxide solution (16.3 ml.), prepared 
from sodium (1.15 g.) and dry ethanol (50 ml.), for 12 hr. under 
anhydrous conditions. The methylating solution (trimethyl-
anilinium ethoxide) was obtained by f11 tration through celi te 
under strictly anhydrous conditions. The concentration of 
the methylating reagent was determined by titration in water 
against O.lN hydrochloric acid USing methyl orange as indicator 
(normally 1 ml. contained 1.15 x 10-3 mol. of methylating 
rea(!ftnt) • 
(ii) Methylation of [2-3H]Morphine.-A suspension of 
[2-3H]morphine (0.4 g. s.a. 1.43 mCi/mmol.) in toluene, 
after azeotroping to remove water, was cooled to ca. 140 c 
and treated with u1ice the required volume of methylating 
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reagent (2. 1f m1., 2 moL), then stirred for 15 min. After 
the morphine had dissolved the solution was heated until ethanol 
distilled over (E,!. 13°C) under reflux (ca. liloc) for 10 mins. 
The solution was cooled and filtered through celite then 
o 
extracted w~ th warm (E,!. 60 C) 2N sulphuric acid (5 x 25 
ml. ). The ~cid extract was basified to pH-l0 b! addition of 
~que9~ potassium hydroxide then steam distilled to remove traces 
Of dimethyl aniline. The aqueous basic solution was extracted 
w~th chloroform (5 x 25 ml.)! which l'Ias wa!;hed witp. water, th.en 
dried over sodium sulPrate. The solvent l'Ias evaporated in vacuo 
.-. - .. -. . , ---.. ~ .... -
to give a colourless 9i1 which contained codeine (~+ 0.40 
al~na~chlorofor~) as the major fractiOn by t,l.c,; a 
Chromatography on 
.... ' '. .. 
a column of alumina in chloroform follol'led by crystallisation from 
. . - . . . . 
benz~~e gave [2-3H)9odeine (0.253 g" 61%! ~,a! +!4~ mC~/~ol.), 
o 101 0 ~ 98100 
m,p, 155 C (lit.,·- +56,,1.57 c); r (qDC13) ,- 3,40 (q, 
1,g~~)! 4.30 (q~ ~ 10 H~ and 2 H~, 7~H), 4.75 (q, ~ 10 Hz and 
? ~z, 8~H)! 5,+5 (d, ~ 6 ~z, 5~H), 5.85 (br9ad ~, 6~~), 6,15 
(~! ArOC~), 7.5Q (s, N~~). 
[2_3H)DihYdrOcode1ne.~ [2-3H)Codeine 
. .' .... ... -. 
(44 mg. s.a. ca • 
... . -
1.3 mCi/!Mlo1,) in methanol (;1.0 m1.) was hydrogepe, ted (uptakl! 
4.~ m+' ~2; c~lc. ?5 ml,) using 10% palladiseq charcoal 
(6 mg.) as 9atalyst. The catalyst ~Ias removed by :f~ltr?-tion 
through celite, and evaporation of the solvent gav~ a colourles~ 
oil (31 mg., 70~, s ,a. 1. 209 mC~/rranol.). The oil was purified 
via the picrate salt, but could not be induced to cry~tal1ise. 
However, the n.m,r. spectrum and t.l.c. of the product were 
identical with those of the radioinactive dihydrocodeine. 
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[2-3H)Isocodeine.-[2-3H)Codeine (102 mg, s.a. 1.45 mCi/mmol.) 
was converted into the correspondingly labelled codeine toluene-
£-sulphonate. The derivative (149 mg, s.a. ~. 1.4 mCi/mmol.) 
in benzene (5 ml.) was treated with a solution of hexadecyl-
trimethylamrnonium acetate (164 mg.) in benzene (5 ml.) then 
stirred for 12 hr. at room temperature. The solvent was 
evaporated, water (20 ml.) added, and the mixture carefully 
(swirling rather than shaking to avoid formation of an emulsion) 
extracted with benzene (4 x 5 ml.). Separation of the aqueous 
and organic layers was achieved by centrifuging. 'll1e benzene 
solvent was evaporated off and the product purified by p.l.c. on 
alumina plates (tI·/O 20 cm x 20 cm) developed in chloroform. In 
this way 6-£-acetyl-[2-3H)isocodeine was obtained as a colourless 
oil (62 mg, 55%);~(CDC13) 3.40 (q, 1,2-H), 4.23 (m, 7-H), 
4.82 (d, ~ 6 Hz, 8-H), 5.25 (broad s, 5-H), 6.18 (s, ArOCH3 ), 
7.58 (s, N-~), 8.00 (s, 6-0Ac). The [2~3H)isocodeine 
acetate (50 mg.) in aqueous-ethanol (1:1) (7 ml.) was treated 
wi th 2N sodium hydroxide (2 ml.) and set aside for 12 hr. The 
solution was neutralised with solid carbon diOXide then extracted 
with chloroform (4 x 5 ml.). The solvent was dried over 
magnesium sulphate and evaporated ~ vacuo to yield an oil 
~Ihich after chromatography on a colunm of alum1na in chloroform 
was crystallised from ethyl acetate to give [2-3H)isocodeine 
(33.8 mg, 34% from codeine, s.a. 1.212 mCi/mrnol.) m.p. l70-1720C 
(lit. ,99 172-1730 C); the t.l.c. of the product was identical 
wi th that of radioinactive material. 
[2-3H)Codeine methyl ether.-All the fast moving fractions 
(Rf 0.65) obtained from the [2-3H]morphine methylations were 
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combined. The total by-product was chromatographed on a column 
of alumina in chloroform. Crystallisation from methanol gave 
[2_3H)codeine methyl ether (46 mg, s.a. 1.294 mCi!mmol.), m.p. 
139_140°C (lit.,76 140-1410);~(CDC13) 3.45 (q, 1,2-H), 4.25 
(m, 7-H), 4.65 (q, ~ 10 Hz and 2 HZ, 8-H), 5.0 (q, ~ 6 Hz and 
2 Hz, 5-H), 6.20 (s, ArOCH3 ), 6.50 (s, 0CH)' 7.56 (s, N-CH3 ). 
From each methylation of [2_3H]morphine typically 26 mg. of 
labelled codeine methyl ether (~. 7%)was obtained. 
[2-3H)Dihydrodesoxycodeine.- [2_3H)Codeine toluene-£-sulphonate 
(181 mg.), obtained from labelled codeine (258 mg, s.a. 1.24 mCi!mmol.), 
o in dry tetrahydrofuran (5 ml.) was treated at 0 C under a dry 
nitrogen atmosphere with a slurry of lithium aluminium hydride 
(30 mg.) in tetrahydrofuran (5 ml.). After the initial reaction, 
the solution was heated under reflux for if hr. with stirring. The 
reaction mixture ~Ias cooled then ether (10 ml.) added followed 
by careful addition of water, to destroy excess of lithium 
aluminium hydride. The mixture was filtered through ceU te, and 
the filtrate extracted with 2N hydrochloric acid (6 x 5 ml.). The 
aqueous acid solution was adjusted to pH-10 by addition of aqueous 
potassium hydroxide, then extracted with chloroform (4 x 10 ml.) 
which, after drying over magnesium sulphate, was evaporated .!!:!. vacuo 
to yield a colourless gum. Chromatography on a column of alumina 
in chloroform gave [2_3H)_ c:I -desoxycodeine (108 mg. ) which was 
hydrogenated (uptake 12.6 ml. of~; calc. 9.6 ml.) in methanol 
USing platinum oxide (20 mg.) as catalyst. Catalyst was removed 
by filtration through celite and the product chromatographed on 
a column of alumina in Chloroform. Crystallisation from methanol 
gave [2-3H)dihydrodesoxycodeine (99 mg, 42~ from codeine, 
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s.a. 0.818 mCi/"~ol.), m.p. 103 C (lit., 102-105 e); again the 
n.m.r. spectrum and t.l.c. of the product were identical with 
those of the radioinactive sample. 
l-Bromo-[2-3H]codeine.-[2-3H]eodeine acetate, prepared from 
[2-3H]codeine (145 mg, s.a. 1.28 mei/mmol.), in acetic acid 
(6 ml.) and acetic anhydride (0.6 ml.) was treated drop-wise 
with a solution of bromine (40 mg.) in acetic acid (25 ml.) then 
kept in the dark at room temperature for 48 hr. The solvents 
were evaporated off and the residue in !'later (30 ml.) was made 
alkaline with sodium hydrogen carbonate and extracted with 
chloroform (4 x 15 ml.). After drying, the chloroform was 
evapora ted !!! vacuo to give an oil (174 mg.) which was hydrolysed 
in aqueous-methanol (1:1) (10 ml.) by treatment with 2N sodium 
hydroxide. After neutralisation with solid carbon dioxide and 
evaporation the residue in water (20 ml.) 11as extracted with 
chloroform (4 x 15 ml.). The Oil, obtained after evaporation, 
was purified by chromatographing on a column of alumina in chloro-
form. Crystallisation from ethanol gave l-bromo-[2-3H]codeine 
(132 mg, 72% from codeine, 
(lit.,104 162_1630 C); both 
o 
s.a. 0.929 mei/mmol.), m.p. 162-163 C 
the n.m.r. spectrum and the t.l.c. of 
the product were identical with those of the radioinactive sample. 
[2-3H]rsocodeine methyl ether.- [2-3H]Codeine toluene-E-
sulphonate (188 mg, s.a. ca. 1.3 mCi/mmol.) in dry methanol (8 
ml.) was treated 11ith 0.43N sodium methoxide (3 ml.), then heated 
under reflux for 10 hr. The solvent was evaporated off and the 
residue, in water (10 ml.), extracted with chloroform (4 x 10 ml.). 
Evaporation of the solvent in vacuo gave a gum which, even after 
chromatography and purification ~ the picrate, could not be 
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induced to crystallise. Distillation ~ vacuo and also sublimation 
S1 
as suggested by Small and Browning did not produce crystalline 
material. Thus, [2-3Hisocodeine methyl ether (liS mg, 8o~ 1.091 
mCi/mmol.) was obtained as an Oil;~(CDC13) 3.40 (q, 1,2-H), 
4.15 (m, 7-H), 4.38 (q, ~ 9 Hz and 2 Hz, 8-H), 5.20 (s,5-H), 
6.17 (s, ArOC~), 6.63 (s, 6-0C~), 7.59 (s, N-C~). 
[2-3H]Dihydroisocodeine methyl ether.- [2-3H]rsocodeine 
methyl ether (48 mg, s.a. 1.2 mCi/mmol.) was hydrogenated 
(uptake 5.2 ml. H2; calc. 3.8 ml.) in methanol (20 ml.) using 
10% palladised charcoal (10 mg.). The catalyst was removed 
by filtration and the solvent evaporated to yield a COlourless 
gum Which, in methanol (2 m1.), was treated with a methanol1c 
(3 ml.) solution of picric acid (40 mg.). The derived picrate 
o 
was recrystallised from ethanol (m.p. 174 C decomp.) and pure 
[2-3H]dihydroisocodeine methyl ether recovered from the salt 
by pouring a chloroform solution through a column of alumina. 
Crystallisation from ethanol gave [2-3H]dihydrO!sOCodeine methyl 
ether (29 mg, 5%, 1.138 mCi/mmo1.), m.p. li6-li7°C; 'r(CDC13 ) 
3.32 (q, 1,2-H), 5.60 (d, ~ 8 Hz, 5-H), 6.12 (s, ArOCH,), 6.54 
(s, 6-OCH3 ), 7.61 (s, N-CH3 ). 
[2-3H]Dihydroisocodeine.- [2-3H]rsocodeine (62 mg, s.a. 
ca. 1.2 mCi/mmo1.) in methanol (10 m1.) toas hydrogenated (uptake 
6.3 ml. of H2; calc. 5.3 ml.) USing 5% palladised charcoal(20 
mg.). Filtration and evaporation of the solvent gave a 
colourless gum which was purified via the picrate. Crystallisation 
from ethanol gave [2-3H]dihydroisocodeine (43 mg, 70%, s.a. 
1.015 mCi/mmol.), m.p. 197-19SoC (lit.,105 199_200oC); 
~ (CDC13 )98 3.32 (t, 1,2-H) 5.65 (d, ~ 8 Hz, 5-H), 6.15 
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(5, ArOCH3 ), 7.60 (5, N-CH3 ). 
14 [N-methyl- C]Codeine.- This material was obtained as the 
hydrochloride from the Radio-Chemical Centre, Amersham, 
14 
with s.a.- C 48 mCi/mmol. 
Cultivation of Plants. 
The seeds of P.somniferum, Halle variety, were sown 
during March in good soil. The plants used during the 1970 
season were cultivated in a greenhouse I',hich was maintained at 
o ~. 18 C. The plants were watered (using rain 11ater) each 
day, and thinned out about every two weeks. Those plants 
used during the 1969 season were grown in a sheltered garden 
(kindly supplied by G.W .K.). '!he plants normally flowered 
about the middle of July and the precursor feedings, full 
details of which have been given in Chapter II, were carried 
out later in the month. 
Ion Exchange Separation of Phenolic and Non-Phenolic Alkaloids. 
(i) Preparation of Resin.- The anion exchange resin (50 g.), 
De-Acidite FF (Permutit Co.Ltd., SRA 71, 100-200 meSh), in 
the chloride form 11as stirred with 0.5N sodium hydroxide solution 
(100 ml.) then, after ~. 10 min., the mixture was fH tered. 
'!he resin, after continuous washing with deionised water until 
the filtrate was neutral to pH paper, was stirred with a 
saturated solution of sodium chloride (100 ml.). The resin 
suspension was again filtered and washed with deionised water 
until the washings were neutral. This I',hole cycle of exchange 
and washing was repeated three more times and finelly, after 
the resin had been obtained in the hydroxide form, was stirred 
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with aqueous-methanol (1:1 (100 ml.). After filtering off the 
methanol solution the resin (E!!' 30 g.) was slurried into a 
glass column (2 x 20 cm.) using aqueous-methanol. 
(11) Separation of Radioinactive Codeine and MorIhl-ne.-
Codeine (33 mg.) was mixed with morPhine (29 mg.) then dissolved 
in 2N hydrochloric <Did (5 ml.) followed by basif1cation to pH~2 
with aqueous potassiwn hydroxide. The basic solution was poured 
onto the ion exchange col1.:n:n which was eluted with aqueous-methanol 
(1:1) (150 ml.) to give the non-phenolic alkaloid. The column of 
resin was then eluted with 0.5N hydrochloriC acid (250 ml.) to 
remove the phenolic. alkaloid. The acid solution was neutralised 
by addition of sodium. hydrogen carbonate and the solvents 
evaporated in vacuo. \'Tater (20 ml.) was added to the residue then 
extraction with chloroform-propan-2-o1 (9:1) (~x 30 ml.) and 
drying over magnesium sumphate gave, after evaporation ~ vacuo, 
morphine (27 ms., 94% recovery). The aqueous methanol solution 
\'Ias evaporated to dryness, water (20 ml,) added and the solution 
extracted with chloroform-propan-2-o1 (1:1) (9:1) to give codeine 
(31 ms, 96% recovery). The above method was repeated in detail for 
separating the material isolated from the plants into phenolic 
and non-phenolic fractions. 
(111) Separation of [2_3H)Morphine and Radioinactive Codeine.-
~lorphine (27.186 ms) was mixed with [2-3H)morphine (3.128 mg, 
s.a. 1.32 mCi/mmol.) then crystallised from methanol to give 
[2-3H)morphine, s.a: 6.03 x 105 dis/min/ms and total activity 
183 x 105 dis/min. Radioinactive codeine (52.551 ms.) was 
added and the two alkaloids separated using the ion exchange method. 
The isolated codeine (52.3 ms, 99% recovery) had s.a. 497 dis/min/ms 
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and total activity 0.2599 x 105 dis/min representing 0.142% 
contamination by morphine. Morphine (27.9 mg, 92% recovery) 
had s.a. 6.49 x 105 dis/min/mg. 
(iv) Separation of [2-3H]Codeine and Radioinactive Morphine.-
[2-3H]Codeine (5.162 mg, s.a. 1.03 mCi/mmol.) was diluted with 
radioinactive codeine (42.461 mg.) and the total crystallised from 
benzene to give [2-3H]codeine (38.4)8 mg.) of s.a. 8.76 x 105 
dis/min/mg and total activity 33.7 x 106 dis/min. Radioinactive 
morphine (42.741 mg) was added and the ion exchange separation 
carried out. Morphine ()8.659 mg, 91% recovery) was isolated with 
s.a. 98 dis/min/mg and total activity 37.9 x 102 dis/min, 
-2 
representing 1.13 x 10 % contamination by codeine. 
Work-Up of Precursor Feeding Experiments. 
The method of isolating the crude alkaloids from the plants 
was described in Chapter II. 
[2_3H, N-methyl-14C[Codeine Feeding:-
The total alkaloids extracted (62 mg.) from the plant 
contained codeine together with a trace of thebaine by t.l.c. on 
alumina and morphine by t.l.c. on basic silica. A volumetric 
count suggested a recovery of at least 23% of the radioinactivity 
fed, based on 3H• Radioinactive codeine (29.39 mg.) and morphine 
(24.9 mg.) were added to the material extracted from the plant 
and the mixture dissolved in 0.5N hydrochloric acid (20 ml.) and 
then basified to pH-12 by addition of LN sodium hydroxide. The 
basic solution was extracted with ether (4 x 10 ml.) to remove tme 
non-phenolic alkaloids, mainly codeine and some thebaine. Solid 
carbon dioxide was added to adjust the pH to 7 - 8 and the 
aqueous solution extracted with chloroform-propan-2-ol 
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(10 x 10 ml.) to remove the phenolic alkaloid morphine. 
Non-Phenolic Alkaloids.- The ether solution was dried and 
evaporated ~ vacuo to give a residue which, by t.l.c. on alumina, 
contained mainly codeine and'some thebaine. The residue was 
chrornatographed on a column of alumina in chloroform to Give 
codeine (22.3 mg.) which was diluted with radioinactive codeine 
(16.4 mg; total 38.7 mg.) then crystallised four times from 
benzene. After each crystallisation the specific activity of 
the codeine was determined and showed that the ~!4C ratio 
decreased and differed from the value calculated for the 
precursor (see Appendix -Table 1). The 3H!4C ratio was 
determined using two methods as follows. The first involved 
addition of ethanol (~. 2 ml.) to the small amount of precursor 
solution, remaining from the feeding, then a small volume ~/as 
removed and a volumetric count determined (gave ratio as 5.42:1). 
The ~ore accurate method involved addition of radioinactive 
codeine (~. 60 mg.) to the ethanol solution of the precursor 
follo\·/ed, after evaporation of the ethanol, by crystallisation of 
o 101 0 
the codeine from benzene, m.p. 155-156 C (lit., 156-157 C) 
and specific activity determination (gave ratio as 5.32:1). 
After the four crystallisations the 3H!4c ratio for the codeine 
recovered from the plants did not compare well with that of the 
original precursor, and even after the mother liquors and 
crystalline codeine were recombined and chromatographed on a 
colunun of alumina the crystallised codeine had a ratio of 
10.92:1. Thus the total pure codeine (38.7 mg.) was i'urther 
diluted with a larger amount of radioinactive codeine (1}~6.6 mg; 
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total 185.3 mg.). Crystallisation from benzene to constant 
specific activity (Table 1. ~ Appen.) gave codeine, m.p. 155-
l57°C (lit~101 156-157°C) with 3H s.a. 150 x 102 dis/min/mg. 
and 14C s.a. 26.4 x 102 dis/min/mg. ~. 3H;l4C ratio 5.69. 
Calculation of Codeine Recovery:-
(i) Recovcry of [2-3H]codelne. -
Tbtal 3H activity as codeine = 150 x 102 x 185.3 x 29.39 dis/min. 
22.3 
Total 3H activity fed = 0.0578 x 2.2 x 109 dis/min.--(Table 1 
Chapter Il) 
% 3H activity recovered as codeine 4 = 150 x 185.3 x 29.39 x 10 
22.3 x 0.578 x 2.2 x 109 
= 2.88~ 
14 (ii) Recovery of [N-methyl- C]codeine.-
14 2 Total C activity isolated as codeine = 26.4 x 10 x 185.)oc29.39 din/ 
22.3 min 
" 9 Tbtal C activity fed = 0.0578 x 2.2 x 10 dis/min. 
5.32 
14 4 % C activity recovered as codeine= 26.4xl85.3x29.39x5.32xl0 
9 22.3xO.0578x2.2xl0 
= 2.69% 
The radiochemical purity of the isolated codeine was 
demonstrated ~ the picrate salt which \'Ias recrystall1sed from 
ethanol, m.p. 196-l97°C (lit.,106 196-19~C). Pure codeine 
~Ias obtained, in the normal way, by pouring a chloroform solution 
of the salt through a column of alumina. 
Phenolic Allcaloids.- The green coloured phenolic extract 
(26 mg.) was dissolved in 2N hydrochloric acid (5 ml.) then, 
after basification to pHl2 with aqueous potassium hydroxide was 
poured down the ion exchange column, as described previously, and 
completely COlourless morphine (16.1 mg, 65% recovery) was isolated. 
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Radioinactive morphine (}6.5 mg; total 52.6)' was added and 
crystallisation to constant specific activity from methanol 
gave morphine, m.p. 245-247°C (lit.,102 247-248°C) with 
3H s.a. 162 x 102 dis/min/mg ~. 46.2 x 105 dis/min/mmol, 
14 2 4 
and C s.a. 29.0 x 10 dis/min/mg. i.e. 82.7 x 10 
dis/min/mmol. The diacetyl derivative of the morphine was 
prepared and after crystallisation from ethyl acetate, m.p. 
171-1730 C (lit.,107 1730 C) gave the molar specific activity as; 
3H _ 47.0 x 105 dis/min/mmol., 14C_82 •4 x 104 dis/min/mmol. 
Calculation of Codeine into Morphine Incorporation:-
(i) Incorporation based on 3H activity. -
Total 3H activity isolated as morphine = 162xl02x52.6x24.9 disim1.n 
16.1 
% incorporation based on 3H activity = 162x52.6x24.9xl04 
9 16.lxO.0578x2.2xl0 
= 1.04% 
14 (ii) Incorporation based on C activity.-
Total 14c activity isolated as morphine=29.0xl02x52.6x24.9 dis/min 
16.1 
14 4 % incorporation based on C activity= 29.0x52.6x24.9x5.32xl0 
16.lxO.0578x2.2xl09 
= 0.99% 
The fact that [2-3H)morphine did not exchan~ 3H during 
its diacetylation \"Ias shown in the following way. [2-3H)Morphine 
(~. 20 mg, molar s.a. 40.3 x 107 dis/min/mmol.) in dry 
distilled pyridine (4 ml.) was treated with acetic anhydride 
(2 ml.) then heated on a water bath for 3 hr. The solvents 
were evaporated off, and the solid chromatographed on a column 
of alumina in chloroform. Crystallisation from ethyl acetate 
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gave diacetylmorphine (22 mg.), m.p. 171-172oC (lit.,1071730C) 
with water s.a. 42.4 x 107 dis/min/mmol). 
Single Labelled [2-3H]DihydrOCodeine Fbeding:-
The plants (wet weight 109 g.) gave a total alkaloid 
extract (38.2 mg.) which, by volumetric count, suggested a 44% 
recovery of 3H activity. Radioinactive codeine (28.2 mg.), 
dihydrocodeine (32.03 mg.) [total non-phenolic alkaloids 
60.23 mg. L morphine (33.5 mg.), and dihydromorphine (40.2 
mg.) [total phenolic alkaloids 73.7] were added for dilution 
and separation into phenolic and non-phenolic alkaloid fractions 
achieved using the ion exchange procedure. 
Non-Phenolic Alkaloids.- The non-phenolic alkaloids were 
initially separated to give dihydrocodeine and codeine using 
p.l.c. on alum1na plates (20 x 20 cm.) impregnated with silver 
nitrate and developed in methanol (respective Rf values 0.2 and 
0.3 ). Subsequent separations were using basic silica plates 
developed in methanol (respective Hf values 0.5 and 0.4). 
Dihydrocodeine Fraction.- Initial separation gave dihydro-
codeine (29.6 mg.) ~lhich was pure by t.l.c. on basic silica; 
volumetric count shoned that the total acti vi ty present was 
326 x 105 dis/min. Attempts to crystallise the dihydrocodeine 
(27.7 mg.) failed even after addition of fUrther radioinactive 
dihydrocodeine (37.9 mg; total 67.5 mg.). A chloroform 
solution of the alkalOid was poured through a column of alumina 
to remove 1races of silver nitrate originating from the initial 
separation. The sum, obtained after evaporation of solvent, 
o 11as sublimed (2mm. of Hg, ~. 140 C) and the resulting oil 
eventually crystallised f.rom ether to give dihydrocodeine of 
constant ~ specific activity 4.84 x 105 dis/min/ms. 
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Recovery of [2-3H]dihydrocodeine.-
Total 3H activity isolated as dihydrocodeine =4.84xl05x67.5x32.03 disl 
27.7 min 
Total 3H activity fed (Table 1. Chapter II)=o.044x2.2xl09 dis/min 
% recovery of dihydrocodeine = 4 • 84x67 .5X32 .03xl0 7 
27.7XO.044x2.2xl09 
=~ 
Codeine Fraction.- Codeine (28.1 mg.) isolated initially was, 
shown, by t.l.c. on basic silica, to be contaminated with dihydro-
codeine and volumetric count showed the total activity present 
4 
was 287 x 10 dis/min. More radioinactive codeine (39.9 mg; 
total 68.0 mg.) was added, and after rechromatographing on basic 
silica plates the recovered codeine (65.6 mg.) showed a total 
activity of ~. 714 x 103 dis/min by volumetric count and the 
presence of some dihydrocodeine by t.l.c. Further chromat-
ography on basic silica plates gave codeine (lf5.9 rng.) with total 
acti vi ty 807 x 102 dis/min. S11icic acid tlas removed from the 
codeine by pouring a chloroform solution through a column of 
alumina, and the recovered material (23.3 mg.) was diluted with 
radioinactive codeine (17.7 mg.; total 41.0 mg.) and mixed with 
dihydrocodeine (30.4 rng.). Separation on basic silica plates gave 
codeine (~.O mg.) \'Ii th total 3H acti vi ty 353 x 102 dis/min. 
A second wash with radioinactive dihydrocodeine (29.4 mg.) 
produced codeine (32.0 mg.) with :in estimated total activity of 
2 215 x 10 dis/min by volumetric count. Treatment on a column 
of alumina removed silicic acid and crystallisation from benzene 
to constant specific activity gave codeine, m.p. 156-157 (lit.,101 
156-157) with 3H s.a. 920 dis/min/mg. (actual determinations gave; 
148 cpm. for 0.367 mg., and 131 cpm. for 0.322 mg. of the codeine). 
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The [2-3H]dihydrocodeine precursor was shown (see later) to 
contain 0.735% [2-3H]codeine. Thus total activity of 
[2-3H]codeine present in precursor (see Table 1. Chapter II) 
= 0.735 x 4.4 x 2.2 x 105 dis/min. 
Total 3H activity isolated as codeine = 920 x 41.0 x 67.9 
23.3 
% recovery of contaminating [2-3H]codeine = 920x41.0x67.9xl0-3 
0.735x4.4x2.2x23.3 
= 15.4% 
The codeine was shown to be radiochemically pure via the 
picrate which was recrystallised from ethanol, m.p. 194_1Q6oc 
(lit.,106 196-197°C) and the regenerated codeine showed, after 
crystallisation, 3H specific activity of 925 dis/min/mg. 
Phenolic Alkaloids.- The alkaloids, dihydromorphine and 
morphine, from ion exchange separation (61.8 mg, 100% recovery) 
were separated by pl.c. on basic silica plates developed in 
methanol (respective Hf values were 0;5 and 0.4). 
Dihydromorphine Fraction.- The dihydromorphine (}6.6 mg.) 
isolated Showed, by t.l.c. on basic silica, that some morphine 
~las present. A wash with radioinactlve mOl'phine (30.0 mg.) gave 
dihydromorphine (29.9 mg.) which was treated with water (10 ml.), 
then extracted with chloroform-propan-2-ol (4 x 5 ml.) to 
give dihydromorphine (24.4 mg.) which was freed from siliCic acid. 
DilutIon \dth radioinactlve material (16.9 mg.; total 41.3 mg.) 
followed by crystallisation from ethanol to constant specific 
activity gave the dihydromorphine, m.p. 155-157°C (lit.,67 
155-157°C) with 3H s.a. 72.2 x 102 dls/mln/mg, ~. 20.7 x 
105 dis/min/mmol. The diacetyl derivative was formed (method 
as for morphine) which crystallised from ethyl acetate, m. p. 
134. 
164-166°c (lit.108 165-167°C) molar specific activity 20.8 x 105 
dis/min/mmol. 
Calculation of dihydrocodeine into dihydromorphine incorporation:-
Total 3H activity isolated as dihydromorphine = 
~ incorporation = 72.2 x 41.3 x 40.2 x 104 
24.4 x 0.044 x 2.2 x 109 
2 72.2xl0 x41.3x40.2dis/ 
24.4 min 
Morphine Fraction.- Morphine (32.1 mg.) obtained from the 
initial separation \'laS pure by t.I.c., and the total activity present 
estimated from the volumetric count was 443 x 102 dis/min. The 
and separation gave material (31.1 mg.) 
morphine was mixed I~ith radioinactive dihydromorphine (20 mg.) / 
2 
with total activity 155 x 10 dis/min. The alkaloid was extracted 
from aqueous solution to remove silicic acid and crystallised 
from ethanol to constant specific activity to give morphine, m.p. 
o 102 0 3 . 2~7 C (Ut., 247-248 C) with H s.a. 525 d~s/min/mg. 1.e. 
15.0 x 104 dis/min/rru1loI. (actual de terminations after correction 
for background gave; 102 cpm for 0.437 mg, and 208 cpm from 0.909 
mg. of the morphine). The diacetyl derivative was formed and 
crystallised from ethyl acetate, m.p. 171-172oC (lit.,107 173°C), 
molar specific activity 14.6 x 104 diE/min/nnnol. Thus, 
Total 3H activity isolated as morphine= 525 x 33.5 dis/min. 
» incorporation of contaminating [2-3H)codeine 
into morphine = 525 x 33.5 
0.735 x 4.4 x 2.2 x 103 
= 2.46% 
Dilution Analysis on [2-3H)Dihydrocodeine Precursor.- The 
precursor material, [2-3H)dihydrOCodeine (28.1 mg, s.a. 1.209 mCi/ 
mmol; total 2.48 x 108 dis/min), was mixed with radioinactive 
135. 
codeine (31.9 mg.) and the codeine reiso1ated by p.l.c. on basic 
silica plates. The codeine (30.5 mg.) isolated was mixed with 
radioinactive dihYdrocodeine (29.2 mg.) and the separation, in 
which a narrow band associated with codeine was cut from the plate, 
was repeated. Crystallisation from benzene to constant specific 
60 101 6 0) activity gave codeine (24.9 mg.), m.p. 15 C (lit., 15 -157 C , 
with specific activity 56.9 x 103 dis/min/mg, total 182 x 104 
dis/min representing 0.735% contamination. Radiochemical purity 
of the codeine was demonstrated ~ the picrate (gave s.a. 
56.7 x 103 dis/min/mg.). 
Double-Labelled [2-3HJDihydrOCodeine Feeding:-
The total alkaloids (43.4 mg.) extracted fro~ the 
plants were diluted Vii th codeine (37.3 mg.), dihydrocodeine 
(41.4 mg.) [total non-phenolic 78.7 mg.], morphine (32.1 mg.), 
and dihYdromorphine (35.3 mg.) [total phenolic 67.4 mg.J. 
Separation by ion exchange gave non-phenolic alkaloids (92.6 
mg.) and phenolic alkaloids (37.3 mg, 56% recovery). The 3H!4c 
ratio for the precursor was determined by volumetric count and 
found to be 3.62:1, i.e. 0.0119 mCi of 14C activity was fed. 
Non-Phenolic Allcaloids .-The alkaloids Imre separated by 
p.1.c. on basic silica and gave codeine (38.2 mg.) and dihYdro-
codeine (43.0 mg.) l1hich by t.l.c. (basic silica-methanol) showed 
a trace of contamination by each other. 
Codeine Fraction.- The small amount of contaminating 
dihYdrocodeine was removed by p.l.c. on basic silica, however, 
the recovered codeine (24 mg.) still showed slight 3H activity. 
Radioinactive dihYdrocodeine (22.2 mg.) was added and chromatograPhY 
14 gave codeine (18.7 mg.) which showed only C activity. Dilution 
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wi th radioinactive codeine (18.5 mg.; total 37.2 mg.) follO\'led 
by crystallisation to constant specific activity from benzene 
gave codeine, m.p. 154-1550 C (lit.,101 156-157°C), with only 
14 _, 
C present, s.a. 68.6 x 10- dis/min/mg. Formation of the 
picrate and regeneration of the free base gave codeine ~lith 
14C s.a. 68.0 x 103 dis/min/mg. 
14 Recovery of [N-methyl- C]codeine.-
U 3 TOtal C activity isolated as codeine=68.6xlO x37.2x37.3 dis/min. 
18.7 
% recovery =68.6x37.2x37.3xl05 
28.7xO • 01l9x2 .2xl09 
= 19.4% 
D1hydrocodeine Fraction.- After one further separation on 
basic silica plates the recovered dihydrocodeine (40.0 mg.) Nas 
mixed 1'lith radioinactive codeine (42.0 mg.) and then rechromato-
graphed. The recovered dihydrocodeine (25.8 mg.) was pure and 
showed only 3H activity and was diluted with radioinactive 
material (65.0 mg., total 90.8 mg.). Many attempts were made 
at direct crystallisation but all 11ere without success; eventually 
the material was sublimed (2.4 mm of Hg, 1530 C) and the rcsultant 
'oil seeded with radioinactive dihydrocodeine to give a crystalline 
product. 'lhe process was repeated twice and the derived dihydro-
codeine showed a 3H s.a. 21.0 x 104 dis/min/mg. 
Recovery of [2-3H]dihydrOCodeine.-
Total 3H activity isolated as 
% recovery 
4 dihydrocodeine=21.0xlO x90.8xJfl.l 
25.8 
6 
= 21.Ox90.8x41.4xlO 
9 25.8x0.0434x2.2xl.0 
= 31.8% 
137. 
1is/ 
min 
Phenolic Alkaloids.- Ion exchange separation gave low recovery 
of the total phenolic alkaloids (37.3 mg.), thus radioinactive 
morphine (21.4 mg.; total 40.0 mg.) and dihydromorphine (30.1. mg.; 
total 48.7 mg.) ~Iere added. It was assumed that an equal amount 
of each of the phenolic alkaloids was present in the total isolated 
1.e. 1.8.6 mg. The alkaloids were again separated by p.l.c. on 
basic silica plates developed 1n methanol. 
Dihydromorphine Fraction.- After the initial separation the 
dihydromorphine contained traces of morphine and volumetric count 
showed mainly 3H but a small amount of 1.4c activity. Radioinactive 
morphine (30 mg.) was added, and the recovered dihydromorphine 
(31..6 mg.) was pure by t.l.c. showing only 3H activity by 
volumetric count. Extraction gave dihydromorphine (29.1 mg.), 
free from silicic acid, and crystallisation from ethanol to 
constant specific activity gave the allmloid, m.p. 1.53-156'C 
(lit. ,67 1.55-157), with 3H s.a. 60.3 x 1.02 dis/min/mg. i.e. 
1.7.3 x 105 dis/min/mmol. The diacetyl derivative crystallised 
from ethyl acetate, m.p. 1.66-1.68°c (lit.,108 l65-1.67°C) and had 
a molar specific activity of 1.7.2 x 1.05 dis/m1n/mmol. 
Incorporation of dihydrocodeine into dihydromorphine.-
Total 3H activity isolated as dihydromorphine=60.3xl02x48.7x35.3 dis/ 
% incorporation 
1.8.6 min 
4 
=60.3x48.7x35.3xlO 
9 1.8.6xO .04}4x2 .2xl.0 
= 0.59% 
Morphine Fraction.- After initial separation, the morphine l1as 
found to be contaminated with a small amount of dihydromorPhtne. 
A second separation gave morphine (35.8 mg.), pure by t.l.c., but 
still containing some 3H activity and this was removed by washing 
with radioinactive dihydromorph1ne (38.4 mg.). Silicic acid 
was removed to give morphine (21.6 mg.) which .Ias then diluted 
with radioinactive material (11.7 mg.; total 33.3 mg.). 
Crystallisation from methanol to constant specific activity 
o 102 14 gave morphine, m.p. 243-246 C (lit., 247-248), with C 
s.a. 31.3 x 102 dis/min/mg. 1.e. 8.92 x 105 dis/min/mmol. 
The diacetyl derivatives of the morphine crystallised from ethyl 
o 
acetate and gave m.p. 173 C (lit.,107 1730 C) molar specific 
activity 9.12 x 105 dis/min/mmol. 
Incorporation 
Total 14 Cacti vHy 
% incorporation 
14 
of [N-methyl- C]codeine into morphine.-
isolated as morphine=31.3xl02x33.3x40.0x32.1 dis/ 
21.6Xl8.6 min 
4 
=31.3x33.3x40.Ox32.lxlO 
9 21.6xl8 .6x0 .0119x2 .2xl0 
= 1.26%. 
ExChange53 of ~ label in [2-3H]Diacetyldihydromorphine 
from Double-Label Feeding.- The [2-3H]diacetYldihydromorphine 
(15.7 mg., s.a. 46.0xl02 dis/min/mg.; total 72.3xl03 dis/min.) 
obtained from the double-labelled feeding was dHuted with 
radioinactive material (51.6 mg., s.a. 10.7 x 102 dis/min/mg.) 
then treated, in an exchange tube, with an aqueous (2 ml.) 
methanol (0.5 ml.) solution of potassium carbonate (51.2 mg., 
3 moL). After flushing, with oxygen and carbon dioxide free 
nitrogen, the tube was sealed and heated at ~. lOOoC for 119 hr. 
After cooling, the tube was opened and the contents poured 
into water. Extraction with chloroform-propan-2-o1, followed 
by crystallisation from ethanol to constant specific activity 
gave dihydromorphine (34.1 mg.); the 3H specific activity was 
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54 dis/min/mg. representing 96.1~ loss of 3H activity. 
Single-Labelled [2-3HJrsocodeine Feeding:-
The plants (wet weight 84 g.) gave a total alkaloid 
extract (122 mg.) which was diluted with radioinactive samples 
of codeine (88.9 mg.), isocodeine· (63.6 mg.) [total non-phenolic 
152.5 mg.], morphine (49.4 mg.), and isomorphine (84.4 mg.) 
[total phenolic 133.8 mg.J. The ion exchange separation 
was utilised. 
non-
Non-Phenolic Alkaloids.- The tota~phenolic fraction isolated 
(192.0 mg.) was found by t.l.c. to contain both codeine and iso-
codeine. The fraction was coloured green presumably by 
contaminating plant material which explained the additional 
material recovered above the weight of dilution compounds 
(152.5 mg.). Separation of the two non-phenolic alkaloids was 
by chromatography on a column of alum1na in chloroform. This 
system gave good separation since the Rf of isocodeine is 0.1 
and of codeine 0 0 4. 
Codeine Fraction.- The codeine (77.4 mg.) isolated from the 
column chromatography was pure by t.l.c. and showed negligible 
3H activity by volumetriC count. Crystallisation from benzene to 
constant specific activity gave codeine, m.p. 154-1560c (lit.,101 
156-157°C),with 3H s.a. 76 dis/min/mg. (actual determinations 
gave; 46 cpn. for 1.396 mg., 34 cpm. for 1.007 mg. of the codeine). 
Because of the very small amount of 3H activity present no 
proof of radiochemical purity was sought. 
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Estimate of [2-3H]1socodeine incorporation into (or:. 
contamination of) codeine.-
Total 3H activity isolated as 
Total 3H activity fed 
Estimated max % incorporation 
codeine = 76 x 88.9 dec/min. 
= 0.0374 x 2.2 x l09 dis/min 
= 76 x 88.9 x lO 2 
0.0374 x 2.2 x 109 
= 8.l x 1O-3% 
~.(8.l x 1O-3% 
Isocodeine Fraction.- Isocodeine (56.0 mg.) isolated by 
column chromatography was, from t.l.c., pure and free from codeine. 
Direct crystallisation to constant specific activity from ethyl 
acetate gave isocodeine, m.p. l70-l71oC (lit.,99 l71-l72oC), 
s.a. l2l x la3 dis/min/mg. No suitable derivative is 
available for proving the radiochemical purity of the isocodeinc 
but the value of specific activity given above remained constant 
over three crystallisations. 
Recovery of [2-3H)isocodeine.-
Total 3H activity isolated as isocodeine=l2l x la3 x 63.6 dec/min. 
% recovery = l21 x 63.6 x l05 
0.0374 x 2.2 x 109 
= 9.4% 
Phenolic Alkaloids.- The ion exchange separation gave the 
phenolic alkaloid fraction which contained about equal amounts 
of morphine and isomorphine by t.l.c. on basic silica (respective 
Rf values 0.4 and 0.2). The alkaloids were converted into 
their 3-Q-acetyl derivatives74 for separation by treating thc 
phenolic fraction (92.4 mg.) in aqueous (9.3 ml.) sodium 
bicarbonate (920 mg.) with acetic anhydride (0.47 ml.). 
Chloroform (If x lO ml.) extraction and solvent evaporation gave 
l41. 
the tl10 3-Q-acetyl-derivative (113 mg.) which were separated by 
chromatographing on a column of neutral grade V alum1na. 
Isomorphine Fraction;- The 3-Q-acetylisomorphine (48.1 
mg.) isolated after separation showed a 3H specific activity 
of 3.89 x 103 dis/min/mg., and total activity 18.7 x 104 
dis/min by volumetric count. The t.l.c. showed the 
3-Q-acetylisomorphine to be pure, however, radioinactive 
3-Q-acetylmorphine (44.5 mg.) was added and the mixture 
rechromatographed. The recovered 3-Q-acetylisomorphine (28.2 
mg.) was pure from t.l.c. and the estimated total activity from 
the volumetric count gave 14.18 x 104 dis/min. The compound was 
further purified by p.l.c. on alum1na plates, then hydrolysed in 
aqueous-methanol (1:1 )(10 ml.) by treatment with 2N sodium 
hydroxide (2 ml.) to give isomorphine (26.5 mg.) which l-raS 
diluted with radioinactive material (36.6 mg.; total 59.1 mg.). 
Crystallisation to constant specific activity from methanol-
ethyl acetate gave isomorphine, m.p. 253-2250C (lit.,102 
251-252°C), with 3H s.a. 1l.6 x 102 dis/min/mg. 1.e. 
331 x 103 dis/min/mmol. The isomorphine was treated with 
diazomethane to yield isocodeine which was crystallised from 
ethyl acetate, m.p. 171-172°C (lit.,99 171-1720C), and molar 
specific activity 329 x 103 dis/min/mmol. 
Incorporation of [2-3H]isocodeine into isomorphinc.-
Total 3H activity isolated as isomorphine=1l.6xl02x59.lx811.4 dis/min 
26.5 
% incorporation 
142. 
11 
= 1l.6x59.lx84.4xlO· 
9 26.5x0.0374x2.2xl0 
= 0.27% 
From other experiments the average value for conversion of codeine 
into morphine is 1.06% which gives for the above an efficiency 
(i.e. X' ~ y'va1ue) of 25.1% C.f. value from double-labelled 
X ..... Y 
feeding was 15.2%. 
Morphine Fraction.- After initial separation the isolated 
3-Q.-acety1morphine (ll.l mg.) appeared pure by t.1.c., a 
volumetric count estimated the 3H specific activity as 13.7 
x 102 dis/min/mg. and total activity 15.2 x 103 dis/min. The 
3-Q.-acety1morphine was diluted with radioinactive material 
(29.5 mg.; total 40.6 mg.) and "washed" using radioinactive 
3-Q.-acety11somorphine (32.3 mg.). The recovered alkaloid 
(24.2 mg.) was hydrolysed with aqueous methanolic sodium hydrox1dp. 
to give morphine (23.3 mg.) ~lhich. was further diluted Hith 
radioinactive morphine (10.5 mg.; total 33.8 mg.). 
Crystallisation from methanol to constant specific activity gave 
o 102 480 the morphine, m.p. 244-246 C (lit., 247-2 C), ~lhich 1·ras 
essentially radioinactive, i.e. 3H s.a. 68 dis/min/mg. (actual 
determinations gave; 17 cpm for 0.631 mg, and 20 cpm for 0.721 
mg. of the morphine). 
Estimate of [2-3H]isocodeine incorporation into morphine.-
(or [2-3H]isomorphine contamination of morphine) 
Total 3H activity isolated as morphine=68x33.8x40.6x49.1~ dis/min 
23.2 x ll.l 
Estimated max % incorporation 
143. 
2 
=68x33.8x40.6x49.4xlO 
9 23.2x1l.lxO.0374x2.2xl0 
= 0.021% 
l.e.( 0.02% 
Double-Labelled [2-'H]Isocodeine Feeding:-
The alkaloid extract (37.7 mg.) was diluted with radio-
inactive samples of codeine (64.9 mg.), isocodeine (50.1 mg.) 
[total non-phenolic 115.0 mg.], morphine (78.9 mg.), and iso-
morphine (46.5 mg.) [total phenolic 125.4 mg.]. The non-phenolic 
(1'5.7 mg.) and phenolic (105.8 mg., 85~) fractions were 
obtained by ion exchange chromatography. 
Non-Phenolic Alkaloids.- These' alkaloids were separated to 
give codeine and isocodeine by chromatographing on a column 
of alumina in chloroform. The 3a;l4c ratio was determined for 
the precursor (described previously) and found to be 3:13:1 
i.e. 0.0126 mCi of 14c activity were fed. 
Codeine Fraction.- The codeine recovered after separation 
(61.9 mg.) was found, by volumetric count, to contain mainly 
14C activity and also a total 'H activity of ,8.1 x 101f 
dis/min. Thus the codeine \~as mixed with radioinactivc iso-
codeine (55.6 mg.) and the alkaloids reseparated. The codeine 
(42.9 mg.) recovered showed negligible'H activity to be present. 
Crystallisation to constant specific activity from benzene 
gave codeine, m.p. 152-154°C (lit.,101 156-157°C), with 11fC 
69.0 x 10' dis/min/mg. and 3H s.a. 144 dis/min/mg. s.a. 
The codeine obtained after picrate formation had 14c s.a. 
69.0 x 10' dis/min/mg. 
14 (i) Recovery of [N-methyl- C]codeine.-
Total 14C activity isolated as codeine=69.0xlo'x64.9 dis/min. 
5 % recovery =6Q.Ox64.9xlO 
0.0126x2.2xl09 
= 16.2%. 
(ii) Estimate of [2-3H)isocodeine incorporation into (or 
contamination by) codeine.-
Total 3H activity isolated as 
Total 3H activity fed 
codeine= l44x64.9 dis/min. 
Estimated max. % incorporation 
9 
=O.0396x2.2xlO dis/min. 
=144x64.9xl02 
9 0.0396x2.2xl0 
,2 
=1.00&10 % 
Le. <0.01% • 
Isocodeine Fraction.- Separation gave isocodeine (59.1 mg.) 
which was pure by t.l.c. and volumetric count showed mainly 3H 
activity but also a total 14c activity of 16.5 x 104 dis/r.lin. 
Radioinactive codeine (52.6 mg.) was added and separation gave 
11f isocodeine (42.4 mg.), pure by t.l.c., showing a total C 
activity of 1032 dis/min. Crystallisation from ethyl acetate 
o 
to constant specific activity gave isocodeine, m.p. 170-172 C 
(lit.,99 l71-1720 C), having 3H s.a. 55.9 x 104 dis/min/mg. 
14 . 
and C s.a. 36 dis/min/mg. The 3H specific activity rc~ained 
constant over three successive crystallisations. 
(i) Recovery of [2-3H)isocodeine.-
Total 3H activity isolated as isocodeine= 55.9xl04x50.l dis/min. 
6 ;5 recovery =55.9x50.lxlO 
0.0396x2.2xl09 
= 32%. 
14 (11) Estimate of [N-methyl- C)codeine incorporation 
(contamination) into isccodcine.-
Total l4C d "':'-50 1 /. activity isolated as isoco eine = ~ • dis m2n. 
Estimated max. % incorporation 
145. 
= 36x50.lxlO 2 
0.0126x2.2xl09 . 
= 3.73xl0:-3% 
Le. < 0.003% 
Phenolic Alkaloids.- The total phenolic alkaloids (105.8 
71} 
mg.) were converted into their 3-Q-acetyl-derivatives and 
separated by chromatographing on a column of neutral grade V 
alumina, to give 3-Q-acetylisomorph1ne and 3-Q-acetylmorphine. 
Morphine Fraction.- The 3-Q-acetylmorphine was obtained 
pure after the column chromatography, and showed no 3H activity 
to be present. Hydrolysis using aqueous methanol1c sodium 
hydroxide followed by extraction gave morphine (41.1 mr;.). 
Crystallisation to constant specific activity was from methanol 
and gave morphine, m.p. 247-248°C (lit.,102 247-24Soc), having 
s.a. 
6 . 
32.0 x 103 dis/min/mg., i.e. 9.12 x 10 dis/min/mmol. 
and no 3H activity. The diacetyl derivative was formed and 
crystallised from ethyl acetate to give material, m.p. 
174-1750 C (lit.,107 173°C), with molar specific activity 
8.98 x 106 dis/min/mmol. 
14 Incorporation of [N-methyl- C)codeine into morphine.-
Total 14C activity isolated as morphine =32.0xl03x78.9 dis/min. 
% incorporation =32.Ox78.9xl05 
0.0126x2.2xl09 
= 9.1%. 
Isomorphine Fraction. - A volumetric count on the 
3-Q-acetylisomorphine (31.0 mg.), obtained after the initial 
separation, gave the total 3H activity as 10.9 x 105 dis/min 
14 4 
and total C activity as 5.77 x 10 dis/min. The fraction was 
diluted with radio1nactive 3-Q-acety11somorphine (211.6 mg.; 
total 55.6 mg.), then rechromatographed on neutr.1.1 wade V 
alumina. The recovered 3-Q-acetyl1somorphine (37.5 J:lG.) still 
14 
showed C activity and was mixed with rad1oinact1ve 
146. 
3-Q-acetylmorphine (32.4 mg.) then reseparated. The isolated 
3-Q-acetyl1somorphine (1.0.5 mg.) was free from 1.4c activity and 
after further dilution with radioinactive material (55.6 mg; 
total 66.1. mg.) was hydrolysed in aqueous methanol1c sodium 
hydroxide to give isomorphine (63.3 mg.). Crystallisation to 
constant specific activity was from ethyl acetate-methanol 
and gave isomorphine, m.p. 247-250 (l1t.,1.03 251.-252°C), with 
3H s.a. 22.1.xl02 dis/min/mg. and 1.4C s.a. 25 dis/min/m~. 
(i) Incorporation of [2-3H]isocodeine into isomorphine.-
Total 3H activity isolated as isomorphine=22.1.xl02x66.lx55.6x46.5diS/ 
% incorporation 
1.0.5X31.0 min 
=22 .1.x66 .1.x55 .6x116 .5X1.0 4 
1.0.5X31.OxO.0396x2.2x1.C9 
=~. 
(11) Estimate of [N_methYl_1.4C ]codeine incorporation into 
1.4 isomorphine.- (or C contamination of isomorphine) 
1.4 Total C activity isolated as isomorphine=25X66.1.x55.6x46.5 dis/ 
Estimated max.% incorporation 
1.0.5X31..0 min 
=25X66.lx55.6xIlG.5x1.02 
9 1.0.5X31..OxO.0126x2.2x1.0 
= 0.047% 
~ (0.05)6 
The isomorphine could not be shown to be radiochemically 
pure since no suitable derivative is available. Methylation, 
as in the single labelled experiment, to give isocodeine, was 
discounted since it would then not be possible to e>Cchange the 
3H label at C-2. Removal of the 3H label was necessary to 
demonstrate that the precursor had been incorporated intact. 
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The specific activity of the isomorphine isolated from this 
latter experiment was" constant over three successive 
, •. , • I 
crystallisations, and 'the incorporation was 15.~ efficient 
(1.e. X'-+ y') which is in reasonable agreement with the 
- X_Y) 
value estimated for the single-labelled feeding (see earlier). 
Exchange of 3H label in [2-3HJrsoniorphine from 
Double-Labelled Feeding.- The isolated [2-3HJisomorPhine (24.3 
mg.; 3H s.a. 22.1 x 102 dis/min/mg.) was diluted wi th radio-
inactive alkaloid (24.7mg.; giving 49.0 mg. with 1R s.a. 
II x 102 dis/min/mg.). After treating with aqueous (2 [11.) 
methanolic (0.5 ml.) potassium carbonate (28 mg.) in an EOCchange 
tube the resultant solution was heated to~. 1000 C for 106 hr. 
'lbe recovered isomorphine (32.4 mg.) had a 3H specific activity 
of 61 dis/min/mg., representing a 94.9% loss of the original 
activity present. 
Single-Labelled [2-3Hlcodeine Methyl Ether Feeding:-
After extraction from the plants (wet weight 83 g.) the 
total alkaloids (47.0 mg.) \"lere diluted with radioinactive samples 
of codeine (40.0 mg.), codeine methyl ether (47.8 mg.) [total 
non-phenolic 87.8 mg.l, morphine (40.2 mg.) and morphine methyl 
ether (42.3 mg.) [total phenolic 82.5 mg.J. The fractions ~lere 
separated by ion exchange chromatography. 
Non-Phenolic Alkaloids.:- This fraction (93.1 mg.) \"Ias found, 
by t.l.c., to contain both codeine and codeine methyl ether. 
Separation and purification of these alkaloids was achieved by 
p.l.c. on alumina plates developed in chloroform, giving initially 
codeine (39.8 mg.) and codeine methyl ether (50.0 mg.) 
148. 
Codeine Fraction.- The isolated codeine (39.8 rng; estimated 
~ s.a. 4.20 x 104 dis/min/ms, totsl 16.7 x 105 dis/min.) was 
miXed with radioinsctive codeine methyl ether ()8.2 mg.) and 
reisolated. The codeine (30.4 ms.; estimated 3H s.a. 3:30 
x 104 dis/min/ms, totsl 10.0 x 105 dis/min.) recovered still 
showed 3H activity by volumetric count, and was therefore washed 
a second time with radioinactive codeine methyl ether (70.5 mg.). 
The recovered codeine (26.8 rng.; estimated 3H s.a. 0.94 x 104 
dis/min/rng., totsl 2.52 x 105 dis/min) was chromatographed on 
a column of alurnins, and the isolated material (22.8 r.l:;.) was 
diluted with radioinactive codeine (24.7 rng.; total 47.5 rng.). 
Crystallisation to constant specific activity from benzene gave 
. 0 101 0 3 
codeine, m.p. 155 C (lit., 156-157 C), with H s.a. 108 x 
2 10 dis/min/rng • 6 0 106 The picrate was formed, m.p. 19 -197 C (lit., 
196-197°C), and the resulting codeine had 3H s.a. 108 x 102 
dis/min/rng. 
Incorporation of [2-3H)codeine methyl ether into codeine.-
Totsl 3H activity isolated as Codeine=l08xl02x47.5X40.0 dis/min 
22.8 
Totsl 3H activity fed 9 =o.0466x2.2xl0 dis/min. 
=l08x47.5X40.0xl04 
9 22.6x0.0466oc2.2xl0 
= 0.88':. 
Codeine Methyl Ether Fraction.- The codeine methyl ether 
(50.0 mg.) isolated from the initial separation was 1~lashed' with 
radioinsctive codeine (51.0 rng.), and the recovered alkalOid 
()6.4 ms.) was diluted with radioinactive codeine methyl ether 
(29.9 mg.; totsl 66.3 rng.). Crystallisation to constant 
specific activity from ethanol gave codeine methyl ether, m.p. 
149. 
4 0 76 0 3 4 139-11 C (lit., 140-141 C), with H s.a. 19.4 x 10 dis/min/ms. 
The picrate was formed, m.p. 182-184 decomp., and vegeneration of 
the free base on a column of alum1na gave codeine methyl ether 
with 3H s.a. 19.3 x 104 dis/min/ms. 
Recovery of [2-3H]codeine methyl ether.-
Total 3H activity recovered as codeine 
% incorporation 
4 MeO =l9.4xlO x66.3x47.8 dis/ 36.4 min. 
6 
=l9.4x66.3x47.OOo 
36.4xO.0466x2.2xl09 
= 16.4% 
Phenolic Alkaloids.- The total phenolic alkaloids (64.0 ms., 
79%) obtained were separated to give morphine and morphine methyl 
ether by p.l.c. on alum1na plates developed in n-butanol/di-n-
butyl ether/ammonium hydroxide ( v lIr , 25:70 :5). The separation 
was not very good although the alkaloids obtained were fairly 
pure. All the subsequent separations were carried out using 
the solvent system n-butanol/di-n-butyl ether/acetic acid83 
(v :v' 40:50:10). 
Morphine Fraction.- The morphine isolated initially (38.9 ms.) 
was mixed with radioinactive morphine methyl ether (40.0 mg.) and 
the separation effected. The morphine (41.8 ms.) recovered was 
contaminated (from t.l.c.) by morphine methyl ether and \'Ias 
rechromatographed on alumina. It was not possible to cI"Jstallise 
directly the recovered morphine (29.5 ms.) and radioinactive 
material (19.0 ms.; total 48.5 mg.) was added. Even then 
crystallisation was very difficult and eventually effected to 
constant specific activity using met9anol, and gave morphine, 
m.p. 246-247°C (lit.,102 247_248°C), with 3H s.a. 748 dis/min/ms. 
150. 
i.e. 2.15 x 105 dis/min/rnmol. The diacetyl derivative was 
o formed and crystallised from ethyl acetate, m.p. 171-173 C 
(lit.,107l73°C), with molar specific activity 2.07 x 105 
dis/min/rnmol. 
Incorporation of [2-3H]codeine methyl ether into morphine.-
Total 3H activity isolated as morphine =748x48.SX40.2 dis/min 
29.5 
% :incorporation =748x48 • SX1fO .2xl02 
9 29.5x0.0466x2.2xl0 
= 0.048%. 
Mor!iline Methyl Ether Fraction.- Morphine methyl ether 
isolated from the initial separation (40.1 mg.) was mixed with 
radioinactive morphine (40.0 mg.) and rechromatographed. The 
recovered morphine methyl ether (36.0 mg.) was pure except for 
some contamination by acetic acid. Therefore the alkaloid was 
dissolved in 0.5N hydrochloric acid (10 ml.), filtered, and after 
basification to pH8 with sodium hydrogen carbonate morphine methyl 
ether (23.3 ms.) was extracted with chloroform-propan-2-ol; 
dilution with radioinactive material (23.8 mg.; total 47.1 mg.) 
\'/as carried out. Crystallisation to constant specific activity 
from ethanol gave morphine methyl ether, m.p. 243°C (lit., 76 
2420 C), with 3H s.a. 12.6 x 103 dis/min/ms. Radiochemical 
purity of the morphine methyl ether was demonstrated via the 
picrate which was crystallised from ethanol, m.p. 261foC 
(decomp.). Morphine methyl ether, obtained from the picrate 
by pouring a chloroform-propan-2-ol (1:1) solution through a 
column of alumina, had a 3H specific activity of 12.2 x 103 
dis/min/ms. 
Incorporation of [2-3H]codeine methyl ether into morphine 
151. 
methyl ether.-
Total 3H activity isolated as morphine methyl ether=12.2xla5x41.1x42.3 dis/ 
23.3 min 
% incorporation =12.2x41.1x1:.2.3xl05 
23.)x0.Ol,66x2 .2xl09 
= 1.02% 
Double-Labelled [2-3H)Codeine Methyl Ether Feeding:-
The alkaloid extract (26.1 mg.) from the plants ~/aS 
diluted with radioinactive codeine (11.1 mg.), codeine methyl ether 
(59.3 mg.) [total non-phenolic 121.0 mg.), morphine (36.2 mg.), 
and morphine methyl ether (31.2 mg.) [total phenolic 13.4 r,}g.). 
Phenolic and non-phenolic fractions were obtained by ion exchange 
chromatography. The 3H/ 14c ratio for the precursor was determined 
by volumetric count and found to be 2.81:1, i.e. 0.0101 mei of 
l4C activity were fed. 
Non-Phenolic Alkaloids.- The non-phenolic alkaloid fraction 
(131.3 mg.), recovered from the ion exchange separation, contained 
both codeine and codeine methyl ether. As with the single-labelled 
experiment these alkaloids were separated by p.l.c. on alumina plates 
and gave codeine (56.2 mg.) and codeine methyl ether (55.5 mg.). 
Codeine Fraction.- Volumetric count of tho codeine (56.2 mg.), 
recovered from the initial separation, showed that both 3H and 
l4C activity were present. Thus a first wash with radioinactive 
codeine methyl ether (54.2 mg.) was carried out and gave codeine 
(44.5 mg.) which again showed 3H and l4C activity using volumetric 
count methods. A second wash with radioinact"i ve codeine methyl 
ether (43.0 mg.) was carried out and the recovered codeine still 
containcd 3H and 14C activity. The alkaloid was further purified 
by chromatographing on a column of alumina (31.0 mg. codeine 
152. 
recovered) and then diluted with radioinactive codeine (28.8 mg.; 
total 65.8 mg.). Crystallisation to constant specific activity 
o 101 6 0 from benzene gave codeine, m.p. 155-157 C (lit., 15 -157 C), 
with 14c s.a. 26.3 x 103 dis/min/mg, and 3H s.a. 23.8 x 102 
o ( 106 dis/min/mg. Formation of the picrate, m.p. 197 C, lit., 
196-197°C), and treatment on a column of alumina gave codeine 
with 14c s.a. 26.9 x 103 dis/min/mg, and 3H s.a. 25.8 x 102 
dis/min/mg. 
14 (i) Recovery of [N-methyl- C)codeine.-
~ , 
Total C activity isolated as codeine = 26.9xl0 x65.8x71.7 dis/min. 
% recovery 
37.0 
= 26.9x65.8x71. 7xl05 
37.0xO.Ol07X2.2xl09 
= 14.6% 
(ii) Incorporation of [2-'H)codeine methyl ether into codeine.-
Total 3H activity isolated as codeine = 25.8xl02x65.8x71.7 dis/min. 
37.0 
Total 3H activity fed 
% incorporation 
= 0.0309x2.2xl09 dis/min. 
4 
= 25. 8x65. 8xIl. 7xlO 
9 37·0xO.0309x2·2xl0 
= 0.49% 
Codeine methyl ether Fraction.- lhe volumetric count of the 
codeine methyl ether (55.5 mg.), isolated after the initial separation, 
gave the 3H s.a. 22.3 x 104 dis/min/mg. and 14c s.a. 11.11 x 102 
dis/min/mg. i.e. 3H!4c ratio ~Ias 196 (allowance was made for the 
contribution of the 3H activity to the Channel II count, i.e. 
0.055%). Thus the alkaloid was mixed with radioinactive codeine 
(67.8 mg.) and volumetric count of the recovered codeine methyl 
ether (32.1 mg,) estimated its 3H s.a. 27.0 x 104 dis/min/~. and 
153. 
14C s.a. 10.1 x 102 dis/min/mg. i.e. 3H!4c ratio is 268. 
After a second wash with radioinactive codeine (37.1 mg.) volumetric 
count of the recovered codeine methyl ether (14.2 mg.) gave 3H s.a. 
4 14 2 34.2 x 10 dis/min/mg. and C s.a. 14.7 x 10 dis/min/ms. i.e. 
The alkaloid was rechremat9graphed on a 
column of alumina (the recovery being 9.6 mg.) then diluted Hi th 
radioinactive codeine methyl ether (41.3 mg.; total 50.9 mg.). 
Crystallisation to constant specific activity from ethanol Gave 
o 76 0 3 
codeine methyl ether, m.p. 142 C (lit., 140-141 C, with H 
3 li! s.a. 41.3 x 10 dis/min/mg, and C s.a. 148 dis/min/ms. (actual 
corrected de terminations, in Channel II gave; 84 cpm for 0.725 
mg., and 81 cpm for 0.660 mg. of the codeine methyl ether) i.e. 
3H!4C ratio was 279 which is in reasonable agreement with that 
obtained throughout the separation stages. Again proof that the 
codeine methyl ether was radiochemically pure was via the picrate, 
m.p. 18~c decomp., the regenerated alkaloid having 3H s.a. 
39.1 x 103 dis/min/ms, 14C s.a. 136 dis/min/ms. ~.3~4c ratio 
was 287. 
(i) Recovery of [2-3H]codeine methyl ether.-
Total 3H activity recovered as codeine MeO=39.1x103x50.9x59.3 dis/min 
9.6 
% recovery =39.lx50.9x59.3xl05 
9 9.6xO.0309x2.2xl0 
= 18.4% 
14 (ii) Incorporation of [N-methyl- C]codeine into 
codeine methyl ether. -
Total 14C activity isolated as codeine MeO=l36x50.9x59.3 dis/min. 
9.6 
% incorporation 
154. 
=l36x50 • 9x59 .3xl02 
9.6xO.0107x2.2xl09 
= 0.182% 
Phenolic Alkaloids.- The total phenolic alkaloids isolated 
(75.6 mg.) were separated to give morphine and morphine methyl 
ether using p.l.o. on alumina plates developed in the n-butanol/ 
di-n-butyl ether/ammonium hydroxide solvent system. However, as 
indicated for the single-labelled experiment, the recovery of 
alkaloids was not good, and all subsequent chromatography utilised 
the acetic acid solvent system. 
Morphine Fraction.- The morphine (31.2 mg.) isolated 
contained a trace of morphine methyl ether, and was therefore 
chromatographed on alumina plates using the acetic acid solvent 
system. A volumetric count for the recovered morphine (11.0 mg.) 
- 2 1.4 gave the specific activities, J H 207 x 1.0 dis/min/mg., and C 
167 x 1.02 dis/min/mg. The morphine (1.1..0 mg.) was dlluted with 
radioinactive material (16.4 mg.; total 27.4 mg.) and washed l'lith 
radioinactive morphine methyl ether (27.1. mg.). Again volumetric 
count on the recovered morphine (1.7.1. mg.) gave the specific 
activities as, 3H 559 dis/min/mg, and 1.4C 24.4 x 1.02 dis/min/mg.-
~. values obtained for crystalline alkaloid. Crystallisation 
to constant specific activity from methanol gave morphine, n.p. 
244_246°C (l1t.,1.02 247-24SoC), 11ith 3H s.a. 563 dis/min/r,1C. i.e. 
4 1.4 2 1.6.1. x 1.0 dis/min/mmol., and C s.a. 23.4 x 1.0 dis/min/111C. i.e. 
66.7 x 1.04 dis/min/mmol. The diacetyl-derivative was formed and 
crystallised from ethyl acetate, m.p. 1.71.-1.73°C (l1t.,1.07 1.7)°C)' 
having the molar specIfIc activities, 3 4 H 16.2 x 1.0 dIs/min/mmol., 
1.4 4 C 64.8 x 10 dIs/min/mmol. 
(i) 1.4 [N-methyl- C]CodeIne incorporation into morphine.-
Total 1.4C activity isolated as morphine= 23.4xl02x27.4x36.2 dis/m1n 
11.0 
1.55. 
% incorjXlration I! = 23.4x27.4x36.2xl0 
1l.OxO.0107x2.2xl09 
= 0.90% 
(11) IncorjXlration of [2-3H]codeine methyl ether into morphine.-
Total 3H activity iso1ated as morphine 
% incorjXlration 
= 563x27.4x36.2 dis/min. 
11.0 
2 
= 563x27.4x36.2xl0 
9 1l.OxO .0309x2 .2xl0 
= 0.08% 
Morphine Methyl Ether Fraction.- The morphine methyl ether 
(25.9 mg.) isolated initially had specific activities, 3H i!1}.8 x 
3 14 2 . 10 dis/min/mg, C 12.6 x 10 dis/min/mg. by volumetric count. 
A 'wash' with radioinactive morphine (28.0 mg.) was carried out, 
but the recovered morphine methyl ether (14.2 mg.) still sho\~ed 
14 
slight C activity. Radioinactive alkaloid (15.5 mg.; total 
29.7 mg.) was added for dilution, but even a fter purification 
~ the hydrochloride and also the picrate the morphine methyl 
ether would not crystallise from ethanol. The recovered morphine 
methyl ether (15.3 mg.) was diluted with further radioinactive 
material (38.6 mg.; total 53.9 mg.) and crystallised to constant 
o 76 0 
specific activity from ethanol, m.p. 242 C (lit., 242 C), 
giving ~ s.a. 14.9 x 102 dis/min/mg. The picrate, m.p. 269°C 
(decomp.), was again, as with the single-labelled experiment, used 
to prove the radiochemical purity of "!he morphine methyl ether; 
3 2 14 H s.a. 14.6 x 10 dis/min/mg. and C B.a. 2!!.. 10 dis/minjmg. 
(i) IncorjXlration of [2-3H]codeine methyl ether into 
morphine methyl ether.-
Total 3H activity isolated as mor~ine 
156. 
2 MeO=14.9xl0 x53.9x29.7x37.2dis/ 
15.)xl.h.2 min. 
% incorporation = 14~53.9x29.7X37.2xl04 
15.jxl4;2x0.0309x2.2xl09 
14 (11) Estimate of [N-methyl- C)codeine incorporation into 
morphine methyl ether.-
14 Total C activity isolated as morphine MeO=lOx53.9x29.7x37.2 dis/ 
Estimated max. % incorporation 
15.jxl4.2 min. 
2 
=10x53.9X29.7x37.2xl0 
9 15.jxl4.2xO.0107x2.2xl0 
6xl _I~c( =11 0 (J 
Exchange of 3H Label in [2-3a)Morphine Methyl Ether from Double-
Label Feeding.- The isolated [2_3H)morphine methyl ether (36.0 mg., 
s.a. 14.6xl02 dis/min/mg; total 52.5 x 103 dis/min) I'ms diluted 
with radioinactive alkaloid (26.5 mg.; total 62.5 mg., s.a. 
8110 dis/min/mg.). After treatment with a solution of methanol 
(0.5 ml.), water (2 ml.) and potassium carbonate (22 me.) at 2!.. 
1000 C for 119 hr. the morphine methyl ether (52.1 mg.) isolated 
showed a 3H specific activity of 28 dis/min/mg. This represented 
a loss of 96.7% of the 3H activity originally present. 
Dilution Analysis on [2-3H)Codeine Methyl Ether Precursor.-
The precursor material, [2-3H]codeine methyl ether (14.2 mg., 
s.a. 1.294 mCi/mmol; total 12.9 x 107 dis/min), was miXed with 
radioinacti ve codeine (1 7 .I~ mg.) then the codeine was rcisolated 
by P.l.c. on alumina plates. The codeine (12.6 mg.) Has diluted 
with radioinactive alkaloid (20.0 mg., total 32.6 mg.) and then 
crystallised from benzene to constant specific activity, m.p. 
o 101 0 3 1/ 157 C (lit., 156-157 C), with H s.a. 172 dis min ffi6. i.e. 
a total activity of 77.5 x 102 dis/min. This represents a 
0.006% contamination of the precursor by codeine and is 
insignificant. 
157. 
Double-Labelled [2-3H]Dihydrodesoxycodeine Feeding.-
The plants (wet 11eight 140 g.) were extracted in the 
manner described to g1 ve the total alkaloids (164.3 me;.) I'/hich 
was diluted with radioinactive codeine (95.4 mg.), dihydrodesoxy~ 
codeine (58.7 mg.) [total non-phenolic 154.1 mg.], morphine 
(65.4 mg.), and dihydrodesoxymorphine (73.9 mg.) [total phenolic 
139.3 mg.]. The total mixture was treated on a column of ion 
exchange resin to give the phenoliC (88.3 mg, 64%) and non-
phenoliC (203.7 mg.) alkaloid fractions. The 3H!4c ratio 
for the precursor was found by volumetric count to be 11.lf3:1 
14 Le. 0.0091.9 mCi of Cacti vi ty were fed. 
Non-Phenolic Alkaloids.- The non-phenolic alkalOids, codeine 
and dihydrodesoxycodeine, were separated by p.l.c. on alumina 
plates developed in chloroform (respective Rf values O.lfO and 
0.70) • Good separation was achieved. 
Codeine Fraction.- The codeine (98.2 mg.) recovered after 
14 initial separation Showed only C activity by volumetric count. 
However, a wash with radioinactive dihydrodesoxycodeine (94.6 mg.) 
was carried out, and the recovered codeine (87.2 mg.) \'las 
chromatographed on a column of alumina to give pure all;aloid 
(86. 1f mg.). Crystallisation to constant specific activity from 
o 101 f benzene gave codeine, m.p. 156-157 C (lit., 156-15 C), 11ith 
14C s.a. 81.7 x 103 dis/m1n/mg, and no 3H activity. '!he codeine 
derived ~ the picrate, m.p. 195-197°C (lit., 106 196-197°C), 
14 3 gave C s.a. 80.7 x 10 dis/min/mg. 
14 Recovery of [N-methyl- C)codeine.-
~ 3 Total C activity isolated as codeines 8o.7xlO x95.4 dis/min 
% recovery = 8o.7x95.4xlO 5 
9 0.OO919x2.2xlO 
-=0 = 38.4% 1:.>'-'. 
Di~rodesoxycodeine Fraction.- The separated dihydrodesoxy-
3 11, 
codeine (85.4 mg.) contained mainly H activity and some C 
activity, thus a wash with radioinactive codeine (80.2 m!>.) \"Ias 
carried out. The recovered dihydrodesoxycodeine (28.4 mg.) contained 
14 
only a small amount of C activity and, after chromatography on 
a column of alumina the recovered material (22.7 mg.) was 
diluted with radioinactive dihydrodesoxycodeine (41.3 mg; total 64.0 
mg.) • Crystallisation to constant specific activity from [lcthanol 
o 71 0 gave dihydrodesokycodeine, m.p. 103-104 C (lit., 102-105 C), 
11, 
and a max. estimated C 
s.a. 101, dis/min/mg. The picrate, m.p. 206-207°C (lit., 71 
207°C), was formed to prove radiochemical purity and the regenerated 
dlhYdrodesoxycodeine had a 3H s.a. of 167 x 103 dis/min/ms. 
(ii) Recovery of [2-3H]dihydrodesoxycodeine.-
Total JH activity isolated as dihydrodasoxycodo1ne~167xl9?X~~~~ dis/ 
22.7 ~in 
Total JH activity fed ~.0407x2.2xl09 dis/min. 
% recovery ~67x64.OxsB.7xl05 
22.7xO.0407x2.2xi09 
~~ 
(11) Estimate of codeine incorporation (contamination)into 
dihydrodesoxycodeine. -
Total 14C activity isolated as dihydrodesoxycodeine~04x61,.ox58.7 22.7----
Estimated max % incorporation 2 ~04x64;Ox58.7xlO 
22. 7xO .00919;.:2 .2xl09 
= 0.08 
i.e. <0.08% 
Phenolic Alkaloids.- Th.e t\'/O phenolic alkaloids were initially 
separated by p.l.c. on basic silica plates developed in methanol. 
159. 
The slO\'1 moving fraction isolated contained mainly dihydrodesoxy-
morphine and some morphine, while the faster moving fraction 
contained mainly morphine together with some dihydrodesoxy-
morphine. Both the separation and recovery of alkaloids was 
ineffiCient, but good separation and purification was obtained 
using a column of neutral grade V alumina with ehloI'Oforr,l as 
solvent. 
Morphine Fraetion.- The initial p.l.e. separation gave the 
morphine (37.2 mg.) fraction which contained, by volumetric count, 
+4c activity and a large amount of 3H activity. Chromatogl~phy 
on grade V alumina gave morphine (27.5 mg.) which contained only 
1.4 C activity and was then diluted with radioinactive alkaloid 
(62.6 mg. total 90.1. mg.). Crystallisation to constant specific 
activity from methanol gave mor~,ine, m.p. 246-247°C (lit.,1.02 
o 1.4 2 247-248 C), having C s.a. 80.9 x 1.0 dis/min/mg. i.e. 2)0 x 
4 1.0 dis/min/mmol. The diacetyl derivative was prepared, and 
crystallisation from ethyl acetate gave the diacetylmorphine, 
o( 1.070) m.p. 1.72-1.73 C lit., 173 C , with molar specific activity 
224 x 1.04 dis/min/mmol. 
1.4 Incorporation of [N-methyl- C]codeine into morphine.-
1.4 Total C activity isolated as 2 morphine =80 .9xl.0 x90 .l.x65 .1, d1s/min 
~ incorporation 
27.5 
if 
= SO.9x90.lx65.4xlO 
9 27·5x0.0091.9X2.2xl.O 
Dihydrodesoxymorphine Fraction.- Initial separation by p.l.c. 
gave the dihydrodesoxymorphine fraction (29.4 mg.), 
t.l.c., some morphine, and by volumetric count some 
1.60. 
containing, by 
1.4 C act! vi ty. 
After chromatography on grade V alumina the recovered dihydro-
desoxymorphine (26.2 mg.), showing mainly ~ acti vi ty, 11as 
'washed' with radioinactive morphine (30.2 mg.) by chromatography 
on the column of alumina. Dihydrodesoxymorphine (24.0 r_~.) Has 
recovered pure, and was diluted I-lith radioinactive material 
(78.2 mg.; total 102.2 mg.). After repeated attempts at 
crystallisation only 65.5 mg. remained and this was diluted 
with radioinactive alkaloid (28.5 mg.; total 94.0 mg.) tlhich "Ias 
chromatographed on neutral grade III alumina to give dihydrodesoxy-
morphine (87.8 mg.). The material was sublimed (0.5 mm. of 
o Hg, 170 C), and crystallised to constant specific activity 
o from ethyl acetate to give dihydrodesoxymorphine, m.p. 186-188 C 
79 0 ) 3 2 / n/ (Ut., 188-189 c , having H s.a. 190 x 10 dis mi mg. and 
14 
an estimated C s .a. 31 dis/min/mg. The dihydrodesoxymorphine 
o Which '-Ias recovered and crystallised, m.p. 187-188 C, after 
formation of the picrate m.p. 216°C (decomp.), had a 3H specific 
activity of 18.4 x 103 dis/min/mg. 
(11) Incorporation of [2-3H]dihydrodesoxycodeine into 
dihydrodesoxymorphine.-
Total 3H activity isolated as dihydrodesoxymorphine = 
18.4xl03Xg4.0xl02.2x73.9 dis/ 
65.5x24.0 min 
;i incorporation =18 .4xg4 .Oxl02 • 2x73. 9xl05 
65.5x24.0xO.0407x2.2xl09 
= 9.27~. 
14 (ii) Estimate of codeine incorporation (or C contamination) 
into dihydrodesoxymorphine.-
14 Total C activity isolated as dihydrodesoxymorphine = 
161. 
~lx94.0xl02.2x73.9 dis/min. 
5.5x24.0 
Estimated max % incorporation =3lx94.0xl02.2x73.9xl02 
65.SX24.exO;00919x2.2xl09 
=0.069% 
~. (0.07% 
Exchange of 3H Label in [2-3H)DihydrOdesoxymorphine from Double-
Label Feeding.-The isolated [2-3H)dihydrodesoxymorphine (66.7 mg., 
s.a. 18.llxl03 dis/min/mg; total 123 x 104 dis/min) was treated 
in methanol (0.5 ml.) with water (2 ml.) and potassium carbonate 
o (32 mg.) then heated at~. 100 C for 104 hr. The dihydro-
desoxym~rphine isolated (42.4 "lg.) had a 3H specific activity 
of 74 dis/min/mg., representing a loss of 95.9% of the oriGinal 
3H activity present. 
Double-Labelled [2-3H)-1-BromOcodeine Feeding.-
The total alkaloids (192 mg.) extracted from the plants 
(wet weight 145 g.) ware diluted with radioinactive codeine 
(72.7 mg.), I-bromocodeine (74.3 mg.) [total non-pPenolic 147.0 
mg.J, morphine (67.8 mg.) and I-bromomorphine (77.5 mg.) [total 
phenolic 145.3 mg.J. The total alkaloid mixture was, by treatment 
on a column of ion exchange resin, separated into phenolic (164 
mg.) and non-phenolic (223 mg.) alkaloid fractions. Again the 
be 7.37, i.e. 
was determined by vollli~tric count and was 
14 0.00456 mCi of C activity was fed. 
found to 
Non-Phenolic Alkaloids.- No separation of the allmloids 
could be achieved using p.l.c. on alumina plates. Reasonablc 
separation to give I-bromocodeine and codeine was obtained by p.l.c. 
on basic silica plates developed in methanol (respective Rf values 
being 0.45 and 0.35.). An initial attempt to separate the 
alkaloids was made using alumina plates but was unsuccessful, thus 
162. 
the recovered fractions were combined and the separation repeated 
us1ng the basic silica plates. 
Codeine Fraction.- Volumetric count on the recovered codeine 
(39.6 mg.) gave the total 14C activity as 302 x 104 dis/min and 3H 
activity as 247 x 104 dis/min i.e. 3~4C ratio was 0.82. The 
alkaloid was mixed wi~~ radioinactive 1-bromocodeine (48.1 rug.) 
and reseparation on basic silica plates gave codeine (21.2 fi~.) 
~ 4 -
w1 th total Cacti vi ty 161 x 10 dis/min and 3H activity )If.O x 
102 d1s/min~. 3H/ 4c ratio was 2.11 x 10-3 • The alkal01d 
was d11uted with radioinactive codeine (48.4 mg.; total 69.6 
mg.) and the total chromatographed on a column of alumina in 
chloroform. Crystallisat10n to constant speCific activity from 
o 101 0 benzene gave codeine, m.p. 157-158 C (lit., 156-157 C), having 
14 2 3-C s.a.246 x 10 dis/min/mg, and estimated H s.a. 68 dis/min/mg, 
o ( 106 0 The p1crate was prepared, m.p. 196 C lit., 196-197 c), and 
11' rad10chemical purity demonstrated in the normal way i.e. 'c s.a. 
258 x 102 dis/min/mg. 
14 (i) Recovery of [N-methyl- C]codeine.-
14 Total C activity 1so1ated as 
% recovery 
4 
codeine=2.58xl0 x69.6x72.7 dis/min. 
21.2 
6 =2.58x69.6x72.7~Q 
9 21.2xO .OO456x2 .2xl0 
= §!% 
(ii) Esti~te of 3H incorporation (contamination) into Codeine.-
Total 3H activity isolated as codeine=68x69.6x72.7 dis/min 
Total 3H activity fed 
163. 
21.2 
=o.0335x2.2xl09 dis/min. 
2 
= 68x69.6x72.7xlO 
9 21.2x0.0335x2.2xl0 
-2", 
=2.20xl0 70 
< -2 Le. 2.2xl0 % 
l-Bromocodeine Fraction.- The l-bromocodeine (66.6 mg.) isolated 
in the in1 tial separation sho~led, by volumetric count, the total 
3H activity present to be 151 x 105 dis/min and 14c activity 
155 x 103 dis/min. The alkaloid was mixed with radioinactive 
codeine (73.9 mg.) and chromatography on basic silica plates 
gave l-bromocodeine (57.9 mg.), total 3H activ1ti being 95 x 
105 dis/min and 14c activity 48 x 102 dis/min (by volumetric count). 
The recovered alkaloid (57.9 mg.) was miXed with radioinacti ve 
material (20.4 mg.; total 78.3 mg.) and was chromatographed on a 
column of alumina in chloroform. Crystallisation (of recovered 
material) to constant specific activity from ethanol gave 
o 104 0 3.. l-bromocodeine, m.p. 160-162 C (lit., 161-162 C), baving -H 
s.a; 259 x 103 dis/min/mg, 1.e. 979 x 105 dis/min/mmol. and 
14 
estimated C activity 32 dis/min/mg. The 6-Q-acetyl-l-
bromocodeine derivative was formed and crystallisation from ethanol 
gave material, m.p. 191-192°C (lit., 109 192-1930 C), and molar 
specific activity 968 x 105 dis/min/mmol. 
(i) Recovery of [2-3H)-1-bromocodeine ." 
Total 3H activity isolated as l-bromocodeine=259xl03x78.)z74.3 dis/min. 
57.9 
» recovery =259x78 .3x71f. 3xl05 
57.9x0.0335x2.2xl09 
= 35.2% 
(11) Estimate of 14C incorporation (contamination) into 
l-bromocodeine.-
14 Total C activity isolated as l-bromocodeine=32x78.3x74.3 dis/min. 
Estimated max. % incorporation 
164. 
57.9 
=32x78.3x74.3xl02 9 
57.9x0.ooh56X2:2Xl.0 
-2ct 
= 3.21 x 10 " 
1.e. = <'0.03% 
Phenolic Jikaloids.- The phenolic alkaloids (164 mg.) were 
treated directly with pyridine (5 ml.) and acetic anhydride 
(2 ml.) and heated on a water bath. Partial separation of 
diacetyl-1-bromomorphine and diacetylmorphine was achieved using 
p.l.c. on alumina plates in chloroform-benzene (1:1). The 
separation was not good, and after hydrolysis purification 1'laS by 
p.l.c. on basic silica plates developed in methanol. 
Morphine Fraction.- Separation of diacetyl-derivatives Gave 
3 14 diacetylmorphine (56.1 mg.) which contained both H and C activity 
(t.l.c. showed a trace of diacetyl-1-bromomorphine). After basic 
hydrolysis the recovered morphine (42.4 mg.) was mixed with 
radioinactive 1-bromomorphine (43.0 mg.) and chromatographcd on 
basic silica plates developed in methanol. The recovered morphine 
(16.0 fig.) contained mainly 14C activity and was diluted 1'1ith 
radioinactive alkaloid (53.1 mg; total 69.1 mg.). Crystallisation 
to constant specific activity Has from methanol and gave morphine, 
m.p. 247-24Soc (lit.,102 247-24Soc), having 14c s.a. 880 
4 7 
dis/min/mg., i.:..!!.. 25.1 x 10 dis/min/mmol. and estimated ,;In s.a. 
56 dis/min/mg. The diacetyl derivative of the morphine was formed 
and crystal'Used from ethyl acetate, m.p. 171-172oC (lit.,107 173°C), 
and molar specific activity 24.5 x 104 dis/min/mmol. 
(11) Incorporation of Codeine into Morphine.-
14 Total C activity isolated as morphine=88Ox69.lx67.S dis/min. 
% incorporation 
165 
15.0 
2 
=880x69 .lx67 • 8xl0 
16.0xO.OO456x2.2xl09 
=~ 
(ii) Estimate of ~ incorporation (contwnination) into morphine.-
Total ~ activity isolated as morphine 
Estimated max.% incorporation 
= iZ:69.lx67.S dis/min • 
• 0 
2 
= S§x69.lx67.8xl0 
9 16.oxO.0335x2.2xl0 
= 2.2xl0-2% 
I-Bromomorphine Fraution.- The initial separation of the 
diacetyl-derivatives gave a faster moving fraction. diacetyl-l-
bromomorphine (33.3 mg.). which from t.l.c. contained some diacetyl-
morphine. The fraction was hydrolysed using base. then miXed with 
radioinactive morphine (30.1 mg.). Chromatography on basic silica 
plates gave pure I-bromomorphine (20.4 mg.) (pure by t.l.c.) which 
3 14 
contained mainly H activity and a trace of C activity. The 
alkaloid was rechromatographed on basic silica plates and the 
recovered material (lS.6 mg.) was diluted with radioinactive 
I-bromomorphine (43.9018.; total 62.5 mg.). The total allmloid was 
dissolved in 0.5N hydrochloric acid (~. 4 ml.). then after addition 
of sodium hydrogen carbonate to adjust to pH7 the solution was 
set aside for ~. 1 hr. The micro-crystalline material formed 
o 
was removed. and after drying in vacuo at 100 C for 3 hr •• its 
speCific activity was determined in the usual way. "Crystallisation" 
to constant specific activity was carried out in this way and gave 
I-bromomorphine with 3H s.a. 712 dis/min/mg. The diacetyl derivative 
was formed and crystallised from methanol to constant specific activity 
0800 
m.p. 206-207 C (lit.. 208 C). and molar specific activity 
4 -
15.2 x 10 dis/min/mmol. which corresponds for I-bromomorphine to 
14 417 dis/min/mg. The estimated C s.a. was 29 dis/nrln/mg. 
(i) Incorporation of [2-3H]-1-BromOcodeine into I-Bromomorphine.-
Total 3H activity isolated as l-bromomorphine =417x62.5xTI.5 dis/min. 
18.6 
166. 
% incorporation = 417x62.5x77.5xl0 2 
18.6xo.033SX2.2xl09 
= 0.15% 
14 (11) Estimate of C incorporation (contamination) into 
l-bromomorphine.-
Total 14C activity isolated as l-bromomorphine=29x62.5x71.5 dis/min. 
18.6 
Estimated max.% incorporation =29x62. 5x77 .2 
18.6xO.00456x22xl09 
= 40.04% 
(B) Experimental details associated with Chapter HI. 
Trifluoroacetic acid was used generally without special 
purification. In one experiment (see Chapter In) the acid ~Ias 
rigorously dried by distillation from phosphorus pentoxide. 
Thebaine Methotrifluoroacetate.- Thebaine (3.76 g.) was heated 
under reflux in methanol (50 ml.) containing an excess of methyl 
iodide for 1 hr. The solution was evaporated and 1l1e residue 
dissolved in methanol and treated with silver trifluoroacetate 
(2.5 g.) in methanol (20 ml.). The preCipitated silver iodide was 
filtered off and the filtrate was evaporated to give thebaine 
methotrifluoroacetate (4.5 g.). Recrystallisation from ethanol-
ether gave material (4.1 g.), m.p. 199°C, darkening from 1860 (Found: 
7,8-Dehydrometathebaine Metho-salts.- (a) A solution of 
thebaine methotrifluoroacetate (1 g.) in trifluoroacetic acid (3 ml.) 
was kept at room temperature for 3 hr. then evaporated. The 
residue, in water, was converted into the chloride form by ion-
167. 
-exchange with De-acidite-F'F SRA 70 resin (Permutit Co.Ltd.). 
Evaporation of the aqueous solution gave 7,8-dehydrometathebainone 
methochloride as a yellow resin (0.7 g.). 
(b) Thebaine methotrifluoroacetate (SOO mg.) ~las 
kept in concentrated hydrochloric acid (5 ml.) for 3 hr. at room 
temperature. The acid was evaporated off ~ vacuo over potassium 
hydroxide and phosphorus pentoxide at room temperature. The 
residual methochloride was freed from traces of acid by addition 
and evaporation of methanol. 
Material from preparations (a) and (b) had identical 
spectroscopic properties: \) 
max. 
-1 (NuJol) 1660 cm. • ·~max. 
(EtOH) 304 run (£ 86SO) shifting to 322 (Eo 5680) and 440 run 
(f. 4570) upon addition of sodium ethoxide. Fleischhacker!!.!~. 
for the corresponding perchlorate, \) 1660 cn. -1, 
max. 
A (H20) 312 run (£ 9500). max. Treatment of this amorphous 
methochloride wit~Reinecke's salt, NH4[Cr(NH3)2(CNS)41. H20, 
in water gave the corresponding metho-salt which crystallised from 
o 
water - 5% ethanol as small pink prisms, m.p. 167 C (Found: 
C, 42.2; H, 4.8. 
Metathebainone metho-salts.- 7,8-Dehydrometathebainone 
methochloride (0.3 g.) in methanol (20 ml.) was hydrogenated 
(uptake 2l.7 ml. of H2 ; calc. 21.1 ml.) using 10% palladised 
charcoal as catalyst. Evaporation of the solvent after filtering 
through celi te gave metathebainone methochloride ~ (EtOH) 
max. 
294 run. (€ 11,000) as a green amorphous solid. An aqueous solution 
of the lstter was poured through an ion-exchange column to l3ive 
the corresponding iodide salt, metatheba1none meth01odide; 
168. 
max. 
660 -1 1. cm. A (EtCH) 295 run. (£ 1.1.,000). The 
malt. 
salt could not be obtained crystalline but its u.v. spectrum 
compared well with that of an authentic sample of metathebainone 
methoiodide, ~ 1.660 cm.-l , ~ (EtCH) 294 run. 
max. rnax. 
(f 1.3,700), prepared by treatment of metathebainone with methyl 
iodide. 
1.69. 
Appendix 
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. ' 
Crystallisation of Codeine 
Crystallisation 
1 
2 
3 
4 
3H~c.actiV1tY 
dls/m1n/mg .xl03 
152 
162 
187 
138 
14 3a?-lj C spec.activity C ratio 
dis/min/mg,xl02 
177 8.61:1 ) 
238 6.81:1 ) ) (a) 
264 7.08:1 ) 
217 6.34:1 ~ 
Crystals and mother liquors combined, columned and recrystallisod. 
1 301 275 10.92:1 
All material recomb1ned and further diluted with radioinactive 
codeine (146.6 mg.) 
_xl02 
1 210 28.5 7.10 ) 
2 192 30.2 6.37 ) ) (a) 
3 156 26.4 5.92 ) 
4 161 27.2 5·91 ~ 
5 150 26.5 5.64 
150 26.1 5.70 
6 148 25·3 5.84 
146 25.6 5.71 
7 150 26.4 5.66 
151 26.4 5.72 
8 Picrate 146 25.9 5.65 
formed and regeneratedl49 26.2 5.69 
(a) Averaged values from two determinations. 
Table 1 
171· 
Analysis of the 3 
4 . 
C ratio for the isolated codeine:-
If xi represents 
xi 
5.64 
5.70 
5.85 
5·71 
5.66 
5.72 
5.65 
5.69 
~xi = 45.62 
xi =~xi 
ni 
the 3~4C ratio then:-
2 
xi 
31.81110 
32.49 
34.22 
32.60 
32.04 
32.72 
31.92 
32.38 
2 2 xi = 260.18 
= 45.62 = 5.702 
8 
Z"Xi 
2 
= 260.18 32.522. = 8 
And 
n i 
2 S (xi) = 
Where S is 
ni 
:E - )2 (xi - xi 
n -1 i 
- (1) 
111 the Standard deviution 
Thus S(Xi ) = 0.093. 
The average ~4C value obtained for the codeine precursor 
(x2 ) (before feeding) was 5.32. This was based on only tl'/O 
de terminations and it will be assumed that the standard deviation 
is the same as that determined for the codeine isolated from 
the plant~. 0.093. To determine if the average value of 
the 3~4c ratio for the isolated codeine is significantly 
112 different from that of the precursor material the t-distribution 
test will be used: 
Where Sp is the pooled estimate of the standard deviations. 
172. 
112 The value of t is given by the equation :-
tg = xi - x2 
SPJ~i +! n2 
= 5.702 - 5.32. 
0.0926J~ + f 
= 3.gg 
(2) 
for g degrees 
From tables tg (P=O.05) 5% confidence limit = 2.31 
tg (P=o.Ol) 1% confidence limit = 3.36 
of freedom. 
tg (P=O.005) 0.5% confidence limit = 3.69. 
'!bus even at the 0.5 confidence limit the averaged 3H!4C 
ratio for the precursor and isolated codeine are significantly 
different. 
173. 
Crystallisation of Morphine 
Crystallisation 
1 
2 
3 
4 
5 Le. 46.2 x 10 
3H spec.activity 
2 dis/min/mg.xlO 
419 
381 
290 
320 
176 
158 
163) 
) 162 
159) 
Diacetyl derivative formed:-
131) 
) 127 
124) 
Table 2 
14 C spec.activity 
2 dis/min/mg.xlO 
62.2 
55.3 
48.5 
53.9 
32.0 
28.7 
29.7 ) 
) 29.0 
6.73 
6.88 
5.98 
5·93 
5·50 
5·50 
5·51 
28.4 ) 5.61 
82.7 x 104 dis/min/mmol. 
22.6) 
) 223 
22.1) 
5.70 
5.62 
4 82.4 x 10 dis/min/mmol. 
Analysis of the 3H/4c ratio for the isolated 
morphine :-
~ 
58) 
5.50 
5.51 
5.61 . 
5.70 
5.62 
:iE ~ = 33.44 
2 
x3 
30.25 where ~ represents the 
30.25 3if4C ratio 
30.36 
31.47 
32.49 
31.58 
2 :£ x3 = 186.40 
174. 
= 33.44 = 5.573 
6 
= 186.40 = 31.066 
6 
2 III 2 Thus S (X-) = 186.40 - (33.44) 
J 6 
---:::5--=---
= 0.006 
= 0.077 •. 
The pooled estimate of the standard deviations (Sp) for 
the precursor and isolated morphine are given as fo11o\-/s:-
Sp = 
= 8 -2 7.9 x 10 
Using equation (2) 
t6 = 5.573 - 5.32 
lf1 1 0.079~ b + r 
= 2.93 
From tables t6 (P = 0.05) 5% confidence limit = 2.45. 
t6 (p = 0.01) 1% confidence limit = 4.32. 
Thus the 3~4c ratio for the isolated morphine is Significantly 
different from that of the precursor at the 5% confidence 
limit. However, the two ratios are not significantly 
different at the 1% confidence limit. 
175. 
-'1 
Difference between 3 4c ratios for isolated codeine and morphine:-
The pooled estimate of the standard deviations Sp is 
0.0798 (as before) 
= 5.702 - 5.573 
: ,/1 1 0.0798",B + b 
= 3.01 
From tables t12 (P = 0.05) 5)~ confidence limit = 2.18 
t12 (p = 0.01) 1% confidence limit = 3.05. 
Thus the 3~4C ratio for both the isolated codeine and 
morphine are Significantly different at the 1% confidence limit. 
Thus after metabolism the 3~4c ratio of the isolated 
codeine and morphine differ from each other, and both are at 
variance with the ratio determined for the codeine precursor. 
In each case the ratio determined for the isolated alkaloids is 
greater than that determined for the precursor and this is most 
14 likely to have occurred by loss of C activity. A possible 
explanation is that, after injection of the codeine precursor 
and after subsequent mixing, some de-!-methylation occurs 
giving rise to an equilibriurJ between codeine and de-N-
methylated codeine. Some of the codeine pool, which \,/ould 
form the major fraction of the equilibrium, could then be 
metabolised to give morphine. The morphine itself may then 
undergo some de-~-methylation leading to 
activity. Thus at the time of worl~-up 
14 
a small loss of C 
the 3~4c ratio for 
the metabolites would be greater than for the precursor. This 
of course presupposes that the precursor material undergoes 
Bome sort of "mixing" process with the plant alkaloids alrcady 
present'; The complete mixing process will take a fin! te time, 
and it must be assumed that this is exceeded by the period of 
time allowed for feeding experiment. 
176. 
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